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Abstract 
Background: Endodontic management of immature necrotic permanent teeth is 
currently undergoing a paradigm shift from the conventional apexification and 
apical plug techniques to biological based regenerative procedures.  The shift 
towards a tissue engineered clinical based procedure is highly attractive.  
However, the ideal scaffold to support pulp-dentine complex regeneration is yet 
to be identified. 
Aim: The primary aim of this work was to develop, characterise, and assess the 
biocompatibility of an acellular extracellular matrix scaffold developed through 
decellularisation of rat and human dental pulp tissues.  The secondary aim was 
to assess the ability of the scaffold to support human dental pulp stem cells 
attachment, viability, and differentiation. 
Methods: Following ethical approval, rat and human dental pulps were 
retrieved and decellularised.  The efficiency of the decellularised protocol was 
assessed using histology and immunohistochemistry staining methods, 
scanning electron microscopy, and DNA quantification assays.  Contact and 
extract cytotoxicity assays were performed to determine the biocompatibility of 
the developed scaffold.  Decellularised scaffolds were recellularised with human 
dental pulp stem cells and cell viability was assessed, for up to 14 days, in 
culture.  Expression of odontoblastic markers and molecular proteins within the 
recellularised scaffold were also investigated.  Quantitative data were analysed 
using Student’s t-test and one-way analysis of variance using GraphPad Prism 
(Version 6). 
Results:  Assessment of decellularised scaffolds revealed an acellular matrix 
with preservation of the connective tissue architecture and composition.  
Acellular scaffolds were biocompatible with normal cell growth in direct contact 
with the acellular scaffold.  No difference in cellular activity was found following 
incubation in acellular scaffold extracts (p > 0.05).  Live/Dead® confocal imaging 
viii 
 
showed high majority of viable cells.  Furthermore, the scaffold was able to 
support human dental pulp stem cells viability and attachment following 
recellularisation.  Immunolabelling of dental pulp stem cells within the 
recellularised scaffold revealed a positive expression against several tested 
odontoblastic markers and molecular proteins. 
Conclusion:  The decellularisation protocol used showed promising results 
following decellularisation of rat and human dental pulp tissues in terms of 
developing an acellular biological scaffold with preserved extracellular structural 
components required for tissue specific regeneration. 
ix 
 
Table of Contents 
Acknowledgements .................................................................................... iii 
Dedication.................................................................................................... vi 
Abstract ...................................................................................................... vii 
Table of Contents ........................................................................................ ix 
List of Figures ........................................................................................... xiv 
List of Tables ........................................................................................... xviii 
List of Abbreviations ................................................................................ xix 
 Literature review ......................................................................... 1 Chapter 1
Introduction: .............................................................................................. 1 
1.1 The dental pulp: ................................................................................ 3 
1.1.1 Dental pulp composition: ......................................................... 5 
1.2 Pulpal necrosis in the developing child: .......................................... 11 
1.3 Endodontic management of immature teeth with pulpal necrosis: .. 12 
1.3.1 Calcium hydroxide apexification: ........................................... 12 
1.3.2 Apical plug techniques: ......................................................... 14 
1.3.3 Regenerative endodontic procedures: .................................. 16 
1.4 Tissue engineering of the dental pulp: ............................................ 21 
1.4.1 Stem cells for dental pulp tissue regeneration:...................... 22 
1.4.2 Signalling molecules for dental pulp tissue regeneration: ..... 26 
1.4.3 Scaffolds for dental pulp tissue regeneration: ....................... 27 
1.5 Tissue decellularisation: ................................................................. 39 
1.5.1 Tissue decellularisation process: .......................................... 40 
1.6 In summary: .................................................................................... 45 
x 
 
1.7 Aim and objectives: ........................................................................ 46 
 General Materials and Methods .............................................. 47 Chapter 2
2.1 General materials: .......................................................................... 47 
2.1.1 Equipment and consumables: ............................................... 47 
2.1.2 Chemicals, reagents and kits: ............................................... 50 
2.1.3 Antibodies: ............................................................................ 52 
2.1.4 Isotype controls: .................................................................... 55 
2.2 General methods: ........................................................................... 56 
2.2.1 Tissue procurement: ............................................................. 56 
2.2.2 Tissue decellularisation: ........................................................ 57 
2.2.3 General histological technique: ............................................. 60 
2.2.4 Histological staining methods: ............................................... 62 
2.2.5 Immunohistochemical labelling: ............................................ 65 
2.2.6 DNA quantification assay: ..................................................... 67 
2.2.7 Scanning electron microscope: ............................................. 69 
2.2.8 Cell culture techniques: ......................................................... 69 
2.2.9 Cytotoxicity evaluation: ......................................................... 73 
2.2.10 Recellularisation of decellularised scaffold with dental pulp 
stem cells: ............................................................................. 76 
2.2.11 Cell viability assay: ................................................................ 77 
2.2.12 Statistical analysis: ................................................................ 78 
 Decellularisation of the dental pulp tissues ........................... 79 Chapter 3
3.1 Introduction: .................................................................................... 79 
3.2 Aim and objectives: ........................................................................ 83 
3.2.1 Aim: ....................................................................................... 83 
xi 
 
3.2.2 Objectives: ............................................................................ 83 
3.3 Methods and experimental approaches: ......................................... 84 
3.3.1 Experiment 1: ........................................................................ 84 
3.3.2 Experiment 2: ........................................................................ 86 
3.4 Results: .......................................................................................... 89 
3.4.1 Results of experiment 1: ....................................................... 89 
3.4.2 Results of experiment 2: ....................................................... 93 
3.5 Discussion: ..................................................................................... 98 
 Characterisation of the developed decellularised dental pulp Chapter 4
tissue ................................................................................................ 103 
4.1 Introduction: .................................................................................. 103 
4.2 Aim and objectives: ...................................................................... 107 
4.2.1 Aim: ..................................................................................... 107 
4.2.2 Objectives: .......................................................................... 107 
4.3 Methods and experimental approaches: ....................................... 108 
4.3.1 Histology characterisation of rat and human pulp tissues: .. 108 
4.3.2 Immunohistochemical labelling of rat and human pulp tissues:
 108 
4.3.3 Scanning electron microscope evaluation: .......................... 109 
4.4 Results: ........................................................................................ 110 
4.4.1 Histological evaluation of native and decellularised dental pulp 
tissues: ................................................................................ 110 
4.4.2 Immunohistochemical evaluation of native and decellularised 
dental pulp tissues: ............................................................. 117 
4.4.3 Scanning electron microscope evaluation: .......................... 132 
4.5 Discussion: ................................................................................... 135 
xii 
 
 Cytotoxicity assessment and recellularisation of the Chapter 5
decellularised scaffold .................................................................... 140 
5.1 Introduction: .................................................................................. 140 
5.2 Aim and objectives: ...................................................................... 145 
5.2.1 Aim: ..................................................................................... 145 
5.2.2 Objectives: .......................................................................... 145 
5.3 Methods and experimental approaches: ....................................... 146 
5.3.1 Cytotoxicity evaluation of decellularised rat and human 
scaffolds: ............................................................................. 146 
5.3.2 Cell seeding density: ........................................................... 148 
5.3.3 Cell viability assay of rat and human scaffolds: ................... 149 
5.3.4 Recellularisation of rat scaffolds using DPSCs: .................. 149 
5.4 Results: ........................................................................................ 151 
5.4.1 Cytotoxicity evaluation of decellularised rat and human 
scaffolds: ............................................................................. 151 
5.4.2 Cell viability assay of rat and human scaffolds: ................... 155 
5.4.3 Recellularisation of rat scaffolds using DPSCs: .................. 157 
5.5 Discussion: ................................................................................... 170 
 General discussion, future work, and conclusions ............. 175 Chapter 6
6.1 General discussion: ...................................................................... 175 
6.2 Conclusions: ................................................................................. 189 
6.3 Recommendations for future work and clinical translation: ........... 190 
xiii 
 
References................................................................................................ 197 
Appendices............................................................................................... 224 
Appendix (A): Tissue bank approval form for teeth collection and the 
use of dental pulp stem cells.......................................................... 224 
Appendix (B): Percentage of pulp tissue water content ....................... 225 
Appendix (C): National and international poster/oral presentations and 
awards achieved. ............................................................................. 226 
xiv 
 
List of Figures 
Figure  1.1: Histological zones of the native dental pulp. ................................ 4 
Figure  1.2: Schematic illustration of tissue engineering elements................ 22 
Figure  1.3: Schematic illustration of tooth derived stem cells. ..................... 25 
Figure  2.1: DNA extraction protocol. ............................................................ 68 
Figure  2.2: Seeding rotator apparatus. ........................................................ 77 
Figure  3.1: Process flow diagram of decellularisation experiment 1. ........... 85 
Figure  3.2: Representative images of decellularised human pulp tissues. ... 86 
Figure  3.3: Process flow diagram of decellularisation experiment 2. ........... 88 
Figure  3.4: Representative images of H&E stained human tissues viewed 
under the light microscope. .......................................................................... 91 
Figure  3.5: Representative images of DAPI stained human pulp tissues 
viewed under the fluorescent microscope. ................................................... 92 
Figure  3.6: Representative images of H&E stained rat pulp tissues viewed 
under the light microscope. .......................................................................... 94 
Figure  3.7: Representative images of DAPI stained rat pulp tissues viewed 
under the fluorescent microscope. ............................................................... 94 
Figure  3.8: Representative images of H&E stained human pulp tissues 
viewed under the light microscope. .............................................................. 95 
Figure  3.9: Representative images of DAPI stained human pulp tissues 
viewed under the fluorescent microscope. ................................................... 95 
Figure  3.10: DNA content of native and decellularised rat pulp tissue 
following DNA extraction determined by NanoDrop™ 2000 
spectrophotometer. ...................................................................................... 97 
xv 
 
Figure  3.11: DNA content of native and decellularised human pulp tissues 
following DNA extraction determined by NanoDrop™ 2000 
spectrophotometer. ...................................................................................... 97 
Figure  4.1: Representative images of Alcian blue stained rat pulp tissues 
viewed under the light microscope. ............................................................ 111 
Figure  4.2: Representative images of Alcian blue stained human pulp tissues 
viewed under the light microscope. ............................................................ 112 
Figure  4.3: Representative images of Picrosirius red stained rat pulp tissues 
viewed under the light microscope. ............................................................ 114 
Figure  4.4: Representative images of Picrosirius red stained human pulp 
tissues viewed under the light microscope. ................................................ 114 
Figure  4.5: Representative images of Picrosirius red stained rat pulp tissues 
viewed under polarised microscope. .......................................................... 115 
Figure  4.6: Representative images of Picrosirius red stained human pulp 
tissues viewed under the polarised microscope. ........................................ 116 
Figure  4.7: Representative images of rat pulp tissues labelled with collagen 
type I antigen viewed under the light microscope. ..................................... 118 
Figure  4.8: Representative images of human pulp tissues labelled with 
collagen type I antigen viewed under the light microscope. ....................... 119 
Figure  4.9: Representative images of rat pulp tissues labelled with collagen 
type III antigen viewed under the light microscope. ................................... 121 
Figure  4.10: Representative images of human pulp tissues labelled with 
collagen type III antigen viewed under the light microscope. ..................... 122 
Figure  4.11: Representative images of rat pulp tissues labelled with 
fibronectin antigen and viewed under the light microscope. ....................... 124 
Figure  4.12: Representative images of human pulp tissues labelled with 
fibronectin antigen and viewed under the light microscope. ....................... 125 
xvi 
 
Figure  4.13: Representative images of rat pulp tissues labelled with laminin 
antigen viewed under the light microscope. ............................................... 127 
Figure  4.14: Representative images of human pulp tissues labelled with 
laminin antigen viewed under the light microscope. ................................... 128 
Figure  4.15: Representative images of rat pulp tissues labelled major 
histocompatibility complex class II antigen and viewed under the light 
microscope................................................................................................. 130 
Figure  4.16: Representative images of human pulp tissues labelled major 
histocompatibility complex class II antigen and viewed under the light 
microscope................................................................................................. 131 
Figure  4.17: Representative images of rat pulp tissues viewed using the 
scanning electron microscope.................................................................... 133 
Figure  4.18: Representative images of human pulp tissues viewed using the 
scanning electron microscope.................................................................... 134 
Figure  5.1: Optimisation of cell seeding density. ........................................ 149 
Figure  5.2:  Contact cytotoxicity assays of decellularised rat scaffolds 
cultured with L-929 cell line for 48 hours, stained with Giemsa stain and 
viewed under brightfield illumination. ......................................................... 152 
Figure  5.3: Contact cytotoxicity assays of decellularised human scaffolds 
cultured with L-929 cell line for 48 hours, stained with Giemsa stain and 
viewed under brightfield illumination. ......................................................... 152 
Figure  5.4: Controls used for contact cytotoxicity assays cultured with L-929 
cell line for 48 hours, stained with Giemsa stain and viewed under brightfield 
illumination. ................................................................................................ 153 
Figure  5.5: Extract cytotoxicity assay measuring the relative cellular ATP 
content of decellularised rat extracts following 24 hour culture. ................. 154 
Figure  5.6: Extract cytotoxicity assay measuring the relative cellular ATP 
content of decellularised human extracts following 24 hour culture. .......... 155 
xvii 
 
Figure  5.7: Cell viability assay of decellularised rat scaffolds seeded with 
DPSCs and analysed with Live/Dead® stain using laser confocal microscopy.
 ................................................................................................................... 156 
Figure  5.8: Cell viability assay of decellularised human scaffolds seeded with 
DPSCs and analysed with Live/Dead® stain using laser confocal microscope.
 ................................................................................................................... 156 
Figure  5.9: Representative images of H&E stained recellularised rat scaffolds 
seeded with DPSCs following 7 days culture viewed under the light 
microscope................................................................................................. 158 
Figure  5.10: Representative images of H&E stained recellularised rat 
scaffolds seeded with DPSCs following 14 days culture viewed under the 
light microscope. ........................................................................................ 159 
Figure  5.11: Representative images of recellularised rat scaffolds labelled 
with DSPP antigen and viewed under the light microscope. ...................... 161 
Figure  5.12: Representative images of recellularised rat scaffolds labelled 
with DMP-1 antigen and viewed under the light microscope. ..................... 162 
Figure  5.13: Representative images of recellularised rat scaffolds labelled 
with ALP antigen and viewed under the light microscope. ......................... 163 
Figure  5.14: Representative images of recellularised rat scaffolds labelled 
with vimentin antigen and viewed under the light microscope. .................. 164 
Figure  5.15: Representative images of recellularised rat scaffolds labelled 
with nestin antigen and viewed under the light microscope. ...................... 165 
Figure  5.16: Representative images of recellularised rat scaffolds labelled 
with α-SMA antigen and viewed under the light microscope. ..................... 166 
Figure  5.17: Representative images of recellularised rat scaffolds labelled 
with VEGF-A antigen and viewed under the light microscope. .................. 168 
Figure  5.18: Representative images of recellularised rat scaffolds labelled 
with VEGFR-2 antigen and viewed under the light microscope. ................ 169 
xviii 
 
List of Tables 
Table  1.1: Classification of stem cells .......................................................... 24 
Table  1.2: Classification of tooth derived stem cells .................................... 25 
Table  1.3: Scaffold performance used for pulp-dentine complex regeneration
 ..................................................................................................................... 31 
Table  2.1: General laboratory equipment used throughout the study .......... 47 
Table  2.2: General laboratory consumables used throughout the study ...... 49 
Table  2.3: Chemicals, reagents and kits used throughout the study ............ 50 
Table  2.4: Details of primary antibodies, the corresponding antigen retrieval 
method and isotypes used throughout the study.......................................... 53 
Table  2.5: Isotype controls used throughout the study ................................. 55 
Table  2.6: Tissue processor protocol ........................................................... 61 
Table  2.7: Cell types used throughout the study .......................................... 70 
 
  
xix 
 
List of Abbreviations 
% Percentage 
°C Degree Celsius 
µ Micron 
µg Microgram 
µL Microliter 
µm Micrometer 
ALP Alkaline phosphatase 
ANOVA Analysis of variance 
Ca(OH)2 Calcium hydroxide 
Ca2+ Calcium 
CO2 Carbon dioxide 
DAB 3,3` -diaminobenzidine 
DAPI  4′,6-diamidino-2-phenylindole 
DMEM Dulbecco’s modified Eagle’s medium 
DMP-1 Dentine matrix protein-1 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
DPSCs Dental pulp stem/stromal cells 
DSPP Dentine sialophosphoprotein 
ECM Extracellular matrix 
EDTA Ethylene-diamine-tetra-acetic acid 
FBS Foetal bovine serum 
xx 
 
GAG Glycosaminoglycan 
H&E Haematoxylin and eosin 
HERS Hertwig’s epithelial root sheath 
KIU Kallikrein inhibitor unit 
mg Milligram 
Mg2+ Magnesium 
MHC Major histocompatibility 
mL Milliliter 
MTA Mineral trioxide aggregate 
PBS Phosphate-buffered saline 
RNA Ribonucleic acid 
RNase Ribonuclease 
rpm Revolutions per minute 
SAPs Self-assembling peptides  
SCAP Stem cells from apical papilla 
SDS Sodium dodecyl sulphate 
SEM Scanning electron microscope 
SHED 
Stem cells from human exfoliated 
deciduous teeth 
TBS Tris-buffered saline 
U Units 
VEGF Vascular endothelial growth factor 
VEGFR-2 
Vascular endothelial growth factor 
receptor-2 
 α-gal Alpha-1,3 Galactose 
α-SMA Alpha-smooth muscle actin 
 1 
 
  Chapter 1
Literature review 
Introduction: 
Endodontic management of immature permanent teeth with necrotic (non-vital) 
pulps is one of the challenging fields in paediatric dentistry.  The clinical 
management of these teeth has evolved throughout the years.  Conventional 
management included promoting a calcific apical barrier through the use of 
calcium hydroxide apexification or creating an artificial apical barrier using 
mainly Mineral Trioxide Aggregate (Duggal et al., 2017).  Despite the clinical 
success of these techniques in the short term, these techniques do not 
contribute to any quantitative increase in root length or thickening of root 
dentinal walls (Petrino et al., 2010; Torabinejad and Abu-Tahun, 2010). 
Recently, the field of dental tissue regeneration has emerged as a new area of 
research with huge potentials for dental pulp regeneration.  Regenerative 
endodontic (revitalisation) procedures are increasingly used in the treatment of 
immature necrotic permanent teeth (Galler, 2016).  Clinically this treatment 
involves root canal disinfection followed by inducing apical bleeding within the 
root canal space (Iwaya et al., 2001; Banchs and Trope, 2004).  Unfortunately, 
the early optimism for using regenerative endodontic procedures in the 
management of immature necrotic teeth has now faded, due to the 
unpredictability in promoting continuation of root development and non-specific 
tissue formation (Jung et al., 2008; Chen et al., 2012; Nosrat et al., 2012).  
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Several reasons for these unpredictable results were suggested (Nazzal and 
Duggal, 2017) such as the effect of disinfectant on stem cells, effect of 
intracanal medicaments on stem cells, the lack of specific growth factors, and 
the controversial use of a blood clot as a scaffold (Ding et al., 2009; Petrino et 
al., 2010; Lenzi and Trope, 2012). 
Therefore, development of regenerative endodontic procedures utilising more 
advanced tissue engineering principles has been recommended (Nör, 2006; 
Cordeiro et al., 2008; Garcia-Godoy and Murray, 2012; Conde et al., 2015) in 
order to guide cells for targeted regeneration of pulp tissues rather than healing 
as seen with the current procedures. 
The selection of an appropriate scaffold is vital for successful tissue 
engineering.  These scaffolds provide sites for cell adhesion, proliferation and 
differentiation.  Various natural and synthetic scaffold materials have been 
tested in an attempt to regenerate the pulp-dentine complex, however, limited 
success has been reported.  Limited control over newly formed tissue, low cell 
survival following implantation, toxicity and biocompatibility concerns still exists 
(Murray et al., 2007).  To overcome previous material limitations, biological 
scaffolds composed of an acellular extracellular matrix developed though the 
process of decellularisation has been advocated (Gilbert et al., 2006; Crapo et 
al., 2011).  The extracellular matrix is a vital and dynamic tissue component 
composed of structural and functional proteins and regarded as the ideal 
scaffold for tissue engineering (Badylak, 2002; Badylak et al., 2009). 
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1.1 The dental pulp: 
Tooth formation occur as a result of interaction between epithelium derived from 
the first branchial arch and ectomesenchymal cells of neural crest origin.  
Developmentally, tooth formation originates from the tooth germ.  The tooth 
germ consists of two components: (i) The ectodermal component (enamel 
organ) which consequently forms enamel; (ii) The ectomesenchymal 
component (dental papilla and dental follicle).  The dental papilla is responsible 
for dentine and pulp formation, while the dental follicle forms cementum and 
tooth supporting structures, the periodontal ligament (Kumar, 2014).  Following 
formation, a dental tooth consists of three mineralised outer layers (enamel, 
dentine and cementum) surrounding a non-mineralised vital pulp tissue (Veis 
and Goldberg, 2014). 
Structurally the dental pulp is a rich cellular, highly vascularised and innervated 
connective tissue.  This unique structure contributes to several functions (Yu 
and Abbott, 2007; Pashley et al., 2008).  Specialised cells of the pulp, the 
odontoblasts’, have a unique ability to form dentine throughout life.  These 
specialised cells together with the underlying blood supply provide nutrition to 
the dentine structure (Yu and Abbott, 2007).  The pulp tissue also contains 
defence cells with the ability to initiate an immune reaction when required (Yu 
and Abbott, 2007). 
Histologically and microscopically, the dental pulp is classically described as 
four zones or regions (Figure  1.1): (i) The odontoblastic (or more precisely the 
sub-odontoblastic) zone is the outermost layer adjacent to dentine and 
composed of cell bodies of the odontoblasts’, capillaries, nerve fibres and 
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dendritic cells; (ii) The so-called cell free (Weil’s) zone (now recognised as a 
fixation artefact) is located adjacent to the sub-odontoblastic zone, devoid of 
cells and transversed by plexuses of capillaries and nerve fibres; (iii) The cell 
rich zone is a highly cellular area located between the cell free zone and pulp 
core; (iv) The central pulp core (pulp proper) zone contains the principal support 
system namely large blood vessels, unmyelinated nerve trunks with collagen 
and ground substances forming the main connective tissue components of this 
zone (Pashley et al., 2008; Goldberg, 2014b; Goldberg, 2014a; Kumar, 2014).  
The dental pulp is described as a specialised loose areolar connective tissue, 
principally composed of cells that secrete and organise its collagen rich 
extracellular matrix (ECM).  Additional supportive elements include blood 
supply, lymphatic supply and nerve fibre bundles (Pashley et al., 2008; 
Goldberg, 2014b; Goldberg, 2014a; Kumar, 2014).  
 
Figure ‎1.1: Histological zones of the native dental pulp. (od) Sub-odontoblastic layer, (cf) 
Cell free zone, (cr) Cell rich zone and (pc) Pulp core. Scale bar at 50 µm. 
 
od 
cf 
cr 
pc 
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1.1.1 Dental pulp composition: 
1.1.1.1 Cells of the dental pulp: 
The pulpal tissue is occupied by two types of cells known as resident and 
non-resident cells.  Non-resident cells form the minority of cells within the dental 
pulp.  These originate or migrate from distant tissues and enter the pulp tissue 
through its apical part.  In contrast, resident cells are considered the main type 
of pulp cells due to their important structural role in shaping the pulp tissue 
construction (Goldberg, 2014b), through the formation and turnover of the non-
mineralised matrix (Goldberg and Smith, 2004). 
Pulp fibroblasts (pulpoblasts) are the most abundant cell type of the dental pulp 
and are largely involved in the synthesis and secretion of collagen fibres and 
ECM components.  Fibroblast cells are elongated spindle shaped cells with a 
large ovoid nucleus.  They contain long protracted processes that connect with 
other fibroblasts through intercellular junctions, desmosome-like and gap 
junctions facilitating cellular communications (Goldberg and Smith, 2004; 
Pashley et al., 2008; Goldberg, 2014b; Kumar, 2014). 
Odontoblastic cells are the second most numerous cell type of the dental pulp 
and are known to be involved in production of the dentine matrix, 
dentinogenesis.  The odontoblasts’ are consistently located in the odontoblastic 
region of the dental pulp and consist of cell bodies and cell processes.  The cell 
processes extend across the pre-dentine and enter the dentinal tubules 
(Pashley et al., 2008; Goldberg, 2014b; Kumar, 2014). 
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Defence cells are equally important and present in the dental pulp, they are 
known to express major histocompatibility complex class II molecules (Jontell et 
al., 1987; Ohshima et al., 1999; Goldberg, 2014a).  In the normal healthy pulp, 
these cells mainly include macrophages (histiocytes), dendritic cells and 
T-lymphocytes playing an important role in immune-surveillance of the pulp 
tissue.  These immune cells phagocytose and eliminate bacteria and apoptotic 
bodies from the pulp tissue (Goldberg, 2014a). 
A limited number of B-lymphocytes, eosinophils and mast cells are also present 
in the healthy pulp (Goldberg and Smith, 2004).  Following pulp injury and 
inflammation a considerable change in the types of defence cells occurs.  
Increase numbers of B-lymphocytes, eosinophils, mast cells with the 
appearance of neutrophils and plasma cells become present in the inflamed 
pulp (Goldberg and Smith, 2004; Pashley et al., 2008; Goldberg, 2014b; Kumar, 
2014). 
Progenitor cells have also been isolated from the dental pulp tissue.  Within the 
dental pulp, these cells represent a small population of undifferentiated stem 
cells accounting for approximately 1 – 2 % of total cell population (Sloan and 
Waddington, 2009; Goldberg, 2014a).  In the adult dental pulp, these cells were 
identified by Gronthos et al. (2000) and termed dental pulp stem cells (DPSCs).  
These mesenchymal derived stem cells are characterised as undifferentiated 
cells with the ability to differentiate into multilineage cells (Sloan and 
Waddington, 2009; Egusa et al., 2012; Lee et al., 2014). 
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1.1.1.2 Extracellular matrix of the dental pulp: 
1.1.1.2.1 Collagen: 
Collagen fibres are a family of fibrous proteins and regarded as the most 
abundant proteins in the ECM of all connective tissues (Gelse et al., 2003).  
They play an essential part in constructing and maintaining the histoarchitecture 
of tissues and organs (Linde, 1985; Goldberg and Smith, 2004) and regarded 
as the fibrillar backbone of the ECM (Gelse et al., 2003).  Collagen fibres are 
synthesised and maintained by resident cells, predominately fibroblasts (Gelse 
et al., 2003; Ricard-Blum and Ruggiero, 2005). 
On a molecular level, several types of collagen fibres have been identified.  
These fibres are characterised by a triple helix structure consisting of three 
polypeptide chains (Gelse et al., 2003; Ricard-Blum and Ruggiero, 2005).  The 
triple helix structure, in collagen type I, is known to be a heteropolymer chain 
consisting of two identical alpha1-chains and one alpha2-chain.  In contrast, 
collagen type III is a homopolymer chain consisting of three alpha1-chains 
(Linde, 1985; Gelse et al., 2003; Ricard-Blum and Ruggiero, 2005). 
The main types of collagen fibres present within the dental pulp include collagen 
type I and type III which account for 56 % and 41 % of total collagen, 
respectively (van Amerongen et al., 1984; Goldberg and Smith, 2004).  
Collagen type V (2 %) and VI (0.5 %) are also present at lesser amounts 
(Goldberg and Smith, 2004). 
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1.1.1.2.2 Fibronectin: 
Fibronectin is a non-collagenous adhesive protein present in the pulp matrix 
(Linde et al., 1982; Veis and Goldberg, 2014).  They are a class of high-
molecular weight structures with an approximate size of 500 kilodaltons (Hynes, 
1985).  On a molecular level, fibronectin is composed of two large subunits 
joined by disulfide bonds (Hynes, 1985; Martinez et al., 2000).  Fibronectin 
exists either in a soluble form, present in blood, or an insoluble form, present in 
the ECM (Hynes, 1985).  Fibronectin proteins are known to mediate cell-cell 
and cell-matrix  interactions (Linde et al., 1982).  These interactions have 
profound effects on a variety of cell functions including adhesion, migration, 
growth, and differentiation (Hynes, 1985; Linde, 1985).   
1.1.1.2.3 Laminin: 
Laminin is a major basement membrane adhesive protein with a large 
molecular size of 400 to 900 kilodaltons (Aumailley et al., 2005).  On a 
molecular level, over 15 laminin isoforms have been identified. They are 
structured as multidomain heterotrimers consisting of alpha (α), beta (β) and 
gamma (γ) chain subunits (Colognato and Yurchenco, 2000; Aumailley et al., 
2005).  Laminin proteins provide unique cellular interactions mediated through 
cell surface receptors and integrin’s.  These interactions contribute towards cell 
adhesion, differentiation, and migration (Aumailley et al., 2005).  During tooth 
formation, laminin proteins regulate peripheral nerve fibres development and 
maturation (Fried et al., 2005). 
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1.1.1.2.4 Proteoglycans and glycosaminoglycans: 
The ground substance of the pulp tissue is largely composed of proteoglycans, 
glycosaminoglycans (GAGs) and water.  On a molecular level, proteoglycans 
consist of a central protein core covalently linked to side chains of GAGs 
present within the ECM (Linde, 1985). Based on their molecular weight, small 
(biglycan and decorin) and large (versican) proteoglycans occupy the pulp 
tissue (Goldberg and Smith, 2004; Veis and Goldberg, 2014). 
GAGs, also known as acidic mucopolysaccharides, are linear polymers 
consisting of repeating disaccharides.  Within the pulp tissue matrix, GAGs 
attach to proteoglycans and constitute approximately 50 % to 90 % of their 
molecular weight (Linde, 1985).  Several types of GAGs are present within the 
dental pulp including chondroitin 4- and 6-sulphate, dermatan sulphate, heparan 
sulphate, hyaluronan and  keratan sulphate (Linde, 1985; Goldberg and Smith, 
2004).  GAGs play important roles in several tissue functions.  They regulate 
water flow and retention, protect against high tissue pressure, transport 
nutrients and waste, and provide binding sites for several cell surface receptors 
and growth factors (Linde, 1973; Kumar, 2014). 
1.1.1.3 Supportive elements of the dental pulp: 
In addition to the above cellular and structural elements, the pulp tissue is a vital 
organ composed of a complex rich network of nerve fibres, lymphatics, and 
blood vascularisation (Goldberg, 2014a). 
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The blood supply of the highly vascularised pulp tissue arises from the superior 
or inferior alveolar artery (Kumar, 2014).  Due to the small size of the pulp 
tissue, the blood vessels mainly consist of arterioles branching into terminal 
arterioles and capillaries.  This pulpal blood flow system is regulated by 
vasoconstriction and vasodilatation actions (Pashley et al., 2008; Goldberg, 
2014b; Kumar, 2014). 
The lymphatic system is implicated in tissue fluid balance and as an immune 
barrier.  They consist of lymphatic capillaries that coalesce with each other 
forming collecting vessels (Pashley et al., 2008; Goldberg, 2014b; Kumar, 
2014). 
The pulp tissue is well innervated with sensory afferent fibres arising from the 
trigeminal ganglion penetrating the root apex into the dental pulp.  The majority 
of nerve fibre bundles, approximately 70 %, contain axons of nonmyelinated 
nerve sheaths that are mainly sympathetic in nature.  Myelinated sensory nerve 
sheaths, approximately 20 – 30 %, that mediate pain sensation are also present 
(Goldberg, 2014a).  These large myelinated fibres branch peripherally in the 
cell-rich zone forming a parietal layer of nerves termed plexus of Raschkow 
(Pashley et al., 2008; Kumar, 2014; Veis and Goldberg, 2014). 
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1.2 Pulpal necrosis in the developing child: 
On average, root formation in the permanent dentition usually completes three 
years following emergence of the tooth in the oral cavity (Kumar, 2014).  
Unfortunately, during this early age, loss of vitality (pulp necrosis) is not 
uncommon.  Several factors including developmental anomalies, dental caries 
and dental trauma can consequently lead to pulp necrosis therefore arresting 
further root development (Diogenes et al., 2013).  The United Kingdom’s child 
dental health survey, carried out in 2003, reported 5 % of 8 year old children 
suffering dental trauma of their anterior teeth with 52 % showing obvious decay 
experience (Lader et al., 2003).  Failure to seal permanent teeth with 
developmental defects such as dens invaginatus and dens evaginatus, although 
to a lesser extent in United Kingdom, can lead to pulpal necrosis.  Loss of 
pulpal vitality prior to root completion results in immature permanent teeth with 
compromised crown to root ratio, thin dentinal walls, and wide open apices 
(Cvek, 1992; Andreasen et al., 2002; Al Ansary et al., 2009).  Indeed, these 
teeth are associated with poor long term survival rates (Cvek, 1992; Jeeruphan 
et al., 2012). 
The early loss of a permanent tooth, especially an anterior tooth, in a growing 
child leads to lifelong consequences (Diogenes et al., 2016).  These 
consequences include malocclusion, altered bone development, and 
interference with speech and masticatory functions (Diogenes et al., 2014; 
Diogenes et al., 2016).  Within the anterior region, changes in dental aesthetics 
including tooth position or colour change is associated with detrimental effects 
on the child’s social and psychological aspects (Traebert et al., 2012).  
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1.3 Endodontic management of immature teeth with pulpal 
necrosis: 
Endodontic management of immature permanent teeth with necrotic pulps 
remains a challenge in clinical dentistry.  Conventional root canal treatment is 
the therapy of choice for most necrotic permanent teeth with complete root 
formation.  While the outcome of conventional endodontic treatment is usually 
excellent in mature teeth, high risks of cervical root fractures are associated 
with endodontically treated immature permanent teeth (Cvek, 1992). 
The two main conventional techniques widely used include calcium hydroxide 
apexification and mineral trioxide aggregate apical plug technique.  More 
recently, newer treatment strategies based on the regenerative ability of the 
pulp tissue are increasingly being used. 
1.3.1 Calcium hydroxide apexification: 
Calcium hydroxide [Ca(OH)2] apexification is defined as a clinical method to 
induce apical closure of the open apex by means of a calcified hard tissue 
barrier formation against which a permanent obturation material can be placed 
(Glossary of Endodontic Terms 9th edition, 2016.).  Chemically, Ca(OH)2 is 
classified as a strong base with high pH (approximately 12.5 - 12.8).  This 
characteristic feature plays an important role in the production of a calcified 
barrier and hard tissue formation when used in apexification cases (Rafter, 
2005; Mohammadi and Dummer, 2011). 
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Clinically the use of Ca(OH)2 for the treatment of immature teeth has been 
regarded as a reliable technique with consistent clinical results (Rafter, 2005; 
Duggal et al., 2017).  However, the formation of the apical barrier requires 
multiple visits of repeated root canal dressing requiring prolonged treatment 
periods (Rafter, 2005; Duggal et al., 2017).  Variation exists in the literature with 
regards to the required time for formation of the hard tissue barrier, with an 
average between 6 to 24 months (Dominguez Reyes et al., 2005; Rafter, 2005; 
Moule and Moule, 2007; Mohammadi and Dummer, 2011).  Observational 
analysis under the scanning electron microscope revealed the formation of a 
calcified barrier with a porous irregular layered structure (Walia et al., 2001). 
Furthermore, the frequency of cervical root fracture in immature teeth treated 
with Ca(OH)2 apexification was increasingly documented.  A retrospective 
clinical study with a 4 year follow-up of traumatised non-vital maxillary teeth 
following Ca(OH)2 apexification reported a high frequency of cervical root 
fracture (Cvek, 1992).  The fractures were more commonly associated with 
immature teeth compared to mature teeth (28 % to 77 % depending on root 
development stage).  The fractures were associated with weak forces, 
suggesting that prolonged contact between Ca(OH)2 and the root dentine may 
increase the brittleness of dentine (Cvek, 1992). 
This assumption was confirmed by several studies which reported a decrease in 
the mechanical properties of root dentine following long term placement of 
intracanal Ca(OH)2 dressing such as that used in the apexification technique 
(Andreasen et al., 2002; Doyon et al., 2005; Twati et al., 2009b).  The 
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underlying mechanism of reduced dentine fracture resistance is possibly linked 
to changes in the physical properties of dentine (Andreasen et al., 2002).   More 
recently, a systematic review of the literature concluded that long term usage of 
Ca(OH)2 within the root canals of immature teeth should be discouraged, (Al 
Ansary et al., 2009; Duggal et al., 2017). 
1.3.2 Apical plug techniques:  
Apical plug techniques consist of packing a biocompatible material into the 
apical end of the immature root.  The packed material acts as an artificial apical 
barrier against which root canal filling, gutta-percha, is condensed (Al Ansary et 
al., 2009).  To overcome Ca(OH)2 limitations, the use of mineral trioxide 
aggregate (MTA) as an apical barrier plug has been advocated (Torabinejad 
and Chivian, 1999; Torabinejad and Abu-Tahun, 2010). 
Recently MTA has gained large usage popularity for treatment of immature 
teeth.  Sarris et al. (2008) reported a high clinical success rate of 94.1 % 
following 12 months follow-up period (Sarris et al., 2008).  Similar high success 
rates have also been reported following either one-visit (93.5 %) or two-visit 
(90.5 %) clinical application (Witherspoon et al., 2008).  This was also in 
agreement with the work of Simon et al. (2007) showing single visit MTA apical 
plug technique to be the preferred treatment approach (Simon et al., 2007).  
Currently, MTA apical plug technique, is considered the gold standard treatment 
option for immature non-vital teeth (Nicoloso et al., 2017). 
The MTA powder contains fine hydrophilic particles with calcium, silica and 
bismuth oxide as the main elemental components.  MTA sets in the presence of 
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moisture with a final pH ranging between 12 to 13 (Torabinejad et al., 1995a).  
MTA material benefits from antimicrobial and biocompatible properties (Parirokh 
and Torabinejad, 2010; Marão et al., 2012).  However, material drawbacks 
include difficult handling properties, long setting time and high material cost 
(Parirokh and Torabinejad, 2010; Marão et al., 2012). 
Comparative studies evaluating the use of Ca(OH)2 and MTA for treatment of 
immature teeth have been performed.  Results of these studies concluded 
higher clinical and radiographic success rates and shorter treatment times 
following the use of MTA apical plug technique (El Meligy and Avery, 2006; 
Pradhan et al., 2006).  However, the majority of reported MTA apical plug 
technique studies are based on a small sample size with the need for controlled 
studies of larger sample size and extended follow-up periods.  In similarity with 
Ca(OH)2, MTA has a high pH and similar mechanism of action to Ca(OH)2 
(Marão et al., 2012).  Indeed, a preliminary in vitro study found comparable 
weakening effect of Ca(OH)2 and MTA on human dentine tooth slices (Twati et 
al., 2009a).  Therefore, further clinical studies to ascertain the effect of MTA on 
the fracture resistance of dentinal walls are needed. 
Despite periapical healing in most of the cases treated with either prolonged 
placement of Ca(OH)2 or MTA apical plug technique, these conventional 
techniques do not restore the natural pulp tissue function (Diogenes et al., 
2016).  The lost tissue functions, due to pulp necrosis, include the lack of pulp/s 
defence ability and pain receptors (Diogenes et al., 2016).  Furthermore, 
conventional techniques do not contribute to any quantitative increase in root 
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lengths or thickening of root dentinal walls (Petrino et al., 2010; Torabinejad and 
Abu-Tahun, 2010). 
1.3.3 Regenerative endodontic procedures: 
To overcome the limitations of conventional endodontic techniques, 
regenerative procedures have been proposed.  These procedures aim to induce 
pulp tissue regeneration, dentine formation and subsequent root development 
(Wigler et al., 2013; Galler, 2016).  This shift towards regenerative therapy is 
regarded as a biological based treatment method (Galler, 2016) and the ideal 
approach in the management of these compromised teeth (Torabinejad and 
Abu-Tahun, 2010; Nakashima and Iohara, 2011). 
According to the American Association of Endodontists, regenerative 
endodontics is considered one of the most exciting developments in dentistry at 
the present time.  The American Association of Endodontists also published a 
position statement (2013) formally acknowledging regenerative endodontics as 
one of the techniques accepted within the scopes of endodontic practice 
(American Association of Endodontists, 2013).  Regenerative endodontic 
procedures in their current format are non-expensive, technically simple and 
accomplished with daily used instruments (Murray et al., 2007; European 
Society of Endodontology, 2016).  Furthermore, the use of patients own blood 
reduces the risk of immune rejection or pathogen transmitted diseases is highly 
advantageous (Murray et al., 2007). 
The concept of pulp regeneration dates back to as early as 1960`s following the 
novel work of Nygaard-Östby (1961) reporting new tissue ingrowth in an empty 
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pulp space following introduction of a blood clot (Östby, 1961).  His work 
showed limited tissue ingrowth and no pulpal regeneration (Galler, 2016).  The 
high regenerative potential of the pulp tissue was later demonstrated by 
revascularisation of the dental pulp reported by Iwaya et al. (2001) as an 
alternative treatment for non-vital immature permanent teeth.  Their work 
involved treatment of a necrotic immature mandibular second premolar with a 
chronic apical abscess in a 13 year old patient.  On the first visit an intracanal 
antibiotic dressing was placed in the canal.  Induction of bleeding through 
insertion of a sharp instrument beyond the root apex was performed on the 
second visit.  Apical closure, thickening of the root canal walls and increased 
root length were visible radiographically 30 months following treatment (Iwaya 
et al., 2001). 
Subsequently, Banchs and Trope (2004) reported successful revascularisation 
of an immature permanent tooth in an 11 year old patient with apical 
periodontitis.  At 24 months follow-up the tooth was asymptomatic, responded 
positively to cold test and showed radiographic evidence of apical closure with 
thickening of the dentinal walls.  The authors further emphasised on this new 
treatment approach in selected cases (Banchs and Trope, 2004). 
One of the main steps in applying regenerative endodontic procedures involves 
evoking bleeding from the periapical tissues.  The formed blood clot, 
subsequently, attracts stem cells from the periapical area and acts as a scaffold 
assisting new tissue formation (Trope, 2008; Lovelace et al., 2011; Diogenes 
and Ruparel, 2017). 
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The introduced blood clot is known to contain a rich supply of stem cells 
originated from the apical papilla termed stem cells of the apical papilla (SCAP) 
(Sonoyama et al., 2006; Sonoyama et al., 2008).  This is in agreement with 
molecular analysis studies of the blood collected inside the root canal.  Their 
results identified a large delivery of undifferentiated mesenchymal stem cells in 
the collected blood samples (Lovelace et al., 2011). 
1.3.3.1 Treatment outcome of regenerative endodontic procedures in their 
current format: 
More than 65 case reports, case series, retrospective and prospective clinical 
trials treating over 320 teeth have been published in the dental literature (Galler, 
2016).  In general, these clinical studies reported favourable treatment 
outcomes in terms of periodontal healing and resolution of periapical infection 
(Thibodeau and Trope, 2007; Jung et al., 2008; Thomson and Kahler, 2010; 
Cehreli et al., 2011; Chen et al., 2012; Miller et al., 2012).  Furthermore, positive 
response to sensibility tests at follow-up appointment has been reported 
(Banchs and Trope, 2004; Thomson and Kahler, 2010; Cehreli et al., 2011; 
Miller et al., 2012). 
However, variable results in regards to continuation of root development and 
thickening of the canal walls have been reported following regenerative 
endodontic procedures.  Jeeruphan et al. (2012) in a retrospective clinical study 
involving 20 treated teeth reported only 28.2 % and 14.9 % increase in root 
width and root length, respectively (Jeeruphan et al., 2012).  Lower success 
rates of 26.5 % increase in root width and 7.7 % increase in root length were 
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reported by Cehrelli et al. (2011) following treatment of six teeth with pulp 
necrosis as a result of caries.  Of these six treated teeth, only two responded 
positively to sensibility testing at 12 months follow-up (Cehreli et al., 2011).  
Furthermore, variable treatment outcome with higher success rates were 
reported by Jung et al. (2008) and Chen et al. (2012).  Despite periapical 
healing in all treated cases, evidence of continued root development was 
reported in 75 % of treated cases (Jung et al., 2008; Chen et al., 2012).  No root 
development following a six year follow-up has also been reported in two 
traumatised non-vital teeth (Nosrat et al., 2012). 
To further understand the nature of the regenerated tissue, histological analysis 
of extracted human and animal teeth treated with regenerative endodontic 
procedures revealed poor resemblance of the developed tissues to the native 
pulp tissues.  The new tissue ingrowth was described, in most studies, as a well 
mineralised cementum- or bone-like tissue within the canal space and at the 
apical ends (Wang et al., 2010b; Shimizu et al., 2013; Becerra et al., 2014; Lin 
et al., 2014). 
Unfortunately, most of the evidence from which regenerative endodontic 
procedures have progressed is stemmed from a large number of case reports 
and case series of low level of evidence (Kontakiotis et al., 2014).  Moreno-
Hidalgo et al. (2013) reported substantial heterogeneity in terms of study types, 
treatments, evaluation periods, and species (animals and human) evaluated 
(Moreno-Hidalgo et al., 2014). 
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Recently, more randomised controls trials, systematic reviews and 
meta-analysis have been published (Kahler et al., 2017; Tong et al., 2017; 
Torabinejad et al., 2017).  These reviews concluded inconsistent treatment 
outcomes, mainly in regards to continued root development and apical closure 
following regenerative endodontic procedures. 
Several hypotheses were made with regards to the reasons for such 
inconsistent results such as: (i) The use of a blood clot as a scaffold; (ii) 
Damage to Hertwig’s epithelial root sheath secondary to traumatic injuries or 
infection; (iii) Lack of radiographic standardisation and root measurement 
techniques (Nazzal and Duggal, 2017). 
Regenerative endodontic procedures in their current format rely on the 
formation of a blood clot.  The formed blood clot is a composed of undefined 
components including immune cells (Palma et al., 2017).  The concentration 
and type of cells incorporated in the blood clot is unpredictable leading to an 
uncontrolled environment which directly affects both quality and quantity of the 
newly generated tissue (Murray et al., 2007; Nazzal and Duggal, 2017). 
Developmentally, the epithelial cells of Hertwig’s epithelial root sheath guide the 
apical papilla cells to form pulp and dentine structure through complex 
epithelial-mesenchymal interactions (Huang et al., 2010).  Therefore, the 
presence of Hertwig’s epithelial root sheath is considered necessary for true 
pulp regeneration (European Society of Endodontology, 2016).  According to 
Sonoyama et al. (2007) cells from Hertwig’s epithelial root sheath guide the 
differentiation of periodontal ligament stem cells and form cementum-like tissue 
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in vivo (Sonoyama et al., 2007).  Consequently, damage to Hertwig’s epithelial 
root sheath following trauma may affect the required cell lineage differentiation 
(cementoblasts), hence prevent further root development (Nagata et al., 2014; 
Saoud et al., 2014; Nazzal and Duggal, 2017).  Therefore, to improve the 
clinical outcome, the incorporation of tissue engineering principles within the 
clinical management of these compromised teeth was proposed. 
1.4 Tissue engineering of the dental pulp: 
Tissue engineering is defined as an interdisciplinary field that aims to restore 
and maintain tissue function using the principles of engineering and life 
sciences (Langer and Vacanti, 1993).  Utilising tissue engineering principles 
namely the appropriate cells, a supporting scaffold material and the correct 
morphogenic signals provides a more controlled approach over tissue response 
and new tissue formation (European Society of Endodontology, 2016; Duggal et 
al., 2017). 
Although the maintenance of a vital pulp is the ultimate goal in restorative and 
paediatric dentistry (European Society of Endodontology, 2016; Duggal et al., 
2017), pulp preservation is not always possible and presents a treatment 
challenge especially in young patients with immature teeth.  Such patients might 
benefit from a tissue engineered treatment strategy, if clinically available 
(Nazzal and Duggal, 2017).  This treatment strategy, if successful, could 
potentially allow the completion of lateral and vertical root surfaces, therefore, 
improving the long-term prognosis of these compromised teeth (Nör, 2006; 
Cordeiro et al., 2008; Garcia-Godoy and Murray, 2012; Conde et al., 2015; 
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Nazzal and Duggal, 2017).  To achieve the desired clinical success, the 
combined presence of cells, scaffolds and signalling molecules within a 
disinfected pulp canal system is required (Figure  1.2).  The use of 1.5 – 3 % 
sodium hypochlorite followed by physiological saline and a final irrigation with 
17 % EDTA is clinically recommended in achieving disinfection of the root canal 
system prior to revitalisation / regeneration procedures (Martin et al., 2014; 
European Society of Endodontology, 2016). 
 
Figure ‎1.2: Schematic illustration of tissue engineering elements.The triad of stem cells, 
scaffolds and growth factors within a disinfected pulp canal system is required for successful 
pulp tissue engineering. 
 
1.4.1 Stem cells for dental pulp tissue regeneration: 
Although pulp-derived fibroblastic cells have been investigated for pulp tissue 
engineering  (Mooney et al., 1996), within the past decade, stem cells have 
gained considerable attention as a preferred candidate for stem-cell based 
therapies.  Stem cells are defined as immature, unspecialised and 
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undifferentiated cells that have an ability to continuously divide into different cell 
lineages (Egusa et al., 2012).  Stem cells reside in a specific area of each tissue 
called stem cell niche, where the regulation of stem cell activity occurs (Sloan 
and Waddington, 2009). 
According to the Mesenchymal and Tissue Stem Cell Committee of the 
International Society for Cellular Therapy (2006) a minimal standard criteria for 
human mesenchymal stem cells has been proposed (Dominici et al., 2006).  
The current set criteria include: (i) Ability to adhere to plastic tissue culture 
flasks under normal tissue culture procedures; (ii) Expression of specific surface 
antigens. More than 95 % of the isolated mesenchymal stem cells should 
positively express CD105 (endoglin), CD73 (ecto 5’ nucleotidase) and CD90 
(Thy-1).  Furthermore, the isolated mesenchymal stem cells should negatively 
express (less than 2 % positive) a panel of antigens.  These antigens include 
CD45 (pan-leukocyte marker), CD34 (hematopoietic progenitor and endothelial 
cell marker), CD14 and CD11b (macrophages and monocytes marker), CD79α 
and CD19 (B cell marker) and human leukocyte antigens class II (HLA-DR) 
molecules in an unstimulated state. (iii) Ability to differentiate in vitro into 
adipocytes, chondroblasts, and osteoblasts lineages (Dominici et al., 2006).  
Their characteristic feature to differentiate into a wide range of specialised cells 
is termed plasticity (Sloan and Waddington, 2009; Galler et al., 2010). Stem 
cells are classified based on their origin, source, and plasticity (Murray et al., 
2007; Galler et al., 2010; Egusa et al., 2012) as listed in Table  1.1. 
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Table ‎1.1: Classification of stem cells 
Origin 
Embryonic (foetal) 
Postnatal (adult) 
Plasticity 
Totipotent: unlimited potency to divide and give rise to all cell 
types of the body 
Pluripotent: cells can differentiate into any (over 200) cell 
types except extraembryonic (placenta) 
Multipotent: cells can differentiate into a limited number of cell 
types (most postnatal stem cells fall into this category) 
Source 
Autologous: donor cells are from the same individual 
Allogenic: donor cells are from the same species 
Xenogenic: donor cells are from different species 
 
Embryonic stem cells are derived from totipotent cells in the inner cell mass of 
the developing embryo during the blastocyst stage (Thomson et al., 1998).  
However, despite their totipotent ability their use is afflicted with both legal and 
ethical issues which restrict their future usage (Murray et al., 2007; Galler et al., 
2010).  On the other hand, postnatal stem cells have been identified and 
isolated from a wide range of different tissues including various oral and 
maxillofacial regions.  These tooth derived mesenchymal stem cells are 
increasingly being studied and are classified as potent self-renewal cells with 
multipotent differentiation capabilities (Sloan and Waddington, 2009; Egusa et 
al., 2012; Lee et al., 2014).  They are categorised based on the tissue and 
location from which they are isolated.  The commonly isolated tooth derived 
stem cells are listed in Table  1.2 and schematically illustrated in Figure  1.3. 
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Table ‎1.2: Classification of tooth derived stem cells 
Tissue source Stem cell terminology 
Pulp tissue of permanent 
dentition 
Dental pulp stem cells (DPSCs) (Gronthos et al., 
2000) 
Pulp tissue of primary 
dentition 
Stem cells from human exfoliated deciduous teeth 
(SHED) (Miura et al., 2003) 
Periodontal tissue 
Periodontal ligament stem cells (PDLSCs) (Seo et 
al., 2004) 
Apical papilla tissue 
Stem cells from apical papilla (SCAP) (Sonoyama 
et al., 2006) 
Dental follicle of an 
un-erupted tooth 
Dental follicle progenitor cells (DFPCs) 
(Morsczeck et al., 2005) 
Gingival tissue 
Gingiva-derived mesenchymal stem cells 
(GMSCs) (Zhang et al., 2009) 
 
 
 
Figure ‎1.3: Schematic illustration of tooth derived stem cells. GMSCs (gingiva-derived 
mesenchymal stem cells), SHED (stem cells from human exfoliated deciduous teeth), PDLSCs 
(periodontal ligament stem cells), DPSCs (dental pulp stem cells), SCAP (stem cells from apical 
papilla) and DFPCs (dental follicle progenitor cells).  
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These tooth derived stem cells are regarded as a viable cell source for 
regeneration of both tooth and non-tooth structures (Lee et al., 2014).  Within 
the context of pulp-dentine engineering several studies have reported 
favourable results following in vitro and in vivo use of DPSCs (Gronthos et al., 
2000; Gronthos et al., 2002; El-Backly et al., 2008; Prescott et al., 2008; 
Kodonas et al., 2012), stem cells from human exfoliated deciduous teeth (Miura 
et al., 2003; Cordeiro et al., 2008; Sakai et al., 2010), and stem cells from apical 
papilla (Sonoyama et al., 2006; Abe et al., 2008; Huang et al., 2008) for pulp 
and dentine tissue engineering. 
1.4.2 Signalling molecules for dental pulp tissue regeneration: 
Signalling molecules, growth factors and cytokines are also regarded as an 
essential element for tissue engineering  (Langer and Vacanti, 1993).  They are 
defined as peptide molecules controlling tissue growth during 
epithelial-mesenchymal interactions (Nakashima and Reddi, 2003; Nakashima 
and Akamine, 2005).  At a molecular level, these interactions involve a complex 
network consisting of signals, receptors and transcriptional control systems 
(Thesleff and Sharpe, 1997).  It is these crucial interactions between cells and 
tissue elements that regulate future tissue development (Thesleff and Åberg, 
1999).   
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Signalling molecules that mediate epithelial-mesenchymal interactions during 
tooth development mainly include, bone morphogenetic proteins (BMPs), 
fibroblast growth factors (FGFs), wingless- and int-related proteins (Wnts), and 
hedgehog proteins (Hhs) (Thesleff and Åberg, 1999; Nakashima and Reddi, 
2003; Ajay Sharma et al., 2013).  
Furthermore for successful engineered pulp tissue, the formation of blood 
vessels is essential for tissue survival (Nör, 2006; Janebodin et al., 2013).  The 
formation of new blood vessels form pre-existing vessels, is termed 
angiogenesis (Folkman, 1995).  Studies have linked angiogenesis to a number 
of growth factors including transforming growth factors (TGF; TGF-α, TGF-β), 
platelet-derived growth factor (PDGF), tumour necrotic factor-α (TNF-α), 
vascular endothelial growth factor (VEGF), and VEGF receptors (VEGFR-1 and 
VEGFR-2) (Matsushita et al., 2000; Grando Mattuella et al., 2007). 
1.4.3 Scaffolds for dental pulp tissue regeneration: 
In addition to the correct signalling cues and the appropriate stem cells, a 
three-dimensional scaffold that can support future cellular repopulation is 
required (Murray et al., 2007; Gotlieb et al., 2008; Waddington and Sloan, 
2017).  Scaffolds play an important role in future tissue regeneration, therefore 
the selection of an appropriate material is considered to be a crucial step for 
successful tissue regeneration (Yuan et al., 2011; Ajay Sharma et al., 2013; 
Nazzal and Duggal, 2017).  Indeed, placement of a scaffold within the root 
canal has been shown to enhance revascularisation procedure and improve the 
quality of tissue formation (Garcia-Godoy and Murray, 2012). 
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Ideally scaffolds, when infiltrated with the desired cells, should facilitate cellular 
recruitment, attachment, growth and differentiation (Murray et al., 2007; Galler 
et al., 2010; Galler et al., 2011b; Yuan et al., 2011).  Providing the conductive 
environment for cellular proliferation facilitates the secretion of ECM 
components.  This is followed by constructive remodelling, scaffold degradation, 
and eventually replacement of the scaffold by the intended tissue (Galler et al., 
2010; Galler et al., 2011b).   
To promote future tissue engineering, several material requirements are 
considered.  To prevent any unwanted tissue response, scaffolds should be 
biocompatible and non-immunogenic (Galler et al., 2010; Galler et al., 2011b; 
Yuan et al., 2011).  They should possess the correct surface chemistry and 
structural framework to support cell attachment, organisation and 
vascularisation (Yang et al., 2001).  A permeable material that effectively 
enables the transport of nutrients, oxygen and waste is highly desirable and 
crucial for cellular survival (Yang et al., 2001).  Scaffolds should also be 
constructed from a biodegradable material, with a biodegradation rate in 
synchrony with constructive remodelling of newly formed tissues (Yang et al., 
2001; Galler et al., 2010; Galler et al., 2011b).  Furthermore, for future clinical 
translation, scaffolds should be easily applicable clinically and cost-effective 
(Yuan et al., 2011). 
Despite the first attempt to engineer a pulp-like tissue on a synthetic scaffold 
dates back to the mid-90s by Mooney et al. (1996), it was not until the discovery 
of DPSCs by Gronthos et al. (2000) which further enhanced this field.  
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Biomaterials research has become of high scientific interest and several 
scaffold materials have been tested for their potential ability to support stem cell 
attachment, proliferation, and tissue formation (Conde et al., 2015).  Several 
synthetic and natural scaffold materials are currently being developed for use in 
dental pulp regeneration. 
1.4.3.1 Scaffolds constructed from synthetic materials: 
Scaffolds constructed from synthetic materials are commercially attractive due 
to their unlimited supply and relative simple production (Galler et al., 2010; 
Colombo et al., 2014).  These scaffolds offer a controlled and well-characterised 
composition with tailored handling characteristics (Galler et al., 2010; Song and 
Ott, 2011).  Despite this tailored mechanical production, material degradation 
issues still exist (Lee and Mooney, 2001). 
On the other hand, degradation of synthetic polymers causes the release of 
acidic by-products which impacts negatively on material biocompatibility (Yang 
et al., 2001). Furthermore, scaffolds constructed from synthetic materials lack 
the natural chemical structure of the ECM (Galler et al., 2011b).  Several 
synthetic materials have been investigated for pulp-dentine complex 
regeneration as summarised in Table  1.3. 
1.4.3.2 Scaffolds constructed from natural materials: 
Scaffolds constructed from natural materials have the advantage of being, in 
most cases, biodegradable and biocompatible (Galler et al., 2010; Galler et al., 
2011b).  However, production issues mainly establishing control over specified 
features are challenging and can ultimately affect their biocompatibility and 
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structural integrity (Colombo et al., 2014).  Furthermore, natural scaffolds lack 
standardisation with large batch variations (Yang et al., 2001; Conde et al., 
2015), processing difficulties (Galler et al., 2010), and the risk of a possible 
immune response (Galler et al., 2010; Conde et al., 2015).  Several natural 
materials have been investigated for pulp-dentine complex regeneration as 
summarised in Table  1.3. 
Acellular biological scaffolds developed through tissue decellularisation have 
recently been advocated over other synthetic and natural scaffolds (Badylak, 
2002; Gilbert et al., 2006; Crapo et al., 2011).  These scaffolds have been 
introduced to overcome previous scaffold limitations mainly the poor 
resemblance to the natural tissue matrix, preservation of three-dimensional 
tissue architecture and natural ECM components consisting of a unique mixture 
of structural and functional proteins (Badylak, 2002; Badylak et al., 2009). 
Within the dental field attempts at decellularising different dental tissues for 
pulp-dentine complex regeneration have been summarised in Table  1.3 and 
further discussed below (Section  1.5). 
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Table ‎1.3: Scaffold performance used for pulp-dentine complex regeneration 
Scaffold type 
Evidence 
Advantages Disadvantages 
Experimental approach Scaffold performance 
Synthetic scaffolds: 
Synthetic bioceramics: 
Hydroxyapatite / 
tricalcium 
phosphate  
Scaffold seeded with DPSCs and 
transplanted into nude mice (Gronthos 
et al., 2000; Gronthos et al., 2002) 
Formation of ectopic dentine-like 
structure 
Biocompatible 
Biodegradable 
 
Limited manufacturing 
ability to produce a 
porous structure 
Osteoconductive 
Brittle 
Porous ceramic 
 
Scaffold seeded with DPSCs and 
cultured in vitro in the presence of 
osteogenic differentiation medium and 
transplanted into nude mice (Zhang et 
al., 2006b) 
Limited amount of hard tissue 
formation 
 
Poorly organised ECM 
 
Tissue resembled a more 
connective tissue than a 
dentine-like structure 
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Synthetic polymers: 
Poly 
(lactic-co-glycoli
c acid) 
Scaffold seeded with DPSCs, cultured 
in vitro and transplanted in rabbits (El-
Backly et al., 2008) 
Early formation of patches of 
osteodentine-like matrix 
 
Tubular bi-layered structure 
 
Limited areas had well-organised 
appearance 
Inexpensive 
 
Standard 
reproducibility 
 
Adjustable 
chemical, 
mechanical, and 
physical 
properties 
 
Lack of ECM 
specific 
environmental cues 
 
Acidic by-products 
on material 
degradation 
Poly- L -lactic 
acid 
Scaffold seeded with SHED utilising 
tooth slice model and transplanted into 
nude mice (Cordeiro et al., 2008; Sakai 
et al., 2010)  
Formation of a vascularised dental 
pulp-like tissue 
 
Positive expression to DSPP 
 
Rapid degradation rate (due to low 
pH environment produced during 
polylactic acid degradation) 
Poly- L -lactic 
acid 
Scaffold seeded with DPSCs, bone 
morphogenetic protein-7, cultured 
within an odontogenic induction 
medium in vitro and transplanted into 
nude mice (Wang et al., 2010a) 
Positive expression to DSPP 
 
Hard tissue formation 
 
No resemblance to tubular dentine 
structure 
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Poly- L -lactic 
acid 
Scaffold seeded with DPSCs utilising 
tooth slice model and transplanted into 
nude mice (Demarco et al., 2010) 
Positive expression to DSPP and 
DMP-1 
Poly-D,L-lactide 
and glycolide 
Scaffold seeded with SCAP and 
DPSCs and placed within root canal of 
extracted human teeth and 
transplanted into nude mice (Huang et 
al., 2010) 
Formation of a vascularised 
pulp-like tissue 
 
Generated odontoblast-like cells 
were not well organised nor well 
aligned 
 
Scattered voids were seen 
throughout the formed tissues 
(remnants of un-resorbed synthetic 
scaffold) 
Synthetic hydrogels: 
Alginate 
hydrogels 
Alginate hydrogels were either 
untreated, acid treated or combined 
with TGF-β1 and cultured in vitro in 
human tooth slices (Dobie et al., 2002) 
Both acid treated alginate and 
alginate hydrogels with TGF-β1 
showed signs of dentinogenesis 
 
Untreated alginate hydrogels 
showed no signs of dentinogenesis  
Injectable 
materials 
 
Biocompatible 
 
Relative ease of 
production 
Poor mechanical 
strength 
 
Early stage of 
research  
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PuramatrixTM 
(self-
assembling 
peptide 
hydrogel) 
Scaffold seeded with DPSCs utilising 
tooth slice model and cultured in vitro 
(Cavalcanti et al., 2013) 
Supported DPSCs survival and 
proliferation 
 
Positive expression to DSPP and 
DMP-1 
Customised 
material 
 
Surface 
modification 
(addition of 
growth factors) 
PuramatrixTM 
(self-
assembling 
peptide 
hydrogel) 
Scaffold seeded with SHED and 
placed within root canal of extracted 
human teeth, cultured in vitro and 
transplanted into immunodeficient mice 
(Rosa et al., 2013) 
Odontoblastic differentiation 
indicated by positive expression to 
DSPP and DMP-1 
 
Unable to support Odontoblastic 
differentiation in the absence of 
root canal (dentine derived growth 
factors) 
 
Formed tissue resembled a 
connective tissue-like appearance 
with a less dense ECM in 
comparison to the native pulps 
Self-assembling 
peptide 
nanofibres 
hydrogel 
Scaffold seeded with DPSCs combined 
with several growth factors utilising 
tooth slice model and cultured in vitro 
and in vivo (Galler et al., 2011c). 
Formation of a vascularised soft 
connective tissue resembling the 
native pulp tissue. 
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Natural scaffolds: 
Natural polymers: 
Collagen 
(produced from 
bovine hide) 
Scaffold seeded with SHED combined 
with bone morphogenic protein-2 and 
TGF-β1, placed within root canal of 
extracted human premolar teeth and 
cultured in vitro (Gotlieb et al., 2008) 
Scaffold supported cell attachment 
 
Limited attachment of the pulp 
constructs to the surrounding root 
canal surfaces (less than 50 % 
contact) Several diverse 
sources (animal, 
bacteria, crops 
and plant) 
 
Biodegradable 
 
Customised 
chemical 
properties 
 
Processing 
difficulties 
 
Lack of 
standardisation 
(material properties 
may vary) 
 
Risk of pathogen 
transmission or 
immune response 
 
Cross-linked 
collagen 
Animal case study comparing the use 
of blood clot with/without collagen 
scaffold (Yamauchi et al., 2011) 
The addition of a collagen scaffold 
increased amount of tissue 
formation compared to use of 
blood clot alone 
 
Formed tissue resembled 
cementum- and bone-like tissue 
Chitosan 
Animal case study comparing the use 
of blood clot with/without chitosan 
scaffold (Palma et al., 2017) 
 
The addition of a chitosan scaffold 
did not enhance tissue formation 
compared to use of blood clot 
alone 
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Natural hydrogels: 
Recombinant 
human collagen 
type I hydrogels 
Scaffold seeded with SHED and 
placed within root canal of extracted 
human teeth, cultured in vitro and 
transplanted into immunodeficient mice 
(Rosa et al., 2013) 
Odontoblastic differentiation 
indicated by positive expression to 
DSPP and DMP-1 when in contact 
with the root canal 
 
Unable to support odontoblastic 
differentiation in the absence of 
surrounding root canal 
 
Formed tissue resembled a 
connective tissue-like appearance 
with less dense ECM in 
comparison to the native pulps 
Injectable 
materials 
 
Biocompatible 
 
Relative ease of 
production 
 
Customised 
material 
 
Surface 
modification 
(addition of 
growth factors) 
Disadvantages of 
original material 
source 
 
Poor mechanical 
strength 
 
Early stage of 
research 
Hyaluronic acid 
cross-linked 
hydrogel 
Scaffold seeded with tooth bud-derived 
dental mesenchymal cells combined 
with growth factors, utilising tooth slice 
model and cultured in vitro and 
transplanted into nude mice (Tan et al., 
2015) 
Odontoblastic differentiation 
indicated by positive expression to 
DSPP and DMP-1 
 
Formed tissue resembled dentinal 
tubular structures, only in the 
presence of the growth factor 
 
The combined use of cells and 
scaffolds resulted in the formation 
of bone-like tissue 
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Platelet-rich plasma: 
Platelet-rich 
plasma 
Human case report comparing the use 
of blood clot with/without platelet-rich 
plasma (Martin et al., 2013) 
Formed tissue resembled 
cementum- and bone-like tissue 
 
Calcifications, necrotic debris and 
dentine chips embedded within the 
mineralised tissue 
 
No evidence of odontoblasts or 
new dentine formation 
 
No difference between the use of 
blood clot alone or the addition of 
platelet-rich plasma 
Autologous tissue 
 
Complex mixture 
of platelets and 
growth factors 
Tissue repair not 
pulp regeneration 
was concluded as 
the clinical outcome 
 
Increase treatment 
cost 
 
Difficult handling 
properties 
 
Invasive procedure 
(especially young 
children as it 
requires drawing 
blood from the 
patient) 
Platelet-rich 
plasma 
Animal case study testing several 
combinations of blood clot, pulp cells 
and platelet-rich plasma (Zhu et al., 
2012) 
Formed tissue resembled 
cementum- and bone-like tissue 
 
No dentine-like tissue formation 
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Acellular biological scaffolds: 
Decellularised 
porcine tooth 
buds 
Porcine molar tooth buds were 
demineralised and decellularised using 
a dual detergent based protocol, 
characterised and recellularised using 
porcine dental mesenchymal cells 
(Traphagen et al., 2012) 
Preservation of the ECM 
 
Positive expression of collagen, 
fibronectin and laminin proteins 
 
Recellularised scaffolds exhibited 
an increased collagen fibre density 
Biocompatible 
 
Tissue specific 
ECM 
 
Favourable 
microenvironment 
for tissue 
engineering 
 
Spatial structure 
 
Preservation of 
vascular network 
Lack of optimised 
tissue specific 
decellularisation 
process 
 
Risk of immune 
response 
 
Early stage of 
research 
Decellularised 
miniature swine 
teeth  
Tissue decellularised using a dual 
detergent based protocol, 
characterised and recellularised using 
DFSCs (Chen et al., 2015) 
preservation of tissue shape 
 
Reduction in collagen type I and III 
 
Preservation of fibronectin and 
laminin proteins 
 
Supported cell survival 
Decellularised 
human root 
slices  
Pulp-dentine disks (1.5 mm) were 
decellularised using a dual detergent 
based protocols, characterised and 
recellularised using SCAP (Song et al., 
2017) 
Preservation of GAGs 
 
Reduced expression of fibronectin 
 
Scaffold supported cell viability 
with positive cellular expression to 
DSP and ALP 
Abbreviations; (ALP) alkaline phosphatase, (DPSCs) dental pulp stem cells, (DSP) dentine sialoprotein, (DSPP) dentine sialophosphprotein, (DMP-1) dentine matrix 
protein-1, (DFSCs) dental follicle stem cells, (GAGs) glycosaminoglycans, (SCAP) stem cells from apical papilla and (TGF-β1) transforming growth factor beta-1. 
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1.5 Tissue decellularisation: 
Tissue decellularisation is defined as the efficient removal of all cellular and 
nuclear contents within a given tissue without negatively affecting its 
composition, mechanical integrity and biological activity of the decellularised 
matrix (Gilbert et al., 2006; Badylak et al., 2009; Fu et al., 2014).  Following 
decellularisation, the produced scaffold is composed of the tissues natural ECM 
components with preserved three-dimensional tissue architecture (Badylak et 
al., 2009; Wilshaw et al., 2012).  ECM components consist of a unique mixture 
of structural and functional molecules that regulate several cellular activities. 
These molecules also contribute to ECM’s strength and structural properties 
(Badylak, 2002; Badylak et al., 2009). 
Although allogenic decellularised scaffolds are the preferred choice, they are 
largely limited by availability.  Therefore, recent research has looked into 
xenogenic decellularised scaffolds as a readily available alternative.  
Decellularisation has been widely reported in the medical literature for various 
tissues and organs including, but not limited to, human pericardial matrix 
(Mirsadraee et al., 2006), human liver (Kajbafzadeh et al., 2013), human 
common femoral arteries (Wilshaw et al., 2012), human amniotic membrane 
(Wilshaw et al., 2006), porcine medial meniscus (Stapleton et al., 2008), porcine 
cornea (Yoeruek et al., 2012), porcine cartilage (Kheir et al., 2011), and porcine 
pulmonary valve (Luo et al., 2014).   
Acellular biological scaffolds have also progressed to human trials and usage.  
Examples of commercially available ECM scaffolds in clinical usage include, 
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Acell Vet (porcine urinary bladder; Acell, Inc.), Alloderm (human dermis; Lifecell, 
Corp.), GraftJacket (human dermis; Wright Medical Technology), Restore 
(porcine small intestine; DePuy Orthopaedics), Oasis (porcine small intestine; 
Cook Biotech, Inc.), and Zimmer Collagen Repair Patch (porcine dermis; 
Zimmer, Inc.) (Gilbert et al., 2009).  Within the dental field, decellularised 
tissues have been investigated as a suitable scaffold for pulp-dentine complex 
(Traphagen et al., 2012; Chen et al., 2015; Song et al., 2017) and whole tooth 
regeneration (Ikeda et al., 2009; Oshima et al., 2011; Zhang et al., 2017).  
These tissues were obtained from different sources (animal and human) and 
decellularised using various process. 
1.5.1 Tissue decellularisation process: 
In general terms, the decellularisation process involves single or combined 
usage of reagents and physical methods.  These include: (i) Chemical agents 
(acids, bases, detergents, hypertonic and hypotonic solutions); (ii) Biological 
agents (enzymes, chelating agents and protease inhibitors); (iii) Physical 
methods (freeze-thaw cycle, snap freezing, mechanical force and agitation) 
(Gilbert et al., 2006; Crapo et al., 2011; Fu et al., 2014).   
1.5.1.1 Chemical agents: 
1.5.1.1.1 Acid and bases: 
Acid and bases are known to solubilise cellular cytoplasmic components and 
aid the removal of nucleic acids.  However, concerns regarding structural 
damage and removal of ECM components, such as collagen and GAG 
molecules, have been reported (Gilbert et al., 2006; Crapo et al., 2011).  
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Examples of commonly used acidic and alkaline reagents include acetic acid, 
peracetic acid, calcium hydroxide, and sodium hydroxide (De Filippo et al., 
2002; Falke et al., 2004; Freytes et al., 2004). 
Bases are incorporated in the early stages of decellularisation process to 
remove hair from the porcine dermis (Reing et al., 2010).  However, they are 
generally considered harsh chemicals and are associated with significant 
reduction of growth factors and mechanical properties.  Reduction of the ECM 
mechanical properties is linked to cleavage of collagen fibrils and damage to the 
collagen crosslinks (Gorschewsky et al., 2005). 
Peracetic acid is commonly incorporated within the decellularisation process, 
mainly as a final step for tissue disinfection and sterilisation process.  Peracetic 
acid acts as an oxidising agent leading to the microorganisms destruction 
(Pruss et al., 1999).  Peracetic acid, at low concentrations of approximately 
0.1 % (v/v), has been regarded as an effective disinfection and sterilisation 
agent for collagen-based biological scaffolds with no or minimal effect on the 
ECM structure and components (Hodde and Hiles, 2002; Hodde et al., 2007). 
1.5.1.1.2 Detergents: 
Detergents are water-soluble molecules composed of a polar head group and a 
hydrophobic tail or chain.  Detergents are divided into ionic, non-ionic and 
zwitterionic based on their hydrophilic or hydrophobic characteristics and ionic 
groups (Seddon et al., 2004; Knight et al., 2008).  They are widely used in 
tissue decellularisation and are regarded as an effective treatment for removal 
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of cellular material through dissociating DNA from proteins and solubilising cell 
membranes (Seddon et al., 2004; Cox and Emili, 2006). 
Ionic detergents contain a charged cationic or anionic head group.  Commonly 
used examples include sodium dodecyl sulphate (SDS), sodium deoxycholate 
and Triton X-200 are known to be effective at solubilising cytoplasmic and 
nuclear membranes (Seddon et al., 2004; Woods and Gratzer, 2005; Gilbert et 
al., 2006).  In contrast to ionic detergents, non-ionic detergents contain an 
uncharged hydrophilic head group.  Non-ionic detergents are known to be 
relatively mild and non-denaturing as they disrupt DNA-protein, lipid-lipid and 
lipid-protein interactions, however protein-protein interactions remains intact 
(Seddon et al., 2004; Woods and Gratzer, 2005; Crapo et al., 2011).  Common 
example of this group in tissue decellularisation includes the use of 
Triton X-100.  Zwitterionic detergent are known to combine properties of both 
ionic and non-ionic detergents, however able to cause more deactivation than 
the non-ionic detergents (Seddon et al., 2004).  Example of this group include 
3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS) 
(Seddon et al., 2004; Crapo et al., 2011). 
1.5.1.1.3 Hypertonic and hypotonic solutions: 
To further enhance the effect of the used detergent, hypertonic and/or hypotonic 
solutions are added to decellularisation protocols (Knight et al., 2008).  The 
action of hypotonic solutions, in which the solute concentration in extracellular 
fluid is less than the cell cytosol, causes cell swelling and breakdown of cell 
membranes by means of osmotic shock.  Hypotonic solutions have been 
reported to cause large influx of water with minimal disruption to ECM (Xu et al., 
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2007).  On the other hand, hypertonic solutions cause water movement out of 
the cell, as the solute concentration is higher than the cell cytosol.  This leads to 
cell dehydration, shrinkage, probable death and cell detachment (Knight et al., 
2008).  Hypertonic solutions are also known to dissociate DNA from proteins  
(Cox and Emili, 2006).  The addition of hypertonic and/or hypotonic rinses within 
a given decellularisation protocol has shown synergistic support aiding cell lysis, 
and removal of cell remnants and chemical residues within the treated tissue 
(Stapleton et al., 2008; Remlinger et al., 2012; Luo et al., 2014). 
1.5.1.2 Biological agents: 
1.5.1.2.1 Enzymes: 
Enzymes are commonly used within decellularisation protocols for efficient 
removal of cellular and nuclear material.  Examples include, but not limited to, 
collagenase, dispase, trypsin and nucleases (Bader et al., 2000; Chen et al., 
2004; Rieder et al., 2004; Prasertsung et al., 2008).  Nucleases (DNases and 
RNases) are known to catalyse the hydrolysis of DNA and RNA chain 
sequence, therefore aiding in the removal of nuclear material (Gilbert et al., 
2006; Crapo et al., 2011).  Within a given decellularisation protocol nucleases 
are, generally, used towards the final steps following disruption of cellular and 
nuclear membranes. 
1.5.1.2.2 Chelating agents: 
Chelating agents also aid in the removal of cellular contents from the treated 
tissue.  They bind and congregate with metal ions present on cell adhesion 
sites, consequently disrupting cellular adhesions (Klebe, 1974; Gailit and 
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Ruoslahti, 1988).  However, chelating agents are inadequate when used alone 
and typically used in combination with other enzymatic or detergent reagents 
(Hopkinson et al., 2008).  Examples include EDTA and ethylene glycol 
tetraacetic acid (EGTA) (Gilbert et al., 2006; Crapo et al., 2011). 
1.5.1.2.3 Protease inhibitors: 
Protease inhibitors are frequently added to various decellularisation solutions in 
order to prevent undesirable ECM damage, that might occur due to the release 
of intracellular proteases following cell lysis (Gilbert et al., 2006; Crapo et al., 
2011; Wilshaw et al., 2012).  Examples of protease inhibitors include Aprotonin 
and leupeptin (Gilbert et al., 2006; Crapo et al., 2011).  Aprotinin acts as a 
broad-spectrum protease inhibitor (Landis et al., 2001).  EDTA, a chelating 
agent, also inhibits matrix metalloproteinase (Seltzer et al., 1976; Galis et al., 
1994). 
1.5.1.3 Physical methods: 
The incorporation of physical methods within a decellularisation protocol is 
known to facilitate the efficiency of tissue decellularisation (Gilbert et al., 2006; 
Crapo et al., 2011; Fu et al., 2014).  However, physical methods are insufficient 
alone in achieving complete cellular removal, therefore, used mainly in 
combination with other treatment steps.  Examples include freeze-thaw cycles, 
snap freezing, mechanical force, and agitation (Gilbert et al., 2006; Crapo et al., 
2011). 
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1.6 In summary: 
The early optimism regarding regenerative endodontic procedures in the 
management of immature teeth with necrotic pulp tissues has now faded, with 
unpredictable results reported especially with regards to continuation of root 
development and increase dentine thickness.  Furthermore, histological studies 
have shown cementum- and bone-like structures rather than pulp-like structure 
formation following such regeneration procedures.  These procedures are 
unlikely to be successful unless basic principles of tissue engineering are 
followed and implemented in their clinical management.  Such clinical protocols 
should be aimed at promoting and guiding the development of the desired 
structures using appropriate cells, signalling molecules, and scaffold material.  
Although several scaffolds are currently being tested, to date, the ideal scaffold 
for pulp-dentine regeneration has not been identified.  The production of 
acellular biological scaffolds composed of tissue specific ECM is highly 
promising in providing the ideal environment for selective tissue regeneration. 
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1.7 Aim and objectives: 
We hypothesise that, therefore, an acellular dental pulp scaffold would facilitate 
regeneration of the dental pulp tissue for future use in clinical management of 
immature teeth with necrotic pulp tissues.  
The overall aim of this research is to assess the feasibility of decellularising rat 
and human dental pulp tissues in producing a biocompatible acellular ECM 
scaffold with intact structural and biochemical components of the native dental 
pulp tissue.  
The objectives of this project, therefore, are: 
 To develop a reproducible decellularisation method capable in removing 
acceptable levels of rat and human pulp tissue cellular and nuclear material 
for use in pulp-dentine tissue regeneration.  
 To determine the efficiency of the decellularisation method used in 
preserving the ECM structural histoarchitecture and components. 
 To determine the decellularised scaffolds biocompatibility and ability to 
support recellularisation. 
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  Chapter 2
General Materials and Methods 
This chapter describes the general materials and methods used throughout the 
study, further details of specific experimental approaches are described in the 
upcoming chapters. 
2.1 General materials: 
2.1.1 Equipment and consumables: 
Details of general laboratory equipment and consumables used throughout this 
study are listed in Table  2.1 and Table  2.2, respectively. 
Table ‎2.1: General laboratory equipment used throughout the study 
Equipment Model Manufacturer 
Argon gas chamber _ 
AGAR Auto Sputter 
Coater 
Autoclave _ Prestige medical 
Balance 13204-S College 
Centrifuge 5804R Eppendorf 
Class II safety cabinet hood N4-437-400E NUAIRE 
Confocal laser scanning 
microscope 
SP2 Leica Microsystems 
Electrical pressure cooker 
Access retrieval 
unit 
MenaPath 
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Fluorescence upright 
microscope 
Axio imager Z1 
with ApoTome 
Zeiss 
Freeze dryer Alpha 2-4 LD plus CHIST 
Freezer MDF-U20865 SANYO 
Hand held drill 395 DREMEL 
Handheld automated cell 
counter 
Scepter™ 2.0 
PHCC20060 
Millipore 
Histology water bath HI1210 Leica 
Hot plate SH3 Stuart Scientific 
Light inverted microscope IX 71 Olympus 
Light upright microscope Axioplan Zeiss 
NanoDrop™ 2000 
spectrophotometer 
Nc/2000 
Thermo Fisher Scientific 
Ltd. 
Oven incubator MCO-20 AIC SANYO 
Paraffin embedding machine EG1150H Leica Microsystems 
Plate reader 
Multiskan 
Spectrum 
Thermo Fisher Scientific 
Ltd. 
Polarised upright microscope M2 Axio imager Zeiss 
Rotatory microtome AS325 Leica Microsystems 
Scanning electron 
microscope 
S-3400N Hitachi 
Shaking incubator C25 New Brunswick 
Tissue processing machine ASP200 Leica Microsystems 
Vice clamp - - 
Vortex VXR 517 IKA-VIBRAX 
Water bath Grant / S4B 
Scientific laboratory 
supplies 
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Table ‎2.2: General laboratory consumables used throughout the study 
Consumables Model/Size Manufacturer 
Bijou tubes 7 mL 
Thermo Fisher Scientific 
Ltd. 
Cell culture flasks 
75 cm2 and 
175 cm2 
Corning incorporated 
CryoTube® vials 1.5 mL and 2 mL Nunc™ 
Eppendorf tubes Various sizes Nunc™ 
Opsite flexigrid 4628 Smith & nephew 
Optiplate™ white plates 96-well PerkinElmerTM 
Pipette tips Various sizes Star Labs 
Plastic histology cassettes M490-3 Simport 
Silane coated microscopic 
slides 
MDC-0102-54A Cell path 
Silicone embedding moulds E4390 Sigma-Aldrich 
Slides coverslips COV12440S Solmedia 
Universal tubes 15 mL and 50 mL Corning incorporated 
Well plates (flat bottomed) 
6-well, 12-well, 
24-well, 48-well, 
96-well 
Corning incorporated 
X-tra® adhesive microslides 3800200AE Leica Biosystems 
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2.1.2 Chemicals, reagents and kits: 
Details of all chemicals, reagents and kits used throughout the study are listed 
in Table  2.3. 
Table ‎2.3: Chemicals, reagents and kits used throughout the study 
Chemicals and reagents Catalogue Manufacturer 
Agar A-9915 Sigma-Aldrich 
Alcian blue RRSK400 Atom Scientific 
Alpha-modified Eagle’s 
medium 
BE12-169F Lonza  
Antibody diluent  003218 Invitrogen  
Antigen unmasking solution; 
citric acid based 
H-3300 Vector Laboratories  
Antigen unmasking solution; 
Tris-EDTA based 
H-3301 Vector Laboratories  
Aprotinin A6279 Sigma-Aldrich  
ATPLite™ assay 6016941 
Perkin Elmer Life 
Sciences 
Bond™ Enzyme Pretreatment 
kit 
AR9551 Leica Biosystems 
Bovine serum albumin A7979 Sigma-Aldrich 
Casein Ssp-5020 Vector Laboratories  
Cyanoacrylate adhesive glue Z105902-1EA Sigma-Aldrich 
Dimethyl sulfoxide D8418 Sigma-Aldrich 
DNase I AMPD1 Sigma-Aldrich 
DNeasy Blood and Tissue Kit 69504 Qiagen 
Synthetic mounting media 
(DPX mountant) 
REA212 Solmedia 
Dulbecco’s modified Eagle’s 
medium 
D6546 Sigma-Aldrich  
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Endogenous peroxidase 
blocking with Bloxall 
(hydrogen peroxide) 
SP-6000 Vector Laboratories 
Eosin RRSP35-D Atom Scientific 
Ethanol 32221-2 Sigma-Aldrich 
Ethylene-diamine-tetra-acetic 
acid 
03698 Sigma-Aldrich 
Foetal bovine serum DE14-802 Lonza 
Giemsa solution 352603R VWR International 
Glacial acetic acid 27013 BDH 
Glutaraldehyde solution 286824Q Sigma-Aldrich 
Horseradish peroxidase- 
conjugated secondary goat 
anti-rabbit antibody 
XCP-P0100 MenaPath 
ImmPACT 
3,3’-diaminobenzidine (DAB) 
Peroxidase substrate 
SK-4105 Vector Laboratories 
ImmPRESS Excel staining kit  MP-7602 Vector Laboratories 
L-glutamine solution G7513 Sigma-Aldrich 
LIVE/DEAD® stain kit  L3224 Molecular Probes™ 
Magnesium chloride solution M1028 Sigma-Aldrich 
Mayer’s haematoxylin RRSP60-D Atom Scientific 
Neutral buffered formalin BAF-6000-08A Cellpath 
Nuclear Fast Red  RRSP4545-B Atom Scientific 
Penicillin-Streptomycin 
solution 
P4333 Sigma-Aldrich  
Peracetic acid 77240 Sigma-Aldrich 
Phosphate-buffered saline 17-516F Lonza 
Phosphate-buffered saline 
(10X) 
70013 
Gibco by Life 
Technologies™  
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Picrosirius red stain 24901 Polysciences, Inc 
RNase A R4642 Sigma-Aldrich 
Scott’s tap water EGW-0200-25A CellPath 
Sodium dodecyl sulphate 71736 Sigma-Aldrich 
Sodium hydroxide 1310-73 
Thermo Fisher Scientific 
Ltd. 
Tris-buffer  T3038 Sigma-Aldrich 
Tris-buffered saline T5912 Sigma-Aldrich 
Tris-buffered saline with 
0.1 % Tween® 20 
T9039 Sigma-Aldrich 
Trizma® hydrochloride buffer 
solution 
93313 Sigma-Aldrich 
Trypsin / EDTA solution T4049 Sigma-Aldrich 
Type I collagen gel (rat tail)  A10483-01 
Gibco by Life 
Technologies™ 
Vectashield antifade 
mounting medium with DAPI 
H-1200 Vector Laboratories 
Wiegert’s haematoxylin HS375 TCS Biosciences Ltd 
Xylene X/0250 
Thermo Fisher Scientific 
Ltd. 
 
2.1.3 Antibodies: 
Details of primary antibodies, corresponding antigen retrieval method and 
secondary antibodies used for immunohistochemical labelling are listed in 
Table  2.4. 
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Table ‎2.4: Details of primary antibodies, the corresponding antigen retrieval method and isotypes used throughout the study 
Antigen Supplier 
Source/ 
Clone/ 
Concentration 
supplied 
Antigen retrieval 
Method 
Secondary 
antibody 
Dilution/ 
Concentration 
used 
Isotype 
Alkaline 
phosphatase 
BioScience 
GTX100817 
Rabbit polyclonal 
48 µg.mL-1 
Heat induced with 
citric acid buffer 
Horseradish 
peroxidase  
1:1000 
48 µg.mL-1 
IgG 
Alpha-smooth 
muscle actin 
Abcam  
ab7817 
Mouse monoclonal 
1A4 
0.2 µg.mL-1 
Heat induced with 
citric acid buffer 
ImmPRESS 
Excel 
1:500 
0.4 µg.mL-1 
IgG2a, Kappa 
Collagen-I  
Abcam  
ab90395 
Mouse monoclonal 
COL-1 
5-10 mg.mL-1 
Heat induced with 
Tris-EDTA buffer  
ImmPRESS 
Excel 
1:100 
50-100 µg.mL-1 
IgG1 
Collagen-III  
Abcam  
ab6310 
Mouse monoclonal 
FH-7A 
3.300 mg.mL-1 
Heat induced with 
citric acid buffer 
ImmPRESS 
Excel 
1:200 
16.5 µg.mL-1 
IgG1 
Dentine matrix 
protein-1  
Santa Cruz 
sc-73633 
Mouse monoclonal 
LFMb-31 
200 µl.mL-1 
Heat induced with 
citric acid buffer 
ImmPRESS 
Excel 
1:100 
2 µg.mL-1 
IgG1, Kappa 
Dentine 
sialophospoprotein 
Santa Cruz 
sc-73632 
Mouse monoclonal 
LFMb-21 
200 µl.mL-1 
Heat induced with 
citric acid buffer 
ImmPRESS 
Excel 
1:1000 
0.2 µg.mL-1 
IgG2b, Kappa 
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Fibronectin  
Abcam  
ab6328 
Mouse monoclonal 
IST-9 
1.140 mg.mL-1 
Enzymatic 
antigen retrieval 
 
ImmPRESS 
Excel 
1:50 
22.8 µg.mL-1 
IgG1 
Major 
histocompatibility 
class II RT1B 
BIO-RAD 
MCA46R 
Mouse monoclonal 
OX-6 
1 mg.mL-1 
Heat induced with 
citric acid buffer 
ImmPRESS 
Excel 
1:200 
5 µg.mL-1 
IgG1 
Major 
histocompatibility 
class II, HLA-DR 
alpha-chain. 
DAKO 
M0746 
Mouse monoclonal 
TAL.1B5 
Heat induced with 
citric acid buffer 
ImmPRESS 
Excel 
1:150 
0.35 µg.mL-1 
IgG1, Kappa. 
Laminin  
NovusBio 
NB300-144 
Rabbit polyclonal 
LAMA1 
1 mg.mL-1 
Enzymatic 
antigen retrieval 
Horseradish 
peroxidase 
1:400 
2.5 µg.mL-1 
IgG 
Vascular 
endothelial growth 
factor receptor-2 
Cell Signaling 
2479 
Rabbit monoclonal 
KDR, Flk-1 
100 µg.mL-1 
Heat induced with 
Tris-EDTA buffer 
Horseradish 
peroxidase 
1:25 
4 µg.mL-1 
IgG 
Vimentin 
DAKO  
M0725 
Mouse monoclonal 
V9 
360 mg.mL-1 
Heat induced with 
citric acid buffer 
ImmPRESS 
Excel 
1:10000 
36 µg.mL-1 
IgG1, Kappa 
Vascular 
endothelial growth 
factor A 
Abcam 
ab46154 
Rabbit polyclonal 
1 mg.mL-1 
Heat induced with 
Tris-EDTA buffer 
Horseradish 
peroxidase 
1:200 (overnight) 
5 µg.mL-1 
IgG 
Nestin 
R&D Systems 
MAB1259 
Mouse monoclonal 
196908 
0.5 mg.mL-1 
Heat induced with 
Tris-EDTA buffer 
ImmPRESS 
Excel 
1:5000 
0.1 µg.mL-1 
IgG1 
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2.1.4 Isotype controls: 
Details of isotype controls used for immunohistochemical labelling are listed in 
Table  2.5.  The concentration used for isotype control was the same as the 
corresponding primary antibody. 
Table ‎2.5: Isotype controls used throughout the study 
Isotype Supplier 
Source/ 
Clone/ 
Concentration supplied 
IgG 
Abcam  
ab199507 
Rabbit monoclonal 
EPR25A 
0.5 mg.mL-1 
IgG1 
Abcam  
ab91353 
Mouse monoclonal 
B11/6 
0.1 mg.mL-1 
IgG1 Kappa 
Sigma-Aldrich 
M9269 
Mouse monoclonal 
MOPC 21 
1.0 mg.mL-1 
IgG2a Kappa 
Sigma-Aldrich 
M-7769 
Mouse monoclonal 
UPC 10 
5 mg.mL-1 
IgG2b Kappa 
DAKO 
X0944 
Mouse monoclonal 
DAK-GO9 
87 µg.mL-1 
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2.2 General methods: 
2.2.1 Tissue procurement: 
2.2.1.1 Rat teeth collection and pulp retrieval:  
Wistar male rats, 28 days (± 2 days), were obtained from Central Biomedical 
Services (University of Leeds, UK) following appropriate methods of humane 
killing listed on Schedule 1 of the Animals (Scientific Procedures) Act 1986.  All 
attempts were made to reduce the number of animals used.  Rats were 
sacrificed with only rat heads collected.  Two mandibular incisors were carefully 
extracted from each rat jaw.  Rat pulp tissues were then carefully retrieved with 
a sterile scalpel and fine tweezers in a Class II safety cabinet. 
2.2.1.2 Human teeth collection and pulp retrieval: 
Human permanent molars and premolars free from any visible decay, fracture 
or developmental anomaly were included in this work.  All teeth were collected 
within 48 hours following extraction from Leeds Dental Institute (University of 
Leeds, United Kingdom).  Full written patient consent and appropriate ethical 
approval (Skeletal Research Tissue Bank; reference number 101013/MME/113; 
Appendix A) were obtained, according to the Human Tissue Act.  Donors were 
both male and female with an age range between 11 - 30 years. 
External tooth surfaces were cleaned with 70 % (v/v) ethanol and cleared from 
any remaining adhering external soft tissue using a sterile scalpel in Class II 
safety cabinet.  Two methods were investigated for dental pulp retrieval as 
described below: 
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Method 1: 
Teeth were initially decoronated (horizontally) followed by two longitudinal cuts 
on both sides of the root surface using a hand-held drill with a diamond disc.  
The root fragments were separated manually using sterile dental instruments 
(tweezers and a flat plastic instrument).  The pulp tissue was then aseptically 
retrieved.  Unfortunately, following testing the above method several times, the 
procedure was impractical.  Holding the tooth stable while drilling was a 
challenge and possessed a significant hazard. 
Method 2: 
Teeth were placed in sterile gloves and broken using a screw vice clamp.  The 
pulp tissues were carefully retrieved with sterile tweezers in a Class II safety 
cabinet.  This method was more reliable and safer then Method 1.  The 
extracted pulp tissue was carefully examined under strong light and 
magnification to remove any adhering dentine chips. 
2.2.2 Tissue decellularisation: 
2.2.2.1 Decellularisation solutions and reagents preparation: 
Solution preparation steps were carried out aseptically in a Class II safety 
cabinet and adjusted to the required pH using hydrochloric acid or sodium 
hydroxide.  Non sterile solutions were sterile filtered through a 0.2 µm filter. 
Hypotonic Tris buffer (10 mM Tris, 0.1 % w/v ethylene-diamine-tetra-acetic acid 
and 10 Kallikrein Inhibitor Unit (KIU).mL-1 Aprotinin) was prepared by adding 
1 mL of Tris solution (1 M Tris, pH 8.0), 680 µL of ethylene-diamine-tetra-acetic 
acid solution (EDTA, 500 mM), 96.2 µL of Aprotinin solution (10,400 KIU.mL-1) 
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and completed to the total volume of 100 mL with distilled water.  This buffer 
was made fresh before usage. 
Hypotonic sodium dodecyl sulphate (SDS)  buffer (0.03 % w/v SDS, 10 mM 
Tris, 0.1 % w/v EDTA and 10 KIU.mL-1 Aprotinin) was prepared by adding 
300 µL of SDS solution (10 % w/v) to 99.70 mL hypotonic buffer (prepared 
above), to make a final volume of 100 mL.  This buffer was made fresh before 
usage. 
Nuclease treatment solution (DNase 50 U.mL-1, RNase 1 U.mL-1) in buffer 
(50 mM Tris-hydrochloric acid, 10 mM magnesium chloride and 50 µg.mL-1 
bovine serum albumin; pH 7.5) was prepared by mixing 5 mL of 
Tris-hydrochloric acid (Tris-HCL) solution (1 M, pH 7.5), 1 mL of magnesium 
chloride solution (1 M) and 14.28 mL of bovine serum albumin solution.  
Followed by the addition of 5 mL DNase solution (1000 U.mL-1) and 40 µL 
RNase solution (2523 U.mL-1) and completed to a total volume of 100 mL with 
distilled water.  This solution was made fresh before usage.   
Phosphate buffered saline (PBS) wash buffer with Aprotinin (10 KIU.mL-1) was 
prepared by adding 0.48 mL of Aprotinin solution (10,400 KIU.mL-1) to 
499.52 mL of PBS (pH 7.4) to make a total volume of 500 mL.  This solution 
was made fresh before usage.  
Peracetic acid solution (0.1 % v/v) was prepared by adding 225 µL of peracetic 
acid PBS without magnesium and calcium (pH 7.4) to a total volume of 100 mL.  
This solution was made fresh before usage.  
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2.2.2.2 Decellularisation protocol: 
The decellularised protocol was carried out according to Wilshaw et al. (2006) 
as described below. All decellularisation treatments were carried out in 7 mL 
bijou tubes containing one pulp tissue in 4 mL solution.  Tissue samples were 
initially washed in PBS (pH 7.4) containing Aprotinin (10 KIU.mL-1) at room 
temperature, three times for 30 minutes.  Samples were then placed into 
hypotonic Tris buffer (10 mM Tris, 0.1 % w/v EDTA and 10 KIU.mL-1 Aprotinin) 
at 4 °C for 16 hours.  The following day samples were incubated in hypotonic 
SDS buffer (0.03 % w/v SDS, 10 mM Tris, 0.1 % w/v EDTA and 10 KIU.mL-1 
Aprotinin) at 25 °C for 24 hours with agitation at 120 revolutions per minute 
(rpm).  The next day samples were washed in TBS (pH 7.6) containing no 
protease inhibitors with agitation at 160 rpm, three times for 30 minutes before 
Incubation with nucleases treatment solution (DNase 50 U.mL-1, RNase 
1 U.mL-1) in buffer (50 mM Tris-HCL, 10 mM magnesium chloride and 
50 µg.mL-1 bovine serum albumin; pH 7.5) at 37 °C for three hours with 
agitation at 80 rpm.  Subsequently, samples were washed in TBS (pH 7.6) 
containing no protease inhibitors with agitation at 160 rpm twice for 20 minutes 
followed by one overnight wash (16 hours).  Samples were then disinfected with 
0.1 % (v/v) peracetic acid solution at room temperature for three hours with 
agitation at 160 rpm.  Finally tissue samples were washed thrice in TBS (pH 7.6) 
with agitation at 160 rpm for 30 minutes each. 
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2.2.3 General histological technique: 
2.2.3.1 Tissue fixation, processing and paraffin embedding: 
Tissue samples were fully immersed in prefilled pots containing 10 % (v/v) 
neutral buffered formalin (4 % formaldehyde) for 24 hours followed by 
immersion in 70 % (v/v) ethanol.  To avoid tissue loss during paraffin 
embedding and to facilitate the orientation of the samples, pulp tissues were 
carefully embedded in 2 % (w/v) agar (dissolved in PBS) using silicone 
embedding moulds. 
The tissue-agar blocks were left to solidify for approximately 30 minutes at 4 °C.  
Tissue-agar blocks were placed in plastic histological cassettes and processed 
using an automated tissue processor using a routine protocol.  Briefly, the 
specimens were dehydrated in series of ascending ethanol concentrations, 
cleared in three consecutive immersions of xylene and finally infused with 
paraffin wax (tissue processing protocol detailed below in Table  2.6). 
The cassettes were transferred into paraffin within the wax embedding machine.  
Tissue-agar blocks were removed from the cassettes and embedded carefully 
in paraffin using stainless steel moulds.  The histology cassettes were replaced 
on the top surface of the moulds, topped up with excess molten wax and left to 
solidify on a cold plate.  Stainless steel moulds were then removed, excess wax 
trimmed and stored until future sectioning. 
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Table ‎2.6: Tissue processor protocol 
Routine processing protocol Time Temperature 
70 % (v/v) ethanol 30 minutes 37 °C 
80 % (v/v) ethanol 30 minutes 37 °C 
90 % (v/v) ethanol 30 minutes 37 °C 
95 % (v/v) ethanol 30 minutes 37 °C 
100 % (v/v) ethanol 60 minutes 37 °C 
100 % (v/v) ethanol 60 minutes 37 °C 
100 % (v/v) ethanol 90 minutes 37 °C 
Xylene 60 minutes 37 °C 
Xylene 90 minutes 37 °C 
Xylene 90 minutes 37 °C 
Wax 60 minutes 65 °C 
Wax 60 minutes 65 °C 
Wax 60 minutes 65 °C 
 
2.2.3.2 Tissue sectioning and slide preparation: 
Tissue embedded wax blocks were serial sectioned at 5 μm thickness for 
histology and immunohistochemistry staining using a rotatory microtome.  
Sections were placed to fluctuate on a hot water bath at 45 °C, collected on 
microscopic glass slides and left to dry overnight at 37 °C.  Then every five in 
20 sections were stained with haematoxylin and eosin to enable the selection of 
the most representative batch of slides to be stained for additional histology and 
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immunohistochemistry studies.  All slides were heated for 20 minutes on a hot 
plate at 60 °C before dewaxing to maximise tissue adherence to glass slides. 
2.2.3.3 Dewaxing and rehydration of paraffin embedded tissue sections: 
The slides were immersed into four changes of xylene for five minutes each, 
rehydrated using descending ethanol series.  This involved two changes of 
100 % (v/v) ethanol, one change of 90 % (v/v) ethanol and one change of 
75 % (v/v) ethanol for two minutes each.  Finally the slides were gently rinsed 
using running tap water for an additional one minute. 
2.2.3.4 Dehydration and clearing of stained tissue sections: 
Following staining, the slides were dehydrated using ascending ethanol series. 
This involved one change of 75 % (v/v) ethanol for five minutes and three 
changes of 100 % (v/v) ethanol for 20 seconds.  The slides were then cleared in 
four successive changes of xylene for five minute each. Finally, the slides were 
mounted using a synthetic resin mounting media (DPX mountant) and a cover 
slip. 
2.2.4 Histological staining methods: 
2.2.4.1 Haematoxylin and eosin staining: 
Haematoxylin and eosin (H&E) staining was used to view general tissue 
histoarchitecture.  Following dewaxing and rehydration (Section  2.2.3.3), tissue 
sections were immersed in Mayer’s haematoxylin for three minutes and rinsed 
under a gentle flow of tap water for one minute.  Sections were then immersed 
in Scott’s tap water for one minute and rinsed with tap water for an additional 
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one minute.  Subsequently, tissue sections were immersed in eosin for four 
minutes and rinsed with tap water for 30 seconds.  Following staining, the slides 
were dehydrated, cleared and mounted (Section  2.2.3.4).  Stained slides were 
kept overnight in a fume cupboard before viewing under bright-field microscopy 
using normal Köhler illumination.  Images were captured digitally using an 
Axioplan Zeiss light microscope fitted with AxioCam colour camera and 
AxioVision Rel. 4.8 software. 
2.2.4.2 4′,6-diamidino-2-phenylindole (DAPI) staining: 
Vectashield Antifade Mounting Medium with DAPI was used to locate cell nuclei 
and/or residual nuclear material.  Following dewaxing and rehydration 
(Section  2.2.3.3), the slides were washed in PBS (pH 7.4) and a drop of 
Vectashield Antifade Mounting Medium with DAPI was placed over the tissue 
section of each slide and mounted with a cover slip.  Slides were viewed under 
fluorescence microscopy equipped with a DAPI filter set at 49 beamsplitter 
FT395 with excitation 365 nm and emission 445 / 450 nm wave lengths.  
Images were captured using a Zeiss Axio imager Z1 with ApoTome fitted with 
black and white Axiocam camera and AxioVision Rel. 4.7 software. 
2.2.4.3 Alcian blue staining: 
Alcian blue staining was used to view acidic mucosubstances and acetic mucins 
within the tissue.  Following dewaxing and rehydration (Section  2.2.3.3), tissue 
sections were immersed in 3 % (v/v) Glacial acetic acid for three minutes, 
stained with 1 % (v/v) Alcian blue (pH 2.5) solution for 30 minutes and rinsed in 
distilled water.  Sections were then counterstained in 0.1 % (w/v) nuclear fast 
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red solution for 10 minutes and rinsed under a gentle flow of tap water for 
one minute.  Following staining, the slides were dehydrated, cleared and 
mounted (Section  2.2.3.4).  Stained slides were kept overnight in a fume 
cupboard before viewing under bright-field microscopy using normal Köhler 
illumination.  Images were captured digitally using an Axioplan Zeiss light 
microscope fitted with an AxioCam colour camera and AxioVision Rel. 4.8 
software. 
2.2.4.4 Picrosirius red staining: 
Picrosirius red staining was used to visualise collagen in the tissue.  Following 
dewaxing and rehydration (Section  2.2.3.3), tissue sections were immersed in 
Wiegert’s hematoxylin for eight minutes and rinsed in distilled water.  Sections 
were then immersed in phosphomolybdic acid for two minutes and rinsed in 
distilled water.  Subsequently, tissue sections were immersed in Picrosirius red 
solution for 60 minutes, hydrochloric acid for two minutes and in 70 % (v/v) 
ethanol for 45 seconds.  Following staining, the slides were dehydrated, cleared 
and mounted (Section  2.2.3.4).  Stained slides were kept overnight in a fume 
cupboard before viewing under bright field and polarised light.  Images were 
captured digitally using a Zeiss M2 Axio imager polarised microscopic and Zen 
Blue 2015 software. 
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2.2.5 Immunohistochemical labelling: 
Immunohistochemical labelling was carried out on formalin fixed paraffin 
embedded samples.  All immunohistochemistry slides were initially dewaxed 
and rehydrated (Section  2.2.3.3), subjected to specific antigen retrieval 
treatment followed by primary and secondary antibody staining procedure as 
described below and summarised in Table  2.4. 
2.2.5.1 Antigen retrieval methods: 
i. Heat-induced antigen retrieval using citric acid buffer:  This step involved a 
commercially available antigen unmasking solution consisting of citric acid 
buffer (pH 6.0).  Slides were placed in a suitable slide rack container, fully 
immersed in citric acid buffer and inserted in a pressure cooker. The pressure 
cooker was heated to full pressure at 125 °C for two minutes and allowed to 
cool before removal of the slides. 
ii. Heat-induced antigen retrieval using Tris-EDTA buffer:  This step involved a 
commercially available antigen unmasking solution consisting of Tris-EDTA 
buffer (pH 9.0).  Slides were placed in a suitable slide rack container, fully 
immersed in Tris-EDTA buffer and inserted in a pressure cooker. The pressure 
cooker was heated to full pressure at 125 °C for two minutes and allowed to 
cool before removal of the slides. 
iii. Enzymatic antigen retrieval:  Bond™ enzyme pretreatment kit was used 
following mixing enzyme concentrate and an enzyme diluent.  Slides were 
placed in an air humidifier chamber with tissue sections covered with enzyme 
mix and incubated at 37 °C for 15 minutes. 
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2.2.5.2 Immunohistochemistry labelling procedure: 
Following antigen retrieval, all tissue sections were subjected to endogenous 
hydrogen peroxidase blocking with Bloxall for 10 minutes.  Tissue sections were 
washed once with TBS containing 0.1 % (v/v) Tween 20 (pH 7.6) for five 
minutes, subjected to protein blocking (1 / 10 casein) for 20 minutes and then 
incubated with the primary antibody or the appropriate isotype control at room 
temperature for one hour. 
Subsequently, the slides were washed twice with TBS containing 0.1 % (v/v) 
Tween 20 (pH 7.6) for five minutes and then subjected to secondary antibody 
staining (immunolabelling) using either ImmPRESS Excel peroxidase 
anti-mouse or Horseradish peroxidase (HRP) anti-rabbit polymer following 
manufacturer’s instructions at room temperature for 30 minutes. 
Next, the slides were washed twice with TBS (pH 7.6) for five minutes and 
stained with ImmPACT 3,3’-diaminobenzidine (DAB) Peroxidase chromogen 
substrate at room temperature for five minutes.  The slides were then rinsed 
under a gentle flow of tap water and counterstained with Mayer’s haematoxylin 
for 30 seconds. 
Following staining, the slides were then dehydrated, cleared and mounted 
(Section  2.2.3.4).  Slides were left to dry overnight in a fume cupboard before 
viewing under bright-field microscopy using normal Köhler illumination.  Images 
were captured digitally using an Axioplan Zeiss light microscope fitted with 
AxioCam colour camera and AxioVision Rel. 4.8 software. 
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2.2.6 DNA quantification assay: 
DNA extraction was performed using DNeasy Blood and Tissue Kit following 
manufacturer’s instructions (summarised in Figure  2.1).  Dental pulp tissues 
were cut into small pieces, placed in a 1.5 mL DNase-and RNase-Free sterile 
microcentrifuge tube and lysed using proteinase K enzyme.  Samples were 
incubated with proteinase K at 56 °C overnight until tissues were completely 
lysed.  Pulse vortexing was regularly performed throughout the experimental 
steps as per manufacturer’s instructions.  The extracted DNA was collected in 
the flow-through of buffer AE and immediately quantified using a 
NanoDrop™ 2000 spectrophotometer with a measuring absorbance wavelength 
of 260 / 280 nm.  The DNA content, of each sample, was normalised to the dry 
weight to determine the DNA content per tissue dry weight.  Three readings per 
sample were taken and the mean of these readings was calculated. 
To assess pulp tissue water content, randomly selected pulp tissues (in 
triplicates) were initially weighted (wet weight).  Pulp tissues then underwent 
freeze-dry procedure and re-weighted (dry weight).  The average pulp tissue 
water content was found to be approximately 70 % water (Appendix B).  The 
percentage of pulp tissue water content was calculated based on the below 
equation: 
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Figure ‎2.1: DNA extraction protocol. 
Step 7 
Place columns in a new 1.5 mL microcentrifuge tubes, add 100 μL of buffer 
AE and centrifuge for at 6000 x g  for one minute 
Step 6 
Place columns in a new 2 mL collection tubes, add 500 μL of buffer AW2 and 
centrifuge at 20,000 x g for three minutes 
Step 5  
Place columns in a new 2 mL collection tubes, add 500 μL of buffer AW1 and 
centrifuge at 6000 x g for one minute 
Step 4 
Transfer the samples into DNeasy Mini spin columns placed in a 2 mL 
collection tubes and centrifuge at 6000 x g for one minute 
Step 3 
Add 200 μL 100 % (v/v) ethanol and mix thoroughly by vortexing 
Step 2 
Add 200 μL buffer AL and mix thoroughly by vortexing 
Step 1 
Add 180 µL buffer ATL and 20 µL proteinase K to pulp tissue and mix 
thoroughly by vortexing  
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2.2.7 Scanning electron microscope: 
Sample preparation for scanning electron microscope (SEM) imaging initially 
involved tissue fixation in 2.5 % (v/v) glutaraldehyde solution overnight at 4 °C.  
Tissue samples were then washed thrice in distilled water for 10 minutes each, 
dehydrated in ascending concentrations of ethanol (30, 50, 70, 80, 90, and 
95 % v/v) for 10 minutes each and a final concentration of 100 % (v/v) ethanol 
thrice for 20 minutes each.  Fixed dehydrated samples were then exposed to 
50 % (v/v) hexamethyldisilazane in ethanol solution for 10 minutes followed by 
100 % (v/v) hexamethyldisilazane solution twice for 15 minutes each.  Finally 
samples were placed in 100 % (v/v) hexamethyldisilazane solution and left to 
evaporate overnight in a fume hood.  Before SEM viewing, samples were 
affixed to 1.2 mm aluminium stubs with adhesive carbon tape and gold sputter 
coated for 80 seconds in an argon gas chamber at 3 millibars. 
2.2.8 Cell culture techniques: 
As standard procedures, all cell culture work was performed aseptically in a 
Class II safety cabinet and incubated in a humidified atmosphere incubator 
containing 5 % (v/v) CO2 and 95 % air at 37 °C.  All tissue culture reagents and 
additives were equilibrated to 37 °C before usage. 
2.2.8.1 Cell types used: 
Cell types used throughout the study are listed in Table  2.7.  Patient consent 
and ethical approval (Skeletal Research Tissue Bank; reference number 
101013/MME/113; Appendix A) was obtained prior to the use of human dental 
pulp stem cells (DPSCs). 
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Table ‎2.7: Cell types used throughout the study 
Cell Type Species Supplier 
L-929 cell line Fibroblasts Murine 
Cell line reserve, 
Oral biology department, 
University of Leeds, UK. 
Dental pulp stem cells Primary cells Human 
Dr Matthew Tomlinson, 
Oral biology department, 
University of Leeds, UK. 
 
Human DPSCs used in this work, kindly provided by Dr M Tomlinson, were 
isolated and cultured as described in (Tomlinson et al., 2015).  Briefly, tooth 
surfaces were disinfected with 70 % (v/v) ethanol and any adherent soft tissue 
removed.  The teeth were fractured and pulp tissue aseptically retrieved.  Pulp 
tissues were mechanically disrupted and enzymatically digested in 3 mg.mL-1 
collagenase type I and 4 mg.mL-1 dispase solution, incubated at 37 °C in 5 % 
(v/v) CO2 and 95 % relative humidity with gentle agitation.  Subsequently, the 
suspension was passed through a 70 μm cell strainer and centrifuged at 200 x g 
for five minutes.  The collected cell pellet was then suspended in alpha-modified 
Eagle’s medium supplemented with 15 % (v/v) foetal bovine serum (FBS), 
1 % (v/v) 2 mM L-glutamine and antibiotics solutions (100 U.mL-1 penicillin and 
100 µg.mL-1 streptomycin).   
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2.2.8.2 Cell specific culture medium: 
L-929 cell line culture medium: 
Dulbecco’s modified Eagle’s medium (DMEM) was used as a standard culture 
medium supplemented with 10 % (v/v) FBS, 1 % (v/v) 2 mM L-glutamine and 
antibiotics solutions (100 U.mL-1 penicillin and 100 µg.mL-1 streptomycin).  The 
complete culture medium was stored at 4 °C for up to seven days. 
Human dental pulp stem cells culture medium: 
Alpha-modified Eagle’s medium was used as a standard culture medium 
supplemented with 10 % (v/v) FBS, 1 % (v/v) 2 mM L-glutamine and antibiotics 
solutions (100 U.mL-1 penicillin and 100 µg.mL-1 streptomycin).  The complete 
culture medium was stored at 4 °C for up to seven days. 
2.2.8.3 Cell resurrection and maintenance: 
Cells were removed from either liquid nitrogen (-196 °C) for long-time storage or 
-80 °C freezer for short-term storage, and rapidly thawed in the water bath set 
at 37 °C.  The defrosted cell stock (1 mL) was immediately transferred in to 
15 mL falcon tube and mixed with 9 mL of the cell specific medium.  The cell 
suspension was then centrifuged at 150 x g for five minutes.   
Following centrifugation, the supernatant was carefully aspirated and the cell 
pellet was initially resuspended in 1 mL followed by 9 mL of cell specific 
medium.  The cell suspension solution was then divided into cell culture flasks 
as per volume and size required.  Cell specific medium was changed every 
three days and cell growth, attachment, and proliferation was checked under 
phase contrast illumination using an inverted light microscope. 
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2.2.8.4 Cell passaging and counting: 
Cells were passaged when they reached approximately 70 – 80 % confluency 
(density) within the cell culture flasks.  Cell medium was aspirated from the cell 
culture flasks and the cell surface monolayer was washed twice with PBS (7.4) 
without calcium and magnesium (10 mL for T75 and 20 mL for T175, size 
flasks) for five minutes.  Cells were then passaged by digestion with 0.25 % 
trypsin and 0.02 % EDTA solution, added to the cell culture flasks (5 mL for T75 
and 10 mL for T175, size flasks) and incubated at 37 °C for three to 
five minutes.  After the short incubation duration, cell detachment (floating cells) 
was assessed using an inverted microscope.  On successful detachment, 
complete cell specific medium (10 mL for T75 and 20 mL for T175, size flasks) 
was added to each flask to deactivate trypsin / EDTA solution activity.  Flask 
contents were then transferred into a universal tube and centrifuged at 150 x g 
for five minutes.  Following centrifugation, the supernatant was discarded and 
the cell pellet was resuspended and homogenised in complete cell specific 
medium.  A viable cell count was performed using a hand held automated cell 
counter fitted with 60 µL tips.  The diluted cell suspension was reseeded into 
fresh cell culture flasks and incubated at 37 °C in 5 % (v/v) CO2 and 95 % 
relative humidity. 
2.2.8.5 Cell cryopreservation: 
For future cell storage, cryopreserved medium consisting of 90 % (v/v) FBS and 
10 % (v/v) filter sterilised Dimethyl sulfoxide (DMSO) was used.  The 
cryopreserved medium was then added to the formed cell pellet.  The cell 
suspension was aliquoted to 1 mL into CryoTube® vials and placed in 
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cryo-freezing pots containing isopropanol at -80 °C for a minimum of three 
hours for gradual temperature reduction.  CryoTube® vials were stored at -80 °C 
or liquid nitrogen (-196 °C) for short or long term storage, respectively. 
2.2.9 Cytotoxicity evaluation: 
2.2.9.1 Contact cytotoxicity assay: 
Contact cytotoxicity assay was performed with L-929 murine fibroblast cell lines 
in direct contact with the study samples and relevant controls.  Controls used 
included cyanoacrylate adhesive glue as a positive control and type I collagen 
gel as a negative control. 
All cell culture well plates were washed using three changes of sterile PBS 
(pH 7.4) without calcium and magnesium for 10 minutes.  L-929 cell lines were 
cultured and maintained in their standard culture medium and diluted to a cell 
concentration of 2 x 105 cells.mL-1.  A volume of 2 mL of the diluted cell 
suspension, 4 x 105 cells per well, was added to the appropriate six-well cell 
culture plates and incubated for 48 hours in a humidified atmosphere incubator 
containing 5 % (v/v) CO2 and 95 % air at 37 °C.  Following incubation, the 
culture medium was carefully aspirated and the well plates were gently washed 
with PBS (pH 7.4) containing calcium and magnesium.  Subsequently, the PBS 
was aspirated and the cells were fixed with 10 % (v/v) neutral buffered formalin 
for 10 minutes.  The fixed cells were then stained with Giemsa solution for an 
additional five minutes.  The plates were gently washed well with distilled water 
and left to air dry.  
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Type I collagen rat tail gel preparation protocol: 
To form a firm collagen gel manufacturer’s instructions were followed as 
described below: 
                            (  )
  
                                               ( )
                              
 
               (   )          (  )   
 
  
 
                                    (  )             
                                  (  )  ( )  (        ) 
The required quantities of distilled water, sodium hydroxide, and PBS (10X) 
were added in a sterile Eppendorf tube.  Collagen gel was slowly pipetted, 
added to the above and mixed well by gently pipetted up and down.  The 
collagen mix was immediately placed on the desired plates and incubated at 
37 °C for 30 to 40 minutes for a formation of a firm gel. 
2.2.9.2 Extract cytotoxicity assay: 
Extract cytotoxicity assay was performed with L-929 murine fibroblast cell lines 
incubated in test material extract and relevant controls.  Controls used included 
40 % (v/v) DMSO in DMEM as a positive control and serum-free DMEM as a 
negative control.  For the test extract decellularised tissues were finely 
macerated and aseptically weighed.  The macerated tissue were placed into 
sterile microcentrifuge tubes containing serum-free DMEM (ratio of 1 mL per 
100 mg tissue) and incubated at 37 °C for 72 hours with agitation.  Following 
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incubation, the microcentrifuge tubes were centrifuged at 500 x g for 15 
minutes.  The supernatants (test extract) were aseptically collected and sterility 
was assured by streaking onto fresh blood agar plates.  The blood agar plates 
were checked for sterility following 48 hours incubation at 37 °C.  The test 
extracts were stored at -20 °C until the experimental day. 
L-929 cell lines were cultured and maintained in their standard culture medium 
and diluted to a concentration of 5 x 104 cells.mL-1.  A volume of 200 µL of the 
diluted cell suspension, 1 x 104 cells per well, was added to the appropriate 
wells of 96-well cell culture plates and incubated for overnight at 37 °C in 5 % 
(v/v) CO2 and 95 % relative humidity. 
On the day of the experiment, the test extracts and controls were warmed to 
37 °C.  At the same time, the medium from each well plate was gently aspirated 
and replaced with 100 µL of double strength DMEM containing 20 % (v/v) FBS, 
2 % (v/v) 2 mM L-glutamine and antibiotics solutions (200 U.mL-1 penicillin and 
200 µ.mL-1 streptomycin).  Followed by, 100 µL of test extracts or control 
solutions.  The cell culture plates were then incubated for 24 hours in a 
humidified atmosphere incubator containing 5 % (v/v) CO2 and 95 % air at 
37 °C. Following incubation, cell viability measuring the relative cellular 
adenosine triphosphate (ATP) content was determined using the ATPLite™ 
assay following manufacturer’s instructions. 
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ATPLite™‎assay: 
The culture medium of test and control well plates were aspirated and 50 µL of 
fresh cell culture medium and 50 µL of mammalian cell lysis solution were 
added to each well and incubated at room temperature for five minutes with 
constant shaking.  The contents of the each well were carefully transferred to 
white 96-well Optiplate™, supplemented with 50 µL of substrate solution and 
incubated for five minutes with constant shaking.  The Optiplate™ was left to 
dark adapt at room temperature for 10 minutes and luminescence measured 
using TopCount™ plate reader. 
2.2.10 Recellularisation of decellularised scaffold with dental pulp 
stem cells: 
The decellularised scaffolds were individually placed in a sterile Eppendorf tube 
(200 µL capacity) supplemented with 180 µL of a diluted cell suspension.  A 
hole was made in each Eppendorf lid and sealed with opsite flexigrid 
membrane, an adhesive polyurethane film that allows gas exchange, while 
keeping the contents of the tube sterile.  The Eppendorf tubes were placed in 
an in-house rotator apparatus (Figure  2.2) set at 10 rpm, to allow dynamic 
seeding, and incubated for 24 hours in a humidified atmosphere incubator 
containing 5 % (v/v) CO2 and 95 % air at 37 °C.  The scaffolds were then 
carefully transferred into a 12-well cell culture plates, topped up with 2 mL of 
fresh cell culture medium.  The culture medium was changed every three days 
throughout the duration of the experiment (7 and 14 days culture period). 
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Figure ‎2.2: Seeding rotator apparatus.  The device consists of two rotating modules attached 
on rotating cylinders powered by a motor source. 
 
2.2.11 Cell viability assay: 
Cell viability of the recellularised scaffolds was assessed using a commercial 
Live/Dead® stain following manufacturer’s instructions.  A solution of 5 µL 
calcein-AM and 20 µL ethidium homodimer-1 in 10 mL in serum-free 
alpha-modified Eagle’s medium was freshly prepared before usage.  Scaffolds 
were individually placed in 48-well tissue culture plates and the prepared stain 
solution was added to each well plate to completely cover the scaffolds.  The 
plates were covered and incubated for 45 minutes in a humidified atmosphere 
incubator containing 5 % (v/v) CO2 and 95 % air at 37 °C.  Stained scaffolds 
were washed on a plate rocker in serum-free alpha-modified Eagle’s medium 
for 30 minutes followed by PBS (pH 7.4) for an additional five minute.  The 
scaffolds were wet mounted using PBS and viewed using a confocal laser 
scanning microscope (SP2) with FITC and Texas red filters for dual-labelled 
samples. 
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2.2.12 Statistical analysis: 
All numerical values were presented as means, standard deviations and 95 % 
confidence intervals for each set of results (n = sample number and p = 0.05).  
The independent student’s t-tests were used for the comparison of groups of 
two means.  One-way analysis of variance (ANOVA) with Bonferroni correction 
was used for the comparison of groups of more than two means.  The 
differences between groups were considered significant with a p-value less 
than 0.05.  All statistical analyses were analysed using GraphPad Prism 
(Software version 6).  
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  Chapter 3
Decellularisation of the dental pulp tissues  
3.1 Introduction: 
Despite several scaffold materials currently being researched, in an attempt to 
regenerate the pulp-dentine complex, only limited success has been reported 
(Galler et al., 2011a).  Limitations mainly include biodegradation, 
biocompatibility concerns (Murray et al., 2007) and poor control over newly 
formed tissue resembling more of a connective tissue than a dentine-like 
structure (Zhang et al., 2006a).  Hence, the ideal scaffold for pulp regeneration 
is yet to be identified (Wang et al., 2010b; Song et al., 2017). 
The natural tissue matrix is considered a vital component of all tissues and, 
possibly, the ideal scaffold for tissue regeneration (Badylak, 2002; Badylak, 
2007; Ma, 2008). The extracellular matrix (ECM) is composed of a unique 
mixture of proteins, glycoproteins and proteoglycans organised in tissue specific 
structure (Badylak, 2002).  Recently, the use of biological scaffolds composed 
of an acellular ECM derived though tissue decellularisation has been advocated 
and intensively researched in regenerative medicine (Gilbert et al., 2006; Crapo 
et al., 2011; Song and Ott, 2011). 
Generally, the decellularisation process involves the combined usage of 
chemical and enzymatic agents in addition to physical methods.  The procedure 
starts initially with lysis of the cell membrane, solubilisation of cytoplasmic and 
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nuclear components, ending with removal of cellular debris from the treated 
tissue.  The incorporation of protease inhibitors in the early steps of the 
decellularisation process is known to protect the ECM against undesirable 
damage caused by the release of intracellular proteases during cell lysis 
(Gilbert et al., 2006; Crapo et al., 2011).  Several washes with agitation are also 
incorporated throughout the decellularisation steps, to enhance the removal of 
chemical residues and cellular fragments from the ECM (Gilbert et al., 2006; Fu 
et al., 2014). 
Several decellularisation protocols are available within the literature and vary 
widely dependent on the chemicals used, their concentration, duration of 
exposure, and most importantly the nature of treated tissue.  The selection of a 
decellularising method is crucial in determining the success for developing an 
acellular pulp matrix.  Ideally, the decellularisation process should aim at 
efficient removal of all its cellular and nuclear material while preserving the 
structural and functional matrix proteins (Badylak et al., 2009). 
Detergents are commonly used for cell membrane lysis.  Sodium dodecyl 
sulphate (SDS) is classified as an ionic detergent that is widely incorporated 
within various decellularisation protocols, it is considered to be an extremely 
effective detergent used for solubilising cytoplasmic and nuclear membranes 
(Seddon et al., 2004; Woods and Gratzer, 2005; Gilbert et al., 2006).  However, 
concerns regarding the potential toxicity of residual SDS and tissue damage 
have been reported with 1 % (w/v) SDS.  Bodnar et al. (1986) used 1 % (w/v) 
SDS as a treatment to porcine valves to prevent or delay calcification.  The 
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results of their work demonstrated extreme structural damage causing tissue 
fragmentation, collagen swelling and significant loss of hydrothermal stability 
(Bodnar et al., 1986).  Reducing the concentration of SDS to 0.1 % (w/v) 
resulted in acellular tissues with retained structural histoarchitecture following 
decellularisation of human pericardial tissue (Mirsadraee et al., 2006), human 
common femoral arteries (Wilshaw et al., 2012) and porcine urinary bladder 
(Rosario et al., 2008).  Yoeruek et al. (2012) decellularised porcine corneas with 
0.3 % (w/v) SDS with the addition of protease inhibitors within the 
decellularisation protocol.  Furthermore, Wilshaw et al. (2006) decellularised 
human amniotic membrane using a low detergent protocol, 0.03 % (w/v) SDS, 
with added protease inhibitors.  Results of the above studies, demonstrated 
complete cellular removal with preservation of the structural matrix (Wilshaw et 
al., 2006; Yoeruek et al., 2012).  Indeed preservation of ECM following SDS 
detergent treatment has been directly linked to the low detergent concentration 
and the addition of protease inhibitors (Knight et al., 2008). 
Triton X-100, non-ionic detergent, is also an effective detergent that is 
commonly used for cell membrane lysis.  However, structural disruption of the 
ECM and removal of GAGs is reported with its usage (Gilbert et al., 2006; 
Crapo et al., 2011).  Significant loss of GAG content was reported following the 
use of Triton X-100 to decellularise porcine aortic heart valves (Liao et al., 
2008).  Within the dental field, attempts to demineralise and decellularise 
porcine tooth buds (Traphagen et al., 2012), dental pulp tissues obtained from 
miniature swine teeth (Chen et al., 2015), and human tooth pulp tissues within 
root slices (Song et al., 2017) have been recently reported in the dental 
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literature.  Although these protocols varied, they shared a similar dual detergent 
(combined use of SDS and Triton X-100) step.  Despite these reported 
successful results, the use of decellularisation protocols with lower 
concentrations of toxic detergents such as SDS and Triton X-100 is 
advantageous for future cell proliferation and differentiation.  Therefore, a low 
concentration detergent based decellularisation protocol utilising multiple gentle 
steps is of clinical interest. 
Therefore, this chapter describes utilising a relatively mild method, composed of 
0.03 % (w/v) SDS detergent, to decellularise the dental pulp tissues of both rat 
and human species.  The efficiency of the decellularisation in terms of general 
histoarchitecture preservation and cellular removal were evaluated. 
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3.2 Aim and objectives: 
3.2.1 Aim: 
The aim of this chapter was to assess the feasibility of decellularising the whole 
dental pulp of both rat and human species through the use of a mild 
decellularisation method described by Wilshaw et al. (2006). 
3.2.2 Objectives: 
The above aim will be achieved through the following objectives: 
 To determine the efficiency of decellularising the dental pulp on removal 
of cellular material in comparison to the native pulp tissue using 
histological qualitative assessment methods. 
 To confirm the efficiency of decellularisation by evaluation of the total 
DNA content of the decellularised matrix in comparison to the native pulp 
tissue using DNA quantification assay. 
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3.3 Methods and experimental approaches: 
This chapter describes the optimisation of the decellularisation protocol 
described by Wilshaw et al. (2006) for use on dental pulp tissues.  The process 
of optimising the protocol involved two experiments.  Experiment 1 involved the 
use of the Wilshaw decellularisation protocol on human dental pulp tissues.  
Based on the results obtained from experiment 1, the protocol was optimised 
through the inclusion of a freeze-thaw cycle prior to the start of decellularisation 
protocol (Experiment 2).   
3.3.1 Experiment 1: 
Human dental pulp tissues were retrieved as described in Section  2.2.1.2 and 
divided into native (control, n = 4) and decellularisation (study, n = 4) groups.  
The decellularisation process was performed as described in Section  2.2.2 and 
summarised in Figure  3.1.  Images of human pulp tissue following 
decellularisation treatment are shown in Figure  3.2.  Analysis of the native and 
decellularised pulp tissues were evaluated using H&E staining (Section  2.2.4.1) 
to view general tissue histoarchitecture and cell distribution and DAPI staining 
(Section  2.2.4.2) to identify cell nuclei and/or residual nuclear material.  H&E 
stained sections were viewed using normal Köhler illumination, while, DAPI 
stained sections were viewed under reflected illumination equipped with a DAPI 
filter with all images captured digitally. 
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Figure ‎3.1: Process flow diagram of decellularisation experiment 1. 
Step 8 
Tris-buffered saline wash  
Step 7 
Peracetic acid solution Three hours at room temperature  
Step 6 
Tris-buffered saline wash  
Step 5 
Nuclease treatment buffer Three hours at 37 °C 
Step 4 
Tris-buffered saline wash  
Step 3 
Hypotonic SDS buffer 24 hours at room temperature  
Step 2 
Hypotonic Tris buffer 16 hours at 4 °C  
Step 1 
PBS wash with Aprotinin  
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Figure ‎3.2: Representative images of decellularised human pulp tissues. (A and C) Human 
pulp tissues following step 1; washing with hypotonic Tris buffer containing (10 mM Tris, 0.1 % 
w/v EDTA and 10 KIU.mL-1 Aprotinin) and (B and D) Human pulp tissues at completion of 
decellularisation steps. 
 
3.3.2 Experiment 2: 
Based on the results obtained from experiment 1 (Section  3.4.1), the 
decellularisation protocol was modified (as summarised in Figure  3.3) to include 
a single freeze-thaw cycle prior to decellularisation treatment to assist removal 
of residual cellular material.  Retrieved rat (n = 8) and human (n = 8) pulp 
tissues were frozen at -80 °C until usage.  Pulp tissues were divided into native 
(control) and decellularised (study) groups.  Analysis of the native [rat (n = 4) 
and human (n = 4)] and decellularised [rat (n = 4) and human (n = 4)] dental 
pulp tissues were evaluated using H&E (Section  2.2.4.1) and DAPI 
A B 
C D 
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(Section  2.2.4.2) staining methods.  H&E stained slides were viewed using 
normal Köhler illumination, while, DAPI stained slides were viewed under 
reflected illumination equipped with a DAPI filter with all images captured 
digitally.   
Measurement of DNA content of the native and decellularised dental pulp 
tissues was also further performed as described in Section  2.2.6.  Additional rat 
(n = 8) and human (n = 8) dental pulps were collected and equally divided into 
control and study groups.  DNA extraction was performed using a DNeasy 
blood and Tissue Kit following manufacturer’s instructions.  Initially, tissue lyses 
were performed by adding proteinase K solution to each sample individually and 
incubated overnight at 56 °C until completely lysed.  Samples were then loaded 
onto spin columns, washed and centrifuged in order to remove all proteins and 
other contaminating matters.  Finally, the DNA was eluted into sterile DNase–
and RNase-Free Eppendrof tubes.  The extracted DNA was collected and 
quantified using a NanoDrop™ 2000 spectrophotometer with a measuring 
absorbance wavelength at 260 / 280 nm.  Samples were normalised to 70 % 
dry weight with data analysis performed using independent student’s t-test 
(p-value < 0.05). 
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Figure ‎3.3: Process flow diagram of decellularisation experiment 2. 
Step 8 
Tris-buffered saline wash  
Step 7 
Peracetic acid solution Three hours at room temperature  
Step 6 
Tris-buffered saline wash  
Step 5 
Nuclease treatment buffer Three hours at 37 °C 
Step 4 
Tris-buffered saline wash  
Step 3 
Hypotonic SDS buffer 24 hours at room temperature  
Step 2 
Hypotonic Tris buffer 16 hours at 4 °C  
Step 1 
PBS wash with Aprotinin  
Freeze-thaw cycle 
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3.4 Results: 
3.4.1 Results of experiment 1: 
3.4.1.1 Histological analysis of native and decellularised dental pulp 
tissues: 
Serial sections of the native and decellularised human pulp tissues based on 
experiment 1 were stained with H&E and DAPI to determine the efficiency of 
decellularisation. 
Images of native H&E stained tissues viewed under light microscopy are shown 
in Figure  3.4 A and B.  The native pulp tissues appeared as a highly cellular 
structure within a porous connective tissue stroma.  The native human pulp 
connective tissue stroma appears pink following H&E staining, with various 
regions of matrix histoarchitecture clearly evident.  The sub-odontoblastic layer 
was seen at the periphery of the pulp, followed by an acellular layer of Weil 
(cell-fee area), a cell-rich layer and a central pulp core.  A fine network of blood 
vessels, nerve fibres and capillaries was dispersed throughout the porous ECM.  
The native pulp tissues also appeared as a dense cellular structure, cells 
stained blue following H&E staining.  The central pulp core contained spindle 
shaped fibroblasts-like cells and endothelial cells lining the blood vessels.  
Heterogeneity of pulp cells was visible throughout the pulp structure. 
Images of native DAPI stained tissues viewed under fluorescence microscopy 
fitted with a DAPI filter are shown in Figure  3.5 A and B.  DAPI stained native 
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tissues revealed highly cellular pulp tissues, with cell nuclei visible as bright 
blue dots on a black background. 
Following decellularisation, images of decellularised tissue stained with H&E 
and DAPI are shown in Figure  3.4 C, D and Figure  3.5 C, D, respectively.  No 
obvious cell nuclei were observed on the H&E stained sections.  The pulp 
connective tissue stroma appeared, in some areas, more porous with the 
formation of larger spaces in the structural matrix.  Despite this, preservation of 
the pulp tissue histoarchitecture composed of various histological regions and 
vascular channels were evident following decellularisation.  However, blue 
nuclear fluorescent staining was seen in DAPI stained images.  The 
fluorescence was not well defined and much smaller in size than that observed 
in the native tissues.  From these observations it was concluded that the 
decellularisation protocol based on experiment 1 resulted in incomplete tissue 
decellularisation due to the presence of cells or, more likely, residual cellular 
material within the pulp matrix following decellularisation. 
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Figure ‎3.4: Representative images of H&E stained human tissues viewed under the light 
microscope.  (A and B) Native pulp tissue showing a highly cellular structure within a porous 
connective tissue stroma and (C and D) Decellularised pulp tissue (experiment 1) showing an 
acellular structure with preservation of a surrounding stroma. (White arrow) Connective tissue 
stroma stained pink, (Solid black arrow) Cell nuclei stained blue, (od) Sub-odontoblastic layer, 
(cf) Cell-fee layer, (cr) Cell-rich layer, (pc) Pulp core, (bv) Blood vessels, (nf) Nerve fibres and 
(cp) Capillaries. Scale bars are at 50 µm. 
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Figure ‎3.5: Representative images of DAPI stained human pulp tissues viewed under the 
fluorescent microscope.  (A and B) Native pulp tissue showing a highly cellular matrix and (C 
and D) Decellularised pulp tissue (experiment 1) showing few remaining nucleic material. (White 
arrow) Cell nuclei stained blue. Scale bars (A) at 50 µm, (C) at 20 µm and (B and D) at 10 µm. 
A B 
C D 
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3.4.2 Results of experiment 2: 
3.4.2.1 Histological analysis of native and decellularised dental pulp 
tissues: 
Serial sections of the native and decellularised rat and human pulp tissues 
based on experiment 2 were stained with H&E and DAPI to determine the 
efficiency of decellularisation.   
H&E staining of the native rat (Figure  3.6 A, B) and human (Figure  3.8 A, B) 
pulp tissues appeared as a highly cellular connective tissue stroma.  Various 
histological regions (sub-odontoblastic, cell rich, and central pulp core zones) 
were also clearly identified.  DAPI stained images of native rat and human pulp 
tissues are shown in (Figure  3.7 A) and (Figure  3.9 A), respectively.  Following 
staining, DAPI also revealed a highly cellular matrix in all native pulp tissues. 
Following decellularisation, H&E staining of the rat (Figure  3.6 C, D) and human 
(Figure  3.8 C, D) pulp connective tissue stroma appeared, in some areas, more 
porous with the formation of larger spaces in the structural matrix.  Despite this, 
preservation of the various histological regions and vascular channels were 
evident.  No cell nuclei were observed on the H&E stained sections.  This was 
further confirmed with DAPI as no blue nuclear fluorescent staining was visible 
in rat (Figure  3.7 B) and human (Figure  3.9 B) tissue sections.  Collectively, 
observational results of this method indicated complete dental pulp tissue 
decellularisation with preservation of the ECM histoarchitecture.   
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Figure ‎3.6: Representative images of H&E stained rat pulp tissues viewed under the light 
microscope.  (A and B) Native pulp tissue showing a highly cellular structure within a porous 
connective tissue stroma and (C and D) Decellularised pulp tissue (experiment 2) showing an 
acellular structure with preservation of a surrounding stroma. (White arrow) Connective tissue 
stroma stained pink, (Solid black arrow) Cell nuclei stained blue, (od) Sub-odontoblastic layer, 
(cf) Cell-fee layer, (cr) Cell-rich layer, (pc) Pulp core, (bv) Blood vessels, (nf) Nerve fibres and 
(cp) Capillaries. Scale bars are at 50 µm.  
 
 
Figure ‎3.7: Representative images of DAPI stained rat pulp tissues viewed under the 
fluorescent microscope.  (A) Native pulp tissue showing a highly cellular matrix and 
(B) Decellularised pulp tissue (experiment 2) showing no cell nuclei.  (White arrow) Cell nuclei 
stained blue.  Scale bars are at 50 µm. 
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Figure ‎3.8: Representative images of H&E stained human pulp tissues viewed under the 
light microscope.  (A and B) Native pulp tissue showing a highly cellular structure within a 
porous connective tissue stroma and (C and D) Decellularised pulp tissue (experiment 2) 
showing an acellular structure with preservation of a surrounding stroma. (White arrow) 
Connective tissue stroma stained pink, (Solid black arrow) Cell nuclei stained blue, (od) Sub-
odontoblastic layer, (cf) Cell-fee layer, (cr) Cell-rich layer, (pc) Pulp core, (bv) Blood vessels, (nf) 
Nerve fibres and (cp) Capillaries. Scale bars are at 50 µm. 
  
Figure ‎3.9: Representative images of DAPI stained human pulp tissues viewed under the 
fluorescent microscope.  (A) Native pulp tissue showing a highly cellular matrix and (B) 
Decellularised pulp tissue (experiment 2) showing no cell nuclei. (White arrow) Cell nuclei 
stained blue. Scale bars are at 50 µm. 
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3.4.2.2 DNA content analysis of native and decellularised dental pulp 
tissues 
Extracted native and decellularised pulp tissue DNA was quantified to 
determine the total DNA content present following decellularisation 
(experiment 2).  Results of both rat and human tissues are shown in Figure  3.10 
and Figure  3.11, respectively.  Independent group student’s t-test revealed 
significant differences between native and decellularised pulp tissues 
(p-value < 0.001) in both rat and human tissues.  The mean DNA content in the 
decellularised tissues was 23.00 ± 1.430 ng.mg-1 in the rat tissues and 19.56 ± 
1.280 ng.mg-1 in the human tissues.  In comparison, the native tissue contained 
and 1765 ± 20.66 ng.mg-1 and 1182 ± 56.24 ng.mg-1 in the rat and human 
tissues, respectively.  The optimised decellularisation protocol used resulted in 
a negligible amount of remaining DNA content, with more than 98 % (dry 
weight) DNA content removal, in both rat and human dental pulp tissues 
(GraphPad Prism, Software 6). 
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Figure ‎3.10: DNA content of native and decellularised rat pulp tissue following DNA 
extraction determined by NanoDrop™ 2000 spectrophotometer.  Data represents mean 
values (n = 4) ± 95 % confidence intervals.  All samples were normalised to the ECM dry 
weight.  The mean DNA content in the decellularised tissues was rat 23.00 ± 1.430 ng.mg
-1
 in 
comparison with 1765 ± 20.66 ng.mg
-1
 of the native tissues.  Data analysis revealed 
significance difference between native and decellularised tissues (student’s t-test, 
****p < 0.0001). 
 
 
 
Figure ‎3.11: DNA content of native and decellularised human pulp tissues following DNA 
extraction determined by NanoDrop™ 2000 spectrophotometer.  Data represents mean 
values (n = 4) ± 95 % confidence intervals. All samples were normalised to the ECM dry weight. 
The mean DNA content in the decellularised tissues was 19.56 ± 1.280 ng.mg
-1
 in comparison 
to 1182 ± 56.24 ng.mg
-1
 in the native tissues.  Data analysis revealed significance difference 
between native and decellularised tissues (student’s t-test, ****p < 0.0001). 
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3.5 Discussion: 
The development of a decellularised scaffold with complete elimination of donor 
cells and antigens while preserving ECM, could provide an excellent platform 
for regeneration (Badylak, 2002).  Not only are these scaffolds 
non-immunogenic, the conserved native intact structures such as ECM proteins 
offer additional advantages.  These proteins are known to be site specific and 
contribute towards future tissue regeneration (Song and Ott, 2011).  Therefore, 
an acellular ECM with similar histological structure, composition and biological 
activity to the native tissue is beneficial for future tissue regeneration (Badylak 
et al., 2009). 
Several decellularisation protocols are available and vary considerably.  
Wilshaw et al. (2006) used a relatively mild decellularisation protocol to 
decellularise human amniotic membrane.  The protocol involved lysis of the cell 
membranes using hypotonic Tris buffer, followed by solubilisation of 
cytoplasmic and nuclear components using a single SDS detergent cycle, 
ending with removal of cellular material using a standard nuclease treatment.  
Several washing steps with agitation were also performed to ensure sufficient 
removal of residual cellular material and reagents used. 
Different decellularisation protocols have been used in decellularising dental 
structures.  In a chemically harsher decellularisation approach, several studies 
have utilised a combined detergent step, mainly SDS and Triton X-100.  
Traphagen et al. (2012) decellularised porcine tooth buds using a dual 
detergent approach.  The Protocol included Tris hypotonic buffer treatment, five 
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cycles of SDS and Triton X-100 detergents (each cycle consisted of 1 or 5 % 
(w/v) SDS and 1 % (w/v) Triton X-100) followed by nuclease treatment.  The 
authors concluded preservation of the tooth buds ECM with the removal of the 
majority of nuclei (Traphagen et al., 2012).  A combined dual detergent based 
protocol, 1 % (w/v) SDS and 1 % (w/v) Triton X-100, was also performed by 
Chen et al. (2015) to decellularise dental pulp tissues obtained from miniature 
swine jaws.  Morphological analysis following decellularisation revealed an 
acellular structure with preservation of natural shape of the pulp tissue.  
Despite, general preservation the odontoblastic layer was removed following 
treatment (Chen et al., 2015).  More recently, Song et al. (2017) evaluated three 
different published protocols to decellularise human tooth slices (pulp-dentine 
disks of 1.5 mm thickness).  They concluded the most efficient protocol with the 
minimal impact on the ECM composition involved treatment with a hypertonic 
buffer followed by three cycles of 1 % (w/v) SDS and one cycle of 1 % (w/v) 
Triton X-100 (Song et al., 2017). 
The use of qualitative and quantitative DNA assessment methods is crucial in 
assessment of any decellularisation method.  Indeed, residual cellular material 
can consequently elicit a host inflammatory response and inhibit future tissue 
remodelling (Brown et al., 2009; Keane et al., 2015).  Therefore the combined 
use of H&E staining (showing a general view of tissue histoarchitecture and 
cellular content), DAPI staining (showing nuclei material) and DNA assays 
(quantitative assessment of DNA content) are essential criteria in assessing the 
used decellularisation protocols. 
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Histological analysis of experiment 1 samples showed an incomplete 
decellularisation of human pulpal tissues.  H&E staining revealed an acellular 
matrix, however, residual cellular material was detected using DAPI staining. 
These results could be explained based on the fact that H&E staining, although 
the gold standard for tissue histoarchitecture,  is an insensitive method for DNA 
detection (Crapo et al., 2011).  Furthermore, the additional use of DAPI staining 
revealed residual DNA material present within the matrix.  Indeed, DAPI 
staining is regarded a sensitive and specific staining method for DNA detection, 
through the formation of fluorescent complexes on binding to specific clusters 
on the DNA surface (Kapuściński and Skoczylas, 1978; Kapuscinski, 1995). 
Freeze-thaw cycles are known to cause cell lysis and reduce the amounts of 
chemical reagents needed to achieve effective decellularisation (Burk et al., 
2014; Fu et al., 2014; Keane et al., 2015).  Decellularisation protocols that 
combine the use of a freeze-thaw cycle and detergents have been successfully 
performed on various tissues including pulmonary valves (Luo et al., 2014), 
medial meniscus (Stapleton et al., 2008) and femoral arteries (Wilshaw et al., 
2012).  Therefore to improve the efficiency of decellularisation used in 
experiment 1 a slightly modified protocol in which a freeze-thaw cycle was used 
at the start of treatment (experiment 2).  This temperature change opens up the 
structural matrix through the formation of ice crystals which consequently 
increases tissue permeability, and enhances the diffusion of decellularisation 
solutions (Gilbert et al., 2006; Crapo et al., 2011; Wilshaw et al., 2012).  This 
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step can improve the consistency and practicality of future experiments allowing 
storage of several samples followed by batch decellularisation. 
Histological analysis of experiment 2 samples resulted in complete 
decellularisation of rat and human pulp tissues.  H&E staining revealed 
complete decellularisation with architectural preservation of the pulpal ECM.  
Preservation of the sub-odontoblastic layer and pulp core zone with retained 
vascular channels were evident.  No nuclear material was stained with H&E and 
DAPI staining.  Therefore, the addition of a single freeze-thaw cycle at the start 
of the process was found to be an essential step for a more successful 
procedure (complete decellularisation). 
Evaluating the residual DNA content within an acellular biological scaffold is an 
important step following decellularisation (Gilbert et al., 2009; Wilshaw et al., 
2012).  Residual DNA material can be further extracted and quantified using 
specific kits.  The United States Federal Drug Administration does not provide 
any regulatory limits to the amount of DNA material present in biological 
scaffolds (Gilbert et al., 2009).  Substantial removal of DNA material is highly 
desirable for future clinical usage (Gilbert et al., 2009; Wilshaw et al., 2012).  In 
this work, DNA content of both native and decellularised pulp tissues was 
extracted and quantified using a NanoDrop™ 2000 spectrophotometer with a 
peak absorbance at 260 / 280 nm.  This simple and sensitive technique enables 
the detection of double and single stranded DNA material, and is commonly 
used for DNA quantification assessment (Wilshaw et al., 2012; Yoeruek et al., 
2012; Song et al., 2017). 
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Following decellularisation, results of this work revealed significant reduction, 
greater than 98 %, in DNA content levels relative to the native tissues.  These 
results are in agreement with a previous study which reported a reduction of 
greater than 97 % DNA content following decellularisation of pulp tooth slices 
(Song et al., 2017).  The estimated remaining DNA content of 19.56 ± 1.280 
ng.mg-1 in human and 23.00 ± 1.430 ng.mg-1 in rat tissues, is well below the 
considered maximum amount (50 ng.mg-1) in a sufficiently decellularised tissue 
(Crapo et al., 2011; Kawecki et al., 2017).  In a study by Gilbert et al. (2009) 
investigating DNA content in commercially available biological scaffolds, trace 
amounts of DNA material were found in several tested scaffolds (Gilbert et al., 
2009).  Despite this finding, it was concluded that such low residual DNA 
content is unlikely to cause any unwanted pro-inflammatory host response 
(Gilbert et al., 2009). 
Collectively, results of this chapter describe complete decellularisation of the 
whole dental pulp tissues of rat and human tissues using the optimised 
decellularisation protocol (experiment 2).  The results indicated a lack of cellular 
or nuclear material with general architectural preservation of a porous ECM 
embedded in a network of decellularised blood vessels, nerve fibres, and 
capillaries.  Therefore further characterisation of the histoarchitecture of the 
decellularised pulp matrix of rat and human tissues was performed and 
described in the following chapter. 
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  Chapter 4
Characterisation of the developed decellularised dental pulp 
tissue 
4.1 Introduction: 
The histological description of the dental pulp ECM is a loose highly hydrated 
viscous connective tissue matrix rich in proteoglycans and glycosaminoglycans 
(GAGs) held together within a network of collagen fibrils, reticular fibrils and 
adhesive proteins (Goldberg and Smith, 2004; Veis and Goldberg, 2014).  This 
complex mixture of collagen and non-collagenous proteins are known to 
contribute to several tissue functions.  These proteins provide structural function 
and binding sites for cell surface receptors (Badylak, 2002). 
GAGs are essential components of dental pulp tissue ground substance.  Within 
the pulp matrix, GAGs are attached to protein cores and exist as proteoglycans 
that contribute significantly to the matrix viscosity (Linde, 1985; Goldberg and 
Smith, 2004).  GAGs play important roles in maintaining the structure of pulp 
tissue, regulate metabolism, water movement, attachment of growth factors and 
cytokines (Linde, 1973; Badylak, 2002).  They are also implicated in collagen 
formation and mineralisation (Linde, 1973).  The average GAG content in both 
rat and human pulp tissues was found to contain approximately 0.36 and 
0.55 µg.mg-1 wet tissue weight, respectively (Linde, 1973). 
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Collagen fibres are the most abundant fibrous component of the pulp 
connective tissue matrix (Linde, 1985).  They are known to largely contribute to 
the development and maintenance of the pulp matrix (Hillmann and Geurtsen, 
1997).  The collagen protein content varies between different teeth of the same 
species and also among the various species.  Analysis of the dried pulp tissue 
revealed that human third molars contained the highest collagen content of 
31.9 %, while human premolars contained 25.7 %.  In comparison, rat pulp 
incisors contained a significantly lower collagen content of around 3.5 % (van 
Amerongen et al., 1983).  Collagen type I and type III are fibril-forming 
collagens and represent the bulk of collagen within the dental pulp (van 
Amerongen et al., 1983; Martinez et al., 2000; Goldberg and Smith, 2004).  In 
agreement with the above, positive immunohistochemical labelling of collagen 
type I and type III fibres were identified in the human dental pulp (Lukinmaa and 
Waltimo, 1992; Hillmann and Geurtsen, 1997; Martinez et al., 2000).  
Furthermore, a positive reactivity to procollagen (precursors of collagen) type I 
and type III were also expressed in the growing apical end of rat incisors 
(Cournil et al., 1979). 
The Picrosirius red-polarisation method is documented as a reliable, specific 
and sensitive method for understanding the presence and distribution of various 
collagen types within a given tissue (Junqueira et al., 1979).  It has been 
documented that both fibre thickness and packing of collagen molecules 
determine the wavelength pattern of polarisation colours following Picrosirius 
red-stained collagen tissue (Dayan et al., 1989).  Collagen type I fibres are 
composed of thick bundles of collagen fibres ranging from 2 - 10 µm in 
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diameter.  Microscopically, when viewed under the Picrosirius red-polarisation 
method, these closely packed thick fibres are strongly birefringent to light and 
appear as a yellow to red hue (Hillmann and Geurtsen, 1997).  In contrast, 
collagen type III (reticulum fibres) are a loose network of individual thin fibres 
with a diameter of 0.5 - 1.5 µm.  These thin fibres are weakly birefringent to light 
and appear green in colour under a polarised light (Montes and Junqueira, 
1991; Hillmann and Geurtsen, 1997).  Therefore, as the collagen fibres 
thickness increases the colour gradually moves from green (thinnest fibre) to 
yellow, orange ending with red (thickest fibre) (Junqueira et al., 1982).  Having 
mentioned the above, scientifically it is inaccurate to conclude that all green 
fibres are collagen type III fibres (Rich and Whittaker, 2005).  Indeed, newly 
deposited collagen type I fibres appear as immature thin fibres of a green hue 
colour (Rich and Whittaker, 2005).  Furthermore, a recent study concluded the 
absorbed amount of light depends on the orientation of the collagen fibres 
(Lattouf et al., 2014).  Hence the Picrosirius red-polarisation method is useful in 
revealing the organisation and heterogeneity of the collagen fibres present 
within the tissue (Lattouf et al., 2014). 
Fibronectin is an extracellular adhesive protein present within the dental pulp 
matrix.  It appears as a reticular pattern scattered throughout the pulp with 
dense concentrations around the blood vessels (Linde et al., 1982; van 
Amerongen et al., 1984).  Fibronectin mediates several cellular and matrix 
interactions (Hynes, 1985).  It assists the attachments of cellular and various 
extracellular components including collagen and proteoglycans (Linde et al., 
1982). 
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The pulp matrix also contains a large family of glycoproteins termed laminin. 
Laminin is a major basement membrane protein with crucial roles in tissue 
development and regeneration (Aumailley et al., 2005; Fried et al., 2005).  It is 
implicated in odontoblast differentiation (Yuasa et al., 2004) and migration of 
dental pulp stem cells (Howard et al., 2010).  Laminin also exhibits a strong 
neurite promoting activity and is a key participant in neuronal outgrowth 
(Aumailley et al., 2005; Fried et al., 2005). 
Cells expressing major histocompatibility complex class II molecules within the 
dental pulp have been documented (Jontell et al., 1987; Ohshima et al., 1999).  
These cells are present throughout the pulp tissue with a high localisation in the 
sub-odontoblastic layer (Ohshima et al., 1999).  This group of cells serve as 
antigen-presenting cells and participate in the initial tissue recognition response 
(Jontell et al., 1987; Ohshima et al., 1999). 
Following each decellularisation step undertaken alteration to the ECM 
composition and ultrastructure is inevitable.  Attempts to reduce any structural 
loss and disruption are objectives of decellularisation (Gilbert et al., 2006; Crapo 
et al., 2011).  The pulp tissues, rat and human, used in this chapter were 
decellularised using experiment 2.  The extent of decellularisation, determined 
by further structural characterisation and identifying the presence and location 
of specific matrix molecules in the produced decellularised pulp tissues (namely 
those described above) were evaluated. 
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4.2 Aim and objectives:  
4.2.1 Aim: 
The aim of this chapter was to characterise and compare the compositions of 
the ECM of the native and decellularised dental pulp tissue of both rat and 
human species. 
4.2.2 Objectives: 
The above aim will be achieved through the following objectives: 
 To determine the efficiency of the decellularised method used on the 
histoarchitecture of the decellularised matrix in comparison with native 
pulp tissue. 
 To determine the efficiency of the decellularised method used on the 
preservation of specific structural proteins of the decellularised matrix in 
comparison with native pulp tissue. 
 To determine the structural topography appearance of the decellularised 
matrix in comparison with native pulp tissue. 
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4.3 Methods and experimental approaches: 
This chapter describes the structural characterisation of the decellularised 
dental pulp tissues utilising the protocol described in experiment 2.  Structural 
characterisation initially involved histological staining methods using Alcian blue 
and Picrosirius red.  Subsequent antibody immunolabelling of the main 
structural component (collagen fibres) and adhesive proteins was performed.  
Finally, scanning electron microscopy was used to visualise surface 
topography. All of the above methods were performed on rat and human 
tissues. 
4.3.1 Histology characterisation of rat and human pulp tissues: 
The histoarchitecture of the native [rat (n = 4) and human (n = 4)] and the 
decellularised [rat (n = 4) and human (n = 4)] dental pulp tissues were further 
characterised using Alcian blue (Section  2.2.4.3) and Picrosirius red 
(Section  2.2.4.4) staining methods.  All stained sections were viewed using 
normal Köhler illumination and all images were captured digitally.  Picrosirius 
red stained sections were additionally viewed using polarised microscopy. 
4.3.2 Immunohistochemical labelling of rat and human pulp tissues: 
Immunohistochemistry labelling of native [rat (n = 4) and human (n = 4)] and 
decellularised [rat (n = 4) and human (n = 4)] dental pulp tissues were further 
performed as described in Section ‎2.2.5.  All immunohistochemical sections 
were subjected to the appropriate antigen retrieval method.  Primary antibodies 
used in this chapter include monoclonal antibodies against anti-collagen type I, 
anti-collagen type III, anti-fibronectin and anti-histocompatibility complex class II 
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antigens, and polyclonal anti-laminin antigen.  As negative controls, primary 
antibodies were omitted and replaced by isotype controls.  Isotype control 
antibodies were used under the same conditions and concentrations as the 
corresponding primary antibody.  Immunohistochemical stained sections were 
viewed using normal Köhler illumination and all images were captured digitally. 
4.3.3 Scanning electron microscope evaluation: 
The surface topography of native and decellularised dental pulp tissues were 
further examined using conventional high vacuum scanning electron 
microscopy (SEM).  Dental pulp tissues [rat (n = 4) and human (n = 4)] were 
fixed in 2.5 % (v/v) glutaraldehyde, washed and dehydrated in a series of 
ethanol concentrations and hexamethyldisilazane solutions as described in 
Section  2.2.7.  On completion, samples were affixed to 1.2 mm aluminium stubs 
with adhesive carbon tape, gold sputter coated for 80 seconds in an argon gas 
chamber at 3 millibars and visualised using high vacuum SEM.
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4.4 Results: 
4.4.1 Histological evaluation of native and decellularised dental pulp 
tissues: 
Histological characterisation of native and decellularised pulp tissues were 
performed using Alcian blue and Picrosirius red staining.  Images of the rat and 
human pulp tissues stained with Alcian blue are shown in Figure  4.1 and 
Figure  4.2, respectively.  In the native tissues, a highly cellular tissue containing 
uniform distribution of GAGs within the tissue matrix was observed (Figure  4.2 
A, B and Figure  4.2 A, B).  Following decellularisation, preservation of a uniform 
distribution of GAGs was also observed in the tissue matrix (Figure  4.1 C, D 
and Figure  4.2 C, D).  No visible differences in staining pattern between the 
native and the decellularised tissues could be seen. 
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Figure ‎4.1: Representative images of Alcian blue stained rat pulp tissues viewed under 
the light microscope. (A and B) Native pulp tissues with abundant GAGs content in the matrix 
and (C and D) Decellularised pulp tissues with preserved GAGs content in the matrix.  GAGs 
molecules stained blue and cell nuclei stained red. Scale bars are at 50 µm. 
A B 
C D 
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Figure ‎4.2: Representative images of Alcian blue stained human pulp tissues viewed 
under the light microscope. (A and B) Native pulp tissues with abundant GAGs content in the 
matrix and (C and D) Decellularised pulp tissues with preserved GAGs content in the matrix. 
GAGs molecules stained blue and cell nuclei stained red. Scale bars are at 50 µm. 
 
A B 
D C 
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Images of the rat and human pulp tissues stained with Picrosirius red and 
viewed under light microscopy are shown in Figure  4.3 and Figure  4.4, 
respectively.  In the native rat tissues, a collagen network composed mainly of 
thin filaments and reticular fibrils occupied the matrix (Figure  4.3 A). In the 
native human tissues, a collagen rich matrix composed of thick fibre bundles 
surrounded by a network of thin filaments occupied the human pulp tissue 
matrix (Figure  4.4 A). 
Under polarised light, rat pulp tissues were mainly composed of thin immature 
collagen fibres, which were weakly birefringent to polarised light and appeared 
green in colour (Figure  4.5 B).  In contrast, thick mature fibre bundles appeared 
to be more dominant in human pulp tissues, these fibres were strongly 
birefringent to polarised light and appeared as a red, orange to yellow in colour 
(Figure  4.6 B).  From these observations it is apparent that following 
decellularisation of rat and human tissues, a porous collagenous architecture 
consisting of abundant collagen fibres and fibrils were visible under light 
(Figure  4.3 B and Figure  4.4 B) and polarised (Figure  4.5 D and Figure  4.6 D) 
microscopy.  The collagen fibres were well preserved and distributed throughout 
the entire tissue, largely concentrated around the vasculature structures.  
However, the tissue became slightly more porous in comparison to the native 
tissues. 
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Figure ‎4.3: Representative images of Picrosirius red stained rat pulp tissues viewed 
under the light microscope. (A) Native tissues showing a porous collagen fibre network and 
(B) Decellularised tissues showing preservation of a porous collagen fibre network.  Collagen 
fibres stained red and cell nuclei stained blue. Scale bars are at 50 µm. 
 
 
  
Figure ‎4.4: Representative images of Picrosirius red stained human pulp tissues viewed 
under the light microscope. (A) Native tissues showing a porous collagen fibre network and 
(B) Decellularised tissues showing preservation of a porous collagen fibre network.  Collagen 
fibres stained red and cell nuclei stained blue. Scale bars are at 50 µm. 
 
A B 
A B 
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Figure ‎4.5: Representative images of Picrosirius red stained rat pulp tissues viewed 
under polarised microscope. (A) Native tissues appear as a cellular and porous collagen 
structure under bright filed view, (B) Native tissues showing immature collagen fibres (green in 
colour) under the polarised light, (C) Decellularised tissues showing an acellular porous 
collagen structure under bright filed view, (D) Decellularised tissues showing immature collagen 
fibres (green in colour) under the polarised light. Scale bars are at 100 µm. 
 
 
A B 
C D 
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Figure ‎4.6: Representative images of Picrosirius red stained human pulp tissues viewed 
under the polarised microscope. (A) Native tissues appear as a cellular and porous collagen 
structure under bright filed view, (B) Native tissues showing heterogeneity of collagen fibres 
(various colours) under the polarised light, (C) Decellularised tissues showing an acellular 
porous collagen structure under bright filed view and (D) Decellularised tissues showing 
heterogeneity of collagen fibres (various colours) under the polarised light. Scale bars are at 
100 µm. 
 
A B 
C D 
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4.4.2 Immunohistochemical evaluation of native and decellularised 
dental pulp tissues: 
Antibody labelling was performed to localise specific ECM proteins present in 
the native and decellularised pulp tissue matrix. 
4.4.2.1 Collagen type I: 
Images of rat and human pulp tissues labelled with anti-collagen type I 
antibodies are shown in Figure  4.7 and Figure  4.8, respectively.  The native rat 
pulp tissues were stained light brown, a weak positive immunoreactivity to 
collagen type I antigens (Figure  4.7 A).  This less intense staining pattern 
consisting of thin fibres and fibrils was consistently seen in all examined native 
rat pulp tissues.  In contrast, the native human pulp tissues were stained darker 
brown, a positive immunoreactivity to collagen type I antigens (Figure  4.8 A).  
The entire pulp depth extending from the sub-odontoblatic layer to the pulp core 
was strongly stained, representing a rich network of collagen type I fibres and 
bundles. 
Following decellularisation, the pulp tissues of both rat (Figure  4.7 B) and 
human (Figure  4.8 B) samples revealed a positive slightly reduced staining 
pattern of collagen type I fibres in comparison to the relative native tissues.  The 
distribution of the collagen type I fibres was mainly concentrated around the 
vasculature structures.  No brown staining was observed in isotype control 
stained sections (Figure  4.7 C, D and Figure  4.8 C, D). 
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Figure ‎4.7: Representative images of rat pulp tissues labelled with collagen type I antigen 
viewed under the light microscope.  (A) Native rat tissue, (B) Decellularised rat tissue, 
(C) Native rat tissue isotype and (D) Decellularised rat tissue isotype. Collagen type I fibres 
stained brown and cell nuclei stained blue. Scale bars are at 50 µm. 
 
A 
C 
B 
D 
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Figure ‎4.8: Representative images of human pulp tissues labelled with collagen type I 
antigen viewed under the light microscope.  (A) Native human tissue, (B) Decellularised 
human tissue, (C) Native human tissue isotype control and (D) Decellularised human tissue 
isotype. Collagen type I fibres stained brown and cell nuclei stained blue. Scale bars are at 
50 µm. 
 
A B 
C D 
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4.4.2.2 Collagen type III: 
Images of rat and human pulp tissues labelled with anti-collagen type III 
antibodies are shown in Figure  4.9 and Figure  4.10, respectively.  The native rat 
pulp tissues were stained light brown, a weak positive immunoreactivity to 
collagen type III antigens (Figure  4.9 A).  This less intense staining pattern, 
resembling a reticular collagen network, was consistently seen in all examined 
native rat pulp tissues.  In contrast, the native human pulp tissues were stained 
darker brown, a positive immunoreactivity to collagen type III antigens 
(Figure  4.10 A).  The entire pulp depth extending from beneath the 
sub-odontoblatic layer to the pulp core was strongly stained, representing a rich 
network of collagen type III fibres and bundles. 
Following decellularisation (in similarity to collagen type I) the pulp tissues of 
both rat (Figure  4.9 B) and human (Figure  4.10 B) samples revealed a positive 
and reduced staining pattern to collagen type III fibres in comparison to the 
relative native tissues.  The distribution of the collagen type III fibres was mainly 
concentrated around and along the vasculature structures.  No brown staining 
was observed in isotype control stained sections (Figure  4.9 C, D and 
Figure  4.10 C, D). 
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Figure ‎4.9: Representative images of rat pulp tissues labelled with collagen type III 
antigen viewed under the light microscope. (A) Native rat tissue, (B) Decellularised rat 
tissue, (C) Native rat tissue isotype and (D) Decellularised rat tissue isotype.  Collagen type III 
fibres stained brown and cell nuclei stained blue. Scale bars are at 50 µm. 
A B 
C D 
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Figure ‎4.10: Representative images of human pulp tissues labelled with collagen type III 
antigen viewed under the light microscope. (A) Native human tissue, (B) Decellularised 
human tissue, (C) Native human tissue isotype control and (D) Decellularised human tissue 
isotype.  Collagen type III fibres stained brown and cell nuclei stained blue. Scale bars are at 
50 µm. 
 
A B 
C D 
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4.4.2.3 Fibronectin: 
Images of rat and human pulp tissues labelled with anti-fibronectin antibodies 
are shown in Figure  4.11 and Figure  4.12, respectively.  The native tissues of 
both rat (Figure  4.11 A) and human (Figure  4.12 A) samples were stained 
brown, a positive immunoreactivity to fibronectin antigens.  Fibronectin staining 
appeared as a fibrous plexus mainly concentrating around blood vessels.   
Following decellularisation, the pulpal tissues of both rat (Figure  4.11 B) and 
human (Figure  4.12 B) samples revealed a positive weak staining pattern to 
fibronectin fibres.  As the native tissues, fibronectin positive fibres were mainly 
concentrated around blood vessels.  No brown staining was observed in isotype 
control stained sections (Figure  4.11 C, D and Figure  4.12 C, D). 
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Figure ‎4.11: Representative images of rat pulp tissues labelled with fibronectin antigen 
and viewed under the light microscope.  (A) Native rat tissue, (B) Decellularised rat tissue, 
(C) Native rat tissue isotype and (D) Decellularised rat tissue isotype.  Fibronectin fibres stained 
brown and cell nuclei stained blue.  Scale bars are at 50 µm. 
A B 
C D 
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Figure ‎4.12: Representative images of human pulp tissues labelled with fibronectin 
antigen and viewed under the light microscope. (A) Native human tissue, (B) Decellularised 
human tissue, (C) Native human tissue isotype control and (D) Decellularised human tissue 
isotype.  Fibronectin fibres stained brown and cell nuclei stained blue.  Scale bars are at 50 µm. 
A B 
C D 
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4.4.2.4 Laminin: 
Images of rat and human pulp tissues labelled with anti-laminin antibodies are 
shown in Figure  4.13 and Figure  4.14, respectively.  The native tissues of both 
rat (Figure  4.13 A) and human (Figure  4.14 A) samples were stained brown, a 
positive immunoreactivity to laminin antigens.  Laminin staining appeared as a 
fibrous plexus scattered throughout the entire ECM mainly concentrated around 
the basement membrane of vasculature structures.   
Following decellularisation, the pulpal tissues of both rat (Figure  4.13 B) and 
human (Figure  4.14 B) samples revealed a positive staining pattern to laminin 
fibres.  Although the staining of laminin was less intense in comparison to the 
relative native tissues, laminin fibres were also distributed throughout the entire 
ECM mainly concentrated around the vasculature structures.  No brown staining 
was observed in isotype control stained sections (Figure  4.13 C, D and 
Figure  4.14 C, D). 
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Figure ‎4.13: Representative images of rat pulp tissues labelled with laminin antigen 
viewed under the light microscope. (A) Native rat tissue, (B) Decellularised rat tissue, 
(C) Native rat tissue isotype and (D) Decellularised rat tissue isotype. Laminin fibres stained 
brown and cell nuclei stained blue.  Scale bars are at 50 µm. 
A B 
C D 
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Figure ‎4.14: Representative images of human pulp tissues labelled with laminin antigen 
viewed under the light microscope. (A) Native human tissue, (B) Decellularised human 
tissue, (C) Native human tissue isotype control and (D) Decellularised human tissue isotype. 
Laminin fibres stained brown and cell nuclei stained blue.  Scale bars are at 50 µm. 
 
A B 
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4.4.2.5 Major histocompatibility complex class II molecules: 
Images of rat and human pulp tissues labelled with major histocompatibility 
complex class II antibodies are shown in Figure  4.15 and Figure  4.16, 
respectively.  A positive immunoreactivity, stained brown, to major 
histocompatibility complex class II antigens was evident in the native pulp of 
both rat (Figure  4.15 A) and human (Figure  4.16 A) tissues.  These antigens 
were located with specific cells, mainly concentrating within the 
sub-odontoblastic layer and around blood vessels in the pulp core, and 
appeared scattered throughout the ECM. 
Following decellularisation, a negative immunoreactivity to major 
histocompatibility antigens was observed throughout both rat (Figure  4.15 B) 
and human (Figure  4.16 B) tissues.  No brown staining was observed in isotype 
control stained sections (Figure  4.15 C, D and Figure  4.16 C, D). 
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Figure ‎4.15: Representative images of rat pulp tissues labelled major histocompatibility 
complex class II antigen and viewed under the light microscope. (A) Native rat tissue, 
(B) Decellularised rat tissue, (C) Native rat tissue isotype and (D) Decellularised rat tissue 
isotype.  Major histocompatibility complex class II positive cells stained brown (black arrow) and 
cell nuclei stained blue.  Scale bars are at 50 µm. 
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Figure ‎4.16: Representative images of human pulp tissues labelled major 
histocompatibility complex class II antigen and viewed under the light microscope. 
(A) Native human tissue, (B) Decellularised human tissue, (C) Native human tissue isotype 
control and (D) Decellularised human tissue isotype.  Major histocompatibility complex class II 
positive cells stained brown (black arrow) and cell nuclei stained blue.  Scale bars are at 50 µm. 
 
A B 
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4.4.3 Scanning electron microscope evaluation: 
A conventional high vacuum SEM was used to view the surface topography of 
the dental pulp tissues.  SEM generated images of the rat and human pulp 
tissues are shown in Figure  4.17 and Figure  4.18, respectively.  Structural 
assessment of both native rat (Figure  4.17 A) and human (Figure  4.18 A) 
tissues revealed a dense irregular fibre mesh structure with interfibriller spaces. 
Following decellularisation, a loose fibre structure appeared to be denuded of 
some components (cells and more likely some of non-collagenous proteins).  
Despite the above alteration, preservation of complex entangled irregular fibre 
mesh was visible in both rat (Figure  4.17 B) and human (Figure  4.18 B) tissues. 
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Figure ‎4.17: Representative images of rat pulp tissues viewed using the scanning 
electron microscope. (A) Native tissues with a dense irregular fibrous structure and (B) 
Decellularised tissues with a preserved porous fibrous structure.  Scale bars A and B are at 
10 µm.  Right side images represent magnification of area delineated with dashed white 
rectangle, scale bar at 5 µm. 
B 
A 
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Figure ‎4.18: Representative images of human pulp tissues viewed using the scanning 
electron microscope. (A) Native tissues with a dense irregular fibre structure and (B) 
Decellularised tissues with a preserved porous fibre structure. Scale bars A and B are at 10 µm.  
Right side images represent magnification of area delineated with dashed white rectangle, scale 
bar at 5 µm. 
 
A 
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4.5 Discussion: 
The aim of the work presented in this chapter was to evaluate the effect of the 
optimised decellularisation protocol, experiment 2, on the natural pulpal ECM 
structural components.  This method involved a freeze-thaw cycle followed by 
the use of a hypotonic Tris buffer, one cycle of 0.03 % (w/v) sodium dodecyl 
sulphate (SDS) hypotonic buffer and nuclease enzymatic treatment.  Protease 
inhibitors and mechanical agitation were also incorporated.   
The use of qualitative assessment methods is crucial for preliminary 
characterisation of the histoarchitecture of the produced decellularised matrix in 
comparison to corresponding native tissues.  Therefore the combined use of 
histological (showing structural elements), immunohistochemical (identifying 
specific matrix components) and SEM (showing the surface topography of pulp 
tissues) analysis was essential in assessing the efficiency of decellularisation 
protocol (experiments 2). 
Histological characterisation using Alcian blue staining in both rat and human 
decellularised tissues revealed no visible differences in GAGs distribution 
following decellularisation.  There are conflicting results reported in the literature 
on the effect of SDS on tissue GAGs removal and/or preservation (Mirsadraee 
et al., 2006; Wilshaw et al., 2006; Kheir et al., 2011; Luo et al., 2014; Song et 
al., 2017).  Results of this work are consistent with Mirsadraee et al. (2006) in 
human pericardial matrix decellularisation, Wilshaw et al. (2006) in human 
amniotic membrane matrix decellularisation and Wilshaw et al. (2012) in human 
common femoral arteries decellularisation.  These studies used one cycle of 
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SDS as an ionic detergent step at either 0.1 % (w/v) or 0.03 % (w/v) SDS 
concentration in a hypotonic buffer for 24 hours at room temperature.  Song et 
al. (2017) reported GAGs preservation following decellularisation of human 
tooth root slices, although, decellularisation was achieved using three cycles of 
1 % (w/v) SDS and 1 % (w/v) Triton X-100 for 24 hours at room temperature. 
In contrast, a significant reduction in GAGs content has been reported by Kheir 
et al. (2011) in porcine cartilage matrices decellularisation and Luo et al. (2014) 
in porcine pulmonary valve decellularisation when incubated with 0.1 % (w/v) 
SDS in a hypotonic buffer for 24 hours at 45 °C.  Increasing the exposure 
temperature during decellularisation treatment might have negatively affected 
GAGs content.  Furthermore, experimental work by Kheir et al. (2011) 
concluded that increasing the number of SDS cycles negatively effects the 
tissue GAGs content level (Kheir et al., 2011). 
Preservation of collagen fibres was also assessed and characterised using 
histological and immunohistochemical staining methods.  Picrosirius red 
staining is a specific method for collagen detection that can be analysed using 
light and polarised microscopy (Junqueira et al., 1979).  Light microscopy 
analysis of both rat and human decellularisation tissues revealed a well 
preserved collagen structure.  The collagen structure appeared slightly porous 
relative to the corresponding native tissues.  This was consistent with Chen et 
al. (2015) following decellularisation of swine dental pulps.  We also observed 
variability in pore size diameter throughout the scaffolds, which might act as a 
positive variable facilitating regeneration of heterogeneous tissues (pulp-dentine 
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complex).  El-Backly et al. (2008) reported that small pore diameter facilitates 
tissue neovascularisation, while larger pores assist regeneration of mineralised 
tissue, cell migration and differentiation, in addition to waste and nutrition 
transportation (El-Backly et al., 2008).  Further visual assessment of Picrosirius 
red staining under polarised light microscopy also revealed preservation of a 
complex heterogeneous porous collagen matrix following decellularisation. 
For more specific assessment, collagen type I and III fibres were further labelled 
using monoclonal antibodies.  The native human pulp tissue contained a rich 
network of collagen fibres, as evident with a strong brown staining pattern 
throughout the matrix.  In contrast, an immature network of collagen fibres was 
evident in the native rat pulp tissues.  The results from this work were in 
agreement van Amerongen et al. (1983) following a qualitative measurement of 
the collagen content of the dried pulp tissues.  Human pulp tissues were found 
to contain 25.7 - 31.9 % collagen, while rat pulp incisors contained a 
significantly smaller content of 3.5 % collagen (van Amerongen et al., 1983).  
Following decellularisation collagen type I and III fibres were retained in both rat 
and human tissues, albeit expressing a slightly weak stain in comparison to 
relevant native tissues.  In contrast to the present study results, Chen et al. 
(2015) reported a significant decline in both collagen type I and III fibres using 
immunohistochemical analysis on the decellularised miniature swine dental 
pulps with collagen fibres largely absent in the sub-odontoblastic layer.  In their 
work, decellularisation was achieved based on a dual detergent method using 
1 % (w/v) SDS and 1 % (w/v) Triton X-100 (Chen et al., 2015). 
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Conventional high vacuum SEM was performed to view the surface topography 
of the rat and human dental pulp tissues.  Electron based signal images were 
produced through electron interaction with surface atoms of tissue samples.  
SEM generated images revealed that the decellularisation process seemed to 
preserve the irregular fibre mesh.  The collagen fibres of the decellularised 
matrix appeared more exposed and an increase in matrix porosity.  The 
formation of interfibriller spaces within the matrix could be more evident due to 
the removal of cells from the tissue or as a consequence of exposure to several 
reagents and temperature changes during the decellularisation process.  
Oliveira et al. (2013) postulated that the vehiculating aqueous solutions used 
throughout the decellularisation treatment produced tissue swelling that 
consequently affected the tissue architecture (Oliveira et al., 2013). 
To further evaluate matrix components immunohistochemical labelling against 
fibronectin and laminin adhesive proteins was performed.  Fibronectin and 
laminin positive fibres in the native rat and human tissues showed similar 
distribution patterns.  These fibres were mainly present within the 
sub-odontoblastic layer, around blood vessels and in the pulp core.  This is in 
agreement with previous findings (Linde et al., 1982; van Amerongen et al., 
1984).  Following decellularisation, qualitative analysis of rat and human tissues 
revealed preservation of these fibres, albeit with a lower staining intensity.  
Preservation of fibronectin and laminin, as detected using immunohistochemical 
staining, was also reported by Chen et al. (2015) for the decellularisation of 
miniature swine pulps and by Traphagen et al. (2012) for the decellularisation of 
porcine tooth buds.  A reduced expression of fibronectin, mainly within the 
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sub-odontoblastic layer, was found following the use of three cycles of 1 % (w/v) 
SDS and 1 % (w/v) Triton X-100 to decellularise tooth root slices (Song et al., 
2017). 
Furthermore, it was deemed appropriate to perform immunohistochemical 
labelling against major histocompatibility complex class II molecules.  These 
molecules are expressed by immune cells including dendritic cells, monocytes 
and macrophages.  These cells are commonly present in the native dental 
pulps, of rat and human tissues, and serve as initial defence cells (Jontell et al., 
1987; Ohshima et al., 1999).  Results of this work revealed negative reactivity to 
major histocompatibility complex class II molecules following decellularisation. 
Collectively, qualitative analysis of this chapter show retention of porous 
collagen matrix with no obvious histoarchitecture disruption of ECM and 
preservation of essential adhesive proteins following decellularisation of the 
whole dental pulp tissues of rat and human species.  Therefore, further analysis 
of the decellularised matrix cytotoxicity and ability to support recellularisation 
was performed and described in the following chapter. 
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  Chapter 5
Cytotoxicity assessment and recellularisation of the 
decellularised scaffold 
5.1 Introduction: 
The decellularisation steps used in the optimised decellularisation protocol 
(experiment 2) involves the use of detergents, enzymes, and other reagents 
with the potential to negatively affect the tissues native extracellular matrix 
(ECM) structure and composition.  Furthermore, any residual chemicals could 
be toxic to cells and ultimately result in a cytotoxic scaffold.  Cytotoxicity is a 
commonly used term to describe a cascade of events which affect either direct 
cell membrane damage or the activation of natural cell suicide mechanisms.  
Cytotoxicity assessment of a given material is initially performed using in vitro 
cell culture methods.  These in vitro cell culture based methods have the 
advantage of simplicity and reproducibility (Hensten-Pettersen, 1988). 
The selection of the appropriate cell type for in vitro cytotoxicity assays remains 
debatable (Murray et al., 2000; Saw et al., 2005).  Although primary cells are 
more clinically relevant, the use of established cell lines such as L-929 mouse 
fibroblasts are commonly used for dental material evaluation due to their high 
reproducibility, relatively standard growth, and morphology characteristics 
(Hensten-Pettersen, 1988; Torabinejad et al., 1995b; Thonemann et al., 2002; 
Saw et al., 2005; Ozdemir et al., 2009).  In vitro cytotoxicity assays with 
established cell lines are also recommended by British and International 
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Organisation for Standardisation for cytotoxicity testing of medical devices 
(International Organisation for Standardisation, 2008; British Standard Institute, 
2009).  Therefore, in this work, in vitro contact and extract cytotoxicity 
assessment of the produced scaffolds were assessed using L-929 mouse 
fibroblast cell lines.  Furthermore, to closely resemble the clinical setting, in vitro 
cell viability assays and recellularisation of the decellularised scaffolds were 
assessed using primary cell culture, dental pulp stem cells (DPSCs). 
Preservation of specific matrix adhesive proteins within the decellularised 
scaffold is desirable due to their crucial roles in mediating cellular activities 
(Howard et al., 2010).  It is this complex integration between the cells and the 
direct surrounding microenvironment (ECM proteins) that regulates future cell 
growth and differentiation (Martinez et al., 2000; Nakashima et al., 2013). 
Several in vitro and in vivo studies have defined DPSCs as undifferentiated 
mesenchymal cells with the ability to differentiate into multiple lineages 
including odontoblastic cells (Gronthos et al., 2002; Zhang et al., 2006a; 
Prescott et al., 2008; Kim et al., 2009; Huang et al., 2010; Kawashima, 2012; 
Paduano et al., 2016).  However, no known single molecule that specifically 
determines stem cell differentiation to odontoblast-like cells (Goldberg and 
Smith, 2004). 
Nevertheless, the use of a panel of markers including dentine 
sialophosphoprotein (DSPP), dentine matrix protein-1 (DMP-1), and nestin to 
identify the odontogenic differentiation has been proposed (Goldberg and 
Smith, 2004).  Other proof-of-principle studies also proposed the use of DSPP, 
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DMP-1 and alkaline phosphatase (ALP) as potential odontoblast markers 
(Almushayt et al. 2006; Prescott et al. 2008; Gronthos et al. 2000; Paduano et 
al. 2016).  DSPP, a non-collagenous protein, is a precursor to two essential 
matrix proteins namely dentine sialoprotein and dentine sialophosphoprotein.  
DSPP is generally considered as a tooth specific gene and regarded as a 
phenotypic marker of dentine and secretory odontoblasts’ (Gronthos et al., 
2000; Goldberg and Smith, 2004).  However, DSPP is also identified in bone, 
albeit a reduced expression level approximately 1 / 400 relative to dentine (Qin 
et al., 2002).  DMP-1 is a non-collagenous protein that is primarily present in the 
mineralised matrix of bone and dentine (He et al., 2003; Narayanan et al., 
2003).  DMP-1 is regarded as an odontoblastic marker, secreted by pre-
odontoblasts’ as well as secretory odontoblasts’ (Almushayt et al., 2005; 
Prescott et al., 2008).  DMP-1 is subsequently exported, from the cells, to the 
surrounding matrix regulating the deposition of a mineralised matrix (He et al., 
2003; Narayanan et al., 2003).  Odontoblasts’ cells also contain high levels of 
ALP enzyme.  ALP enzymes are believed to contribute to the odontoblasts’ 
ability to produce dentine and affect mineralisation (Yoshiki and Kurahashi, 
1971; Goseki et al., 1990). 
Furthermore, the characterisation of DPSCs, based on the expression of growth 
factors and cytoskeleton proteins (genes), is of equal importance.  In general 
terms, the cellular cytoskeleton is composed of three types of structures 
including microfilaments, microtubuli and intermediate filaments.  Several types 
of intermediate filaments are expressed in various cell types and are 
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functionally crucial for cellular and tissue organisation and function (About et al., 
2000). 
Vimentin is a major intermediate filament protein of mesenchymal cells and is 
known to participate in several protein functions mainly cell signalling, adhesion, 
and migration (Ivaska et al., 2007).  Vimentin is expressed in the cytoplasm of 
pulp cell and extends peripherally from the central body to the cell processes 
(Murakami et al., 2012).  Nestin, also an intermediate filament protein, is 
classified as neural progenitor marker and was originally identified in 
neuroepithelial stem cells (Sejersen and Lendahl, 1993; About et al., 2000).  
Nestin has also been identified in DPSCs and known as an early neuronal-
associated marker (Arthur et al., 2008).  In human and rodent teeth nestin was 
found to be expressed in functioning and newly differentiated odontoblast cells 
(Terling et al., 1995; Kuratate et al., 2008; Lee et al., 2012). 
The expression of Alpha-smooth muscle actin (α-SMA), a cytoskeletal protein, 
in the vascular smooth muscle cells and pericytes of the normal dental pulp has 
been demonstrated (Shi and Gronthos, 2003; Yoshiba et al., 2012).  During 
early stages of dental pulp healing, numerous α-SMA positive cells were 
expressed in newly differentiated odontoblast like cells (Yoshiba et al., 2012).  It 
is also localised in various tissues during tissue repair and regeneration 
following injury (Yoshiba et al., 2012). 
For successful pulp engineering, the formation of blood vessels via 
angiogenesis is a key factor (Gerhardt and Betsholtz, 2003; Nakashima et al., 
2009; Janebodin et al., 2013; Saghiri et al., 2015).  Studies have linked 
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angiogenesis to a number of growth factors including basic fibroblast growth 
factor (bFGF), transforming growth factor (TGF; TGF-α, TGF-β), 
platelet-derived growth factor (PDGF), tumour necrosis factor-α (TNF-α), and 
vascular endothelial growth factor (VEGF) (Grando Mattuella et al., 2007; 
Saghiri et al., 2015).  VEGF, a heparin-binding glycoprotein of 45 kilodaltons, is 
regarded as the potent regulatory molecule controlling vascular permeability 
and angiogenesis (Ferrara, 2004; Grando Mattuella et al., 2007).  VEGF family 
is composed of six members namely VEGF-A, B, C, D, E, and PDGF.  Of these 
family members, VEGF-A is known as the key member that largely regulates 
angiogenesis (Ferrara, 2004; Grando Mattuella et al., 2007).  In addition to the 
main molecule VEGF receptor tyrosine kinases, fms-like tyrosine kinase (Flt-1, 
also known as VEGFR-1) and kinase-insert domain containing receptor (KDR, 
also known as VEGFR-2) are present in the dental pulp.  Although both 
receptors are present, VEGFR-2 is known to have the highest signalling activity 
and mediates human pulp cells proliferation, migration and vascular 
permeability (Matsushita et al., 2000; Grando Mattuella et al., 2007).  According 
to Janebodin et al. (2013) the ability of DPSCs to function as pericyte-like cells 
and support angiogenesis is VEGFR-2 dependent (Janebodin et al., 2013). 
The rat and human pulp tissues used in this chapter were decellularised using 
the optimised decellularisation protocol developed as previously described 
(experiment 2).  The biocompatibility of the developed scaffolds was determined 
using cytotoxicity analysis.  Furthermore, the differentiation ability of the DPSCs 
following recellularisation was evaluated by the identification of specific cellular 
molecules (namely those described above). 
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5.2 Aim and objectives: 
5.2.1 Aim: 
The aim of this chapter is to evaluate the decellularised scaffold cytotoxicity and 
to assess its potential to support human DPSCs attachment, proliferation and 
differentiation in vitro. 
5.2.2 Objectives: 
The above aim will be achieved through the following objectives: 
 To determine the cytotoxicity of the decellularised rat and human scaffold 
using in vitro techniques. 
 To evaluate the ability of human DPSCs to attach and migrate following 
recellularisation of the decellularised rat scaffolds. 
 To evaluate the ability of human DPSCs to express odontoblast markers 
and molecular proteins following recellularisation of the decellularised rat 
scaffolds. 
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5.3 Methods and experimental approaches: 
This chapter describes assessing the biocompatibility of the produced 
decellularised rat and human scaffolds using in vitro cytotoxicity evaluation 
methods with an established cell line.  Subsequently, the produced 
decellularised rat and human scaffolds were recellularised with DPSCs and cell 
viability assessed following in vitro culture.  Finally, the recellularised rat 
scaffolds were assessed for their ability to further support cell growth and 
differentiation using histology and immunohistochemistry staining methods.  
DPSCs were kindly provided by Dr M Tomlinson following patient consent and 
ethical approval (Skeletal Research Tissue Bank; reference number 
101013/MME/113; Appendix A).  DPSCs used in this work (passage 5) were 
harvested from a single donor and isolated via enzymatic digestion as 
described in Section  2.2.8.1. 
5.3.1 Cytotoxicity evaluation of decellularised rat and human 
scaffolds: 
To determine the in vitro cytotoxicity of the decellularised scaffolds, a new batch 
of rat and human dental pulp tissues were decellularised as described in 
experiment 2 (Section  3.3.2).  Representative tissues were further checked 
using histological methods (H&E and DAPI) to ensure effective 
decellularisation.  Decellularised tissues were obtained under aseptic conditions 
in a Class II safety cabinet and stored temporarily in PBS (pH 7.4) to avoid 
tissue dehydration.  Cytotoxicity evaluations were undertaken using contact and 
extract cytotoxicity assays.  Both assays were performed using L-929 murine 
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fibroblast cell line.  Normal cell culture methods including cell resurrection, 
culturing and, passaging were performed as described in Section  2.2.8. 
5.3.1.1 Contact cytotoxicity assay: 
To assess the direct cytotoxicity of the decellularised scaffolds, contact 
cytotoxicity assays were performed as described in Section  2.2.9.1.  Briefly, 
decellularised rat (n = 4) and human (n = 4) scaffolds were attached to the 
centre of six-well cell culture plates using collagen type I gel.  Six-well plates 
containing collagen type I gel, as a negative control, and cyanoacrylate 
adhesive glue, as a positive control, were also prepared.  L-929 cell lines were 
cultured in their standard culture medium and a cell concentration of 
2 x 105 cells.mL-1 (2 mL) was added to each well plate and incubated for 48 
hours at 37 °C in 5 % (v/v) CO2 and 95 % relative humidity.  Following 
incubation, the cell layers were fixed and stained with Giemsa solution.  
Changes in cell growth and morphology were viewed using an inverted light 
microscope (Cell^B software) under bright field illumination with all images 
captured digitally. 
5.3.1.2 Extract cytotoxicity assay: 
To assess any potential extract cytotoxicity resulting from residual chemicals in 
decellularised scaffolds, extract cytotoxicity assays were performed as 
described in Section  2.2.9.2.  Briefly, decellularised rat (n = 8) and human 
(n = 8) scaffolds were finely macerated and incubated with plain DMEM at 
37 °C for 72 hours with agitation.  The collected test extracts were used for this 
assay.  Controls used included plain DMEM, as a negative control, and 
 148 
 
40 % (v/v) DMSO in DMEM, as a positive control.  L-929 cell lines were cultured 
in their standard culture medium and a diluted cell concentration of 
5 x 104 cells.mL-1 (200 µL) was added to each well plate and incubated for 
48 hours at 37 °C in 5 % (v/v) CO2 and 95 % relative humidity.  The cell viability 
was determined using ATPLite™ assay.  Results were statistically analysed 
using one-way analysis of variance (ANOVA; p-value of < 0.05). 
5.3.2 Cell seeding density: 
Optimisation of a suitable cell seeding density was initially performed. 
Consistent scaffold lengths, approximately 5 - 6 mm, were dynamically seeded 
(Section  0) with two densities 5 x 103 and 1 x 104 cells per scaffold.  Scaffolds 
were analysed using cell viability assay (Section  2.2.11) following 7 day culture.  
At the lower seeding density, 5 x 103 cells per scaffold, limited cells were 
populated within the scaffold.  However, a seeding density of 1 x 104 cells per 
scaffold revealed adequate cell population throughout the scaffold.  Based on 
these results (Figure  5.1), a cell seeding density of 1 x 104 cells per scaffold 
(5.55 x 104 cells.mL-1) was selected as the most appropriate and used in future 
recellularisation experiments. 
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Figure ‎5.1: Optimisation of cell seeding density. (A) 1 x 104 cells per scaffold and (B) 5 x 103 
cells per scaffold analysed with Live/Dead
®
 stain using laser confocal microscopy. 
5.3.3 Cell viability assay of rat and human scaffolds: 
The decellularised scaffolds were recellularised with human DPSCs at a 
concentration of 1 x 104 cells per scaffold (5.55 x 104 cells.mL-1).  The ability of 
the decellularised rat (n = 3 / time point) and human (n = 3 / time point) 
scaffolds in supporting cell viability were assessed using Live/Dead® stain as 
described in Section  2.2.11.  Stained scaffolds were analysed following 7 and 
14 days culture under confocal laser scanning microscopy at 
excitation/emission wavelengths (calcein-AM = 494 / 517 nm and Ethidium 
homodimer-1 = 528 / 617 nm) using FITC and Texas red filters for dual-labelled 
samples.  The signals of the two dyes were assessed at different depths of the 
scaffolds.  
5.3.4 Recellularisation of rat scaffolds using DPSCs: 
Decellularised rat scaffolds were recellularised with human DPSCs at a 
concentration of 1 x 104 cells per scaffold (5.55 x 104 cells.mL-1).  The ability of 
the decellularised rat scaffolds to support cell growth and differentiation 
A B 
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following recellularisation were analysed following 7 and 14 days culture using 
histological and immunohistochemical staining methods. 
5.3.4.1 Histological evaluation of the recellularised rat scaffolds: 
The attachment and migration of human DPSCs following recellularisation on 
the decellularised rat scaffolds (n = 3 / each time point) were analysed using 
H&E staining methods (Section  2.2.4.1).  H&E stained sections were viewed 
using normal Köhler illumination and all images were captured digitally. 
5.3.4.2 Immunohistochemical evaluation of the recellularised rat 
scaffolds: 
Immunohistochemistry labelling of decellularised (n = 3 / each time point) and 
recellularised (n = 3 / each time point) rat scaffolds were performed as 
described in Section ‎2.2.5.  All immunohistochemical sections were subjected 
the appropriate antigen retrieval method.  Primary antibodies used in this 
chapter include monoclonal antibodies against α-SMA, DMP-1, DSPP, 
VEGFR-2, nestin and vimentin antigens, and polyclonal antibodies against ALP 
and VEGF-A antigens.  As negative controls, primary antibodies were omitted 
and replaced by isotype controls.  Isotype control antibodies were used under 
the same conditions and concentrations as the corresponding primary antibody.  
Immunohistochemical stained sections were viewed using normal Köhler 
illumination with all images captured digitally. 
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5.4 Results: 
5.4.1 Cytotoxicity evaluation of decellularised rat and human 
scaffolds: 
5.4.1.1 Contact cytotoxicity assay: 
The contact cytotoxicity assays were performed to assess the cytotoxicity of the 
decellularised pulp scaffolds by culturing cells directly in contact with the 
scaffolds.  Results of the rat (Figure  5.2) and human (Figure  5.3) decellularised 
scaffolds indicated no apparent cytotoxicity.  L-929 cells exhibited standard 
morphology, vacuolisation and established an adherent monolayer on the 
seeded well plates.  The cells grew in the area surrounding and in contact with 
all examined scaffolds. 
Negative control, using collagen gel, indicated no apparent cytotoxicity with 
L-929 cells surrounding and in contact with the collagen gel (Figure  5.4 A).  
L-929 cells also, as above, exhibited standard morphology, vacuolisation and 
established an adherent monolayer on the seeded well plates.  No differences 
in cell morphology and growth were also observed between cells cultured with 
the decellularised pulp scaffolds or solely with the collagen gel negative control. 
On the contrary, positive controls, using cyanoacrylate glue, resulted in cell lysis 
with zones of no cell growth.  L-929 cells exhibited a round morphology and 
were detached from the well plates (Figure  5.4 B).   
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Figure ‎5.2:  Contact cytotoxicity assays of decellularised rat scaffolds cultured with 
L-929 cell line for 48 hours, stained with Giemsa stain and viewed under brightfield 
illumination. Images representative of n = 4. (A and B) Rat decellularised scaffold showing no 
apparent cytotoxicity. Scale bars A at 500 µm and B at 100 µm.  
 
 
  
Figure ‎5.3: Contact cytotoxicity assays of decellularised human scaffolds cultured with 
L-929 cell line for 48 hours, stained with Giemsa stain and viewed under brightfield 
illumination. Images representative of n = 4. (A and B) Human decellularised scaffold showing 
no apparent cytotoxicity. Scale bars A at 500 µm and B at 200 µm.  
 
 
A B 
A B 
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Figure ‎5.4: Controls used for contact cytotoxicity assays cultured with L-929 cell line for 
48 hours, stained with Giemsa stain and viewed under brightfield illumination. I 
(A) Collagen gel (negative control) showing no apparent cytotoxicity, and (B) Cyanoacrylate 
glue (positive control) showing marked cytotoxicity with cell lysis.  Scale bars A and B at 
500 µm.  Right side images represent magnification of area delineated with dashed black 
rectangle, scale bars at 100 µm.  
 
Cyanoacrylate glue 
Collagen gel A 
B 
 
 154 
 
5.4.1.2 Extract cytotoxicity assay: 
The results of the relative cellular ATP content of rat and human scaffolds are 
presented in Figure  5.5 and Figure  5.6, respectively.  
The relative cellular ATP content measurements were significantly lower in the 
positive control (DMSO) in comparison to the negative control (DMEM).  In 
contrast, there was no significant difference in ATP content between the study 
group (decellularised extracts) and negative control (DMEM).  This indicated 
that there wasn’t any soluble extract cytotoxicity produced from the 
decellularised extracts.  All statistical analyses was performed using ANOVA, 
p < 0.05, (GraphPad Prism, Software 6). 
 
Figure ‎5.5: Extract cytotoxicity assay measuring the relative cellular ATP content of 
decellularised rat extracts following 24 hour culture. Data analysis revealed no significance 
difference between decellularised extracts and negative control (DMEM). Error bars represent 
± 95 % confidence intervals. “***” indicates a significant difference when compared to positive 
control (DMSO); p < 0.0002, ANOVA; CPS, counts per second. 
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Figure ‎5.6: Extract cytotoxicity assay measuring the relative cellular ATP content of 
decellularised human extracts following 24 hour culture. Data analysis revealed no 
significance difference between decellularised extracts and negative control (DMEM). Error bars 
represent ± 95 % confidence intervals. “****” indicates a significant difference when compared to 
positive control (DMSO); p < 0.0001, ANOVA; CPS, counts per second. 
 
5.4.2 Cell viability assay of rat and human scaffolds: 
The cell viability of human DPSCs following recellularisation of rat and human 
scaffolds were evaluated following 7 and 14 days culture using a commercial 
Live/Dead® stain.  Confocal laser microscope images of rat and human 
recellularised scaffolds are presented in Figure  5.7 and Figure  5.8, respectively.  
These images represent a composite of merged Z-series laser images.  The 
pulp constructs showed that most areas of the decellularised pulp scaffolds 
were populated with viable cells exhibiting an elongated morphology (stained 
green with calcein-AM) and only a few cells were dead (stained red with 
ethidium homodimer). 
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Figure ‎5.7: Cell viability assay of decellularised rat scaffolds seeded with DPSCs and 
analysed with Live/Dead
®
 stain using laser confocal microscopy. Representative images of 
(A) Recellularised scaffolds (n = 3) following 7 day, and (B) Recellularised scaffolds (n = 3) 
following 14 day culture. Both images indicate scaffold populated with viable cells and only a 
few cells were dead. Live cells stained green (white arrow) and dead cells stained red (red 
arrow). Scale bars are at 300 µm.  
 
  
Figure ‎5.8: Cell viability assay of decellularised human scaffolds seeded with DPSCs and 
analysed with Live/Dead
®
 stain using laser confocal microscope. Representative images of 
(A) Recellularised scaffolds (n = 3) following 7 day, and (B) Recellularised scaffolds (n = 3) 
following 14 day culture. Both images indicate scaffold populated with viable cells and only a 
few cells were dead. Live cells stained green (white arrow) and dead cells stained red (red 
arrow). Scale bars are at 300 µm. 
A B 
A B 
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5.4.3 Recellularisation of rat scaffolds using DPSCs:  
5.4.3.1 Histological evaluation of the recellularised rat scaffolds: 
Serial sections of the recellularised rat scaffolds stained with H&E (Figure  5.9 
and Figure  5.10) were assessed to determine the ability of DPSCs to attach and 
migrate within the decellularised scaffold. 
Following 7 and 14 days culture, DPSCs were attached to the outer surface and 
also migrated between the collagen fibres within the scaffold. Under the light 
microscope they appeared elongated, adherent and spindle-shaped 
morphology.  Furthermore, as time elapsed, there was an apparent change in 
the scaffold shape from a longitudinal (7 days, Figure  5.9; A) to a contracted 
circular shape (14 days, Figure  5.10; A). 
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Figure ‎5.9: Representative images of H&E stained recellularised rat scaffolds seeded 
with DPSCs following 7 days culture viewed under the light microscope. (A) Seeded rat 
scaffold with apparent cell attachment and migration.  Scale bar at 100 µm.  Right side images 
represent magnification of area delineated with dashed black rectangle, with scales bars of 
50 µm and 20 µm. Nuclei stained blue (black arrow) and ECM stained pink.  
 
 
A 
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Figure ‎5.10: Representative images of H&E stained recellularised rat scaffolds seeded 
with DPSCs following 14 days culture viewed under the light microscope. (A) Seeded rat 
scaffold with apparent cell attachment and migration.  Scale bar at 100 µm.  Right side images 
represent magnification of area delineated with dashed black rectangle, with scales bars of 
50 µm and 20 µm. Nuclei stained blue (black arrow) and ECM stained pink.  
 
 
A 
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5.4.3.2 Immunohistochemical evaluation of the recellularised rat 
scaffolds: 
Antibody labelling was performed in order to assess the ability of the seeded 
stem cells to express odontoblastic markers and specific cellular cytoskeleton 
components.  Odontoblastic markers evaluated in this work included DSPP, 
DMP-1, and ALP.  To further assess the potential of the seeded DPSCs to 
differentiate and express various markers, a panel of genes were investigated. 
These included vimentin, nestin, α-SMA, VEGF-A, and VEGFR-2 genes. 
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5.4.3.2.1 DSPP: 
Images of recellularised and non-seeded rat scaffolds labelled with anti-DSPP 
antibodies are shown in Figure  5.11.  The seeded DPSCs were stained dark 
brown, indicating a strong positive cellular immunoreactivity to DSPP antigens 
(Figure  5.11 A and B).  DSPP positive cells were evident in the cells scattered 
throughout the scaffold cultured for 7 and 14 days.  In contrast, negative 
immunoreactivity was consistently evident in all non-seeded scaffolds 
(Figure  5.11 C).  Also, the isotype control staining was negative (Figure  5.11 D). 
  
  
Figure ‎5.11: Representative images of recellularised rat scaffolds labelled with DSPP 
antigen and viewed under the light microscope. DSPP positive cells seen following 
(A) 7 and (B) 14 days culture, (C) Non-seeded scaffolds with negative expression and 
(D) Isotype controls with negative expression.  DSPP positive cells stained brown (black arrow) 
and ECM stained purple.  Scale bars are at 20 µm.  
A B 
C D 
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5.4.3.2.2 DMP-1: 
Images of recellularised and non-seeded rat scaffolds labelled with anti-DMP-1 
antibodies are shown in Figure  5.12.  At 7 days, very few light brown stained 
cells were identified, indicating a weak positive immunoreactivity to DMP-1 
antigens (Figure  5.12 A).  Following 14 days culture, more cells were positively 
stained with a moderate intensity (Figure  5.12 B).  A negative immunoreactivity 
was consistently evident in all non-seeded scaffolds (Figure  5.12 C).  Also, the 
isotype control staining was negative (Figure  5.12 D). 
  
  
Figure ‎5.12: Representative images of recellularised rat scaffolds labelled with DMP-1 
antigen and viewed under the light microscope. DMP-1 positive cells weakly expressed 
following (A) 7 and (B) 14 days culture, (C) Non-seeded scaffolds with negative expression and 
(D) Isotype controls with negative expression.  DMP-1 positive cells stained brown (black arrow) 
and ECM stained purple.  Scale bars are at 20 µm.  
A B 
C D 
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5.4.3.2.3 ALP: 
Images of recellularised and non-seeded rat scaffolds labelled with anti-ALP 
antibodies are shown in Figure  5.13.  At 7 days, the seeded DPSCs were not 
stained brown, indicating negative immunoreactivity to ALP antigens 
(Figure  5.13 A).  Following 14 days culture, however, some ALP positive cells, 
although lightly stained, were observed within the scaffold (Figure  5.13 B).  In 
contrast, negative immunoreactivity was consistently evident in all non-seeded 
scaffolds (Figure  5.13 C).  Also, the isotype control staining was negative 
(Figure  5.13 D). 
  
  
Figure ‎5.13: Representative images of recellularised rat scaffolds labelled with ALP 
antigen and viewed under the light microscope. (A) Negative expression to ALP seen at 
7 days culture, (B) ALP positive cells weakly expressed at 14 days culture, (C) Non-seeded 
scaffold with negative expression and (D) Isotype controls with negative expression.  ALP 
positive cells stained brown (black arrow), unstained DPSCs (white arrow) and ECM stained 
purple.  Scale bars are at 20 µm.  
A B 
C D 
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5.4.3.2.4 Vimentin: 
Images of recellularised and non-seeded rat scaffolds labelled with 
anti-vimentin antibodies are shown in Figure  5.14.  The seeded DPSCs were 
stained brown, indicating a strong positive immunoreactivity to vimentin 
antigens.  Vimentin positive cells were scattered throughout the scaffold 
cultured for 7 and 14 days (Figure  5.14 A and B).  In contrast, negative 
immunoreactivity was consistently evident in all the non-seeded scaffolds 
(Figure  5.14 C).  Also, the isotype control staining was negative (Figure  5.14 D). 
  
  
Figure ‎5.14: Representative images of recellularised rat scaffolds labelled with vimentin 
antigen and viewed under the light microscope. Vimentin positive cells seen following 
(A) 7 and (B) 14 days culture, (C) Non-seeded scaffolds with negative expression and 
(D) Isotype controls with negative expression.  Vimentin positive cells stained brown (black 
arrow) and ECM stained purple.  Scale bars are at 20 µm.  
A B 
C D 
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5.4.3.2.5 Nestin: 
Images of recellularised and non-seeded rat scaffolds labelled with anti-nestin 
antibodies are shown in Figure  5.15.  The seeded DPSCs were stained brown, 
indicating a positive immunoreactivity to nestin antigens.  Nestin positive cells 
were evident in the majority of cells scattered throughout the scaffold cultured 
for 7 and 14 days (Figure  5.15 A and B).  In contrast, negative immunoreactivity 
was consistently evident in all non-seeded rat scaffolds (Figure  5.15 C).  Also, 
the isotype control staining was negative (Figure  5.15 D). 
  
  
Figure ‎5.15: Representative images of recellularised rat scaffolds labelled with nestin 
antigen and viewed under the light microscope. Nestin positive cells seen following (A) 7 
and (B) 14 days culture, (C) Non-seeded scaffolds with negative expression and (D) Isotype 
controls with negative expression.  Nestin positive cells stained brown (black arrow) and ECM 
stained purple.  Scale bars are at 20 µm. 
 
A B 
C D 
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5.4.3.2.6 Alpha-SMA: 
Images of recellularised and non-seeded rat scaffolds labelled with anti-α-SMA 
antibodies are shown in Figure  5.16.  At 7 days, the seeded DPSCs were not 
stained brown, indicating a negative immunoreactivity to α-SMA antigens 
(Figure  5.16 A).  Following 14 days culture, however, some α-SMA positive 
cells, stained brown, were observed within the scaffold (Figure  5.16 B).  A 
negative immunoreactivity was consistently evident in all non-seeded scaffolds 
(Figure  5.16 C).  Also, the isotype control staining was negative (Figure  5.16 D). 
  
  
Figure ‎5.16: Representative images of recellularised rat scaffolds labelled‎ with‎ α-SMA 
antigen and viewed under the light microscope. (A) Negative expression to α-SMA seen at 7 
days, (B) α-SMA positive cells seen at 14 days culture, (C) Non-seeded scaffolds with negative 
expression and (D) Isotype controls with negative expression. α-SMA positive cells stained 
brown (black arrow), unstained DPSCs (white arrow) and ECM stained purple. Scale bars are at 
20 µm. 
A B 
C D 
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5.4.3.2.7 VEGF-A and VEGFR-2: 
Images of recellularised and non-seeded rat scaffolds labelled with 
anti-VEGF-A and anti-VEGFR-2 antibodies are shown in Figure  5.17 and 
Figure  5.18, respectively.  The seeded DPSCs were stained brown, indicating a 
positive immunoreactivity to VEGF-A and VEGFR-2 antigens.  VEGF-A and 
VEGFR-2 positive cells were evident in the majority of cells, cell body and 
process, scattered throughout the scaffold cultured for 7 and 14 days 
(Figure  5.17 A, B and Figure  5.18 A, B).  In contrast, negative immunoreactivity 
was consistently evident in all non-seeded scaffolds (Figure  5.17 C and 
Figure  5.18 C).  Also, the isotype control staining was negative (Figure  5.17 D 
and Figure  5.18 D). 
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Figure ‎5.17: Representative images of recellularised rat scaffolds labelled with VEGF-A 
antigen and viewed under the light microscope. VEGF-A positive cells seen following (A) 7 
and (B) 14 days culture, (C) Non-seeded scaffolds with negative expression, (D) Isotype 
controls with negative expression.  VEGF-A positive cells stained brown (black arrow) and ECM 
stained purple.  Scale bars are at 20 µm. 
 
A B 
C D 
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Figure ‎5.18: Representative images of recellularised rat scaffolds labelled with VEGFR-2 
antigen and viewed under the light microscope. VEGFR-2 positive cells seen following (A)  7 
and (B)  14 days culture, (C) Non-seeded scaffolds with negative expression, (D) Isotype 
controls with negative expression.  VEGFR-2 positive cells stained brown (black arrow), 
unstained DPSCs (white arrow) and ECM stained purple. Scale bars are at 20 µm. 
 
A B 
C D 
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5.5 Discussion: 
Results of previous chapters described the development of a decellularised pulp 
scaffold derived from both rat and human dental pulp tissues.  The use of a mild 
decellularisation protocol that can produce a biocompatible ECM scaffold able 
to support cell attachment and proliferation is desirable.  To achieve tissue 
decellularisation, low concentration detergents are incorporated within the 
modified protocol to achieve efficient cellular removal. 
Sodium dodecyl sulphate (SDS), an ionic detergent, is widely used within 
various decellularisation protocols for efficient cellular and nuclear membrane 
solubilisation (Gilbert et al., 2006; Crapo et al., 2011).  Despite efficient cellular 
removal, concerns regarding residual SDS toxicity and tissue damage are 
reported when using concentrations at or above 1 % (w/v) SDS (Bodnar et al., 
1986; Courtman et al., 1994).  Indeed, residual detergents that remain within 
the scaffold following decellularisation could be cytotoxic and ultimately inhibit 
scaffold function and recellularisation (Rieder et al., 2004). 
No cytotoxicity was apparent following the use of 0.03 % (w/v) SDS for 
decellularisation of rat and human pulp tissues.  Contact cytotoxicity results 
indicated a non-toxic tissue with cell growth surrounding and in direct contact 
with the decellularised tissues.  Extract cytotoxicity assays also found no 
reduction in cellular viability following incubation in decellularised tissue extracts 
in comparison to the negative controls.  These results are in line with other 
biocompatible studies including decellularised human pericardial matrix 
(Mirsadraee et al., 2006), human amniotic membrane (Wilshaw et al., 2008), 
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porcine medial meniscus (Stapleton et al., 2008), human arteries (Wilshaw et 
al., 2012), and porcine pulmonary valves (Luo et al., 2014).  The lack of tissue 
toxicity observed has been linked to the low concentration of SDS, the use of 
extensive washing cycles and mechanical agitation (Wilshaw et al., 2012).  
Indeed, extensive washing with agitation between decellularisation steps and at 
the end of treatment has been advocated by several authors to wash out 
residual chemicals and cellular remnants (Stapleton et al., 2008; Luo et al., 
2014). 
As the decellularised dental pulp revealed a biocompatible scaffold, it was 
deemed necessary to investigate if the decellularised dental pulp offers an 
appropriate environment to support the growth and differentiation of DPSCs.  
The Live/Dead® assay uses two compounds, calcein-AM and ethidium 
homodimer, that provide a distinguishing colour between live and dead cells.  
Calcein-AM is transported across a cell membrane, only entering live cells 
producing a bright green colour.  In contrast, ethidium homodimer is membrane 
impermeable, only entering dead cells and binds to nucleic acid due to 
damaged cell membrane producing a bright red colour.  Live/Dead® staining of 
the pulp constructs showed that most areas of the decellularised pulp scaffolds 
were populated with viable cells exhibiting elongated spindle morphology.  Dead 
cells, small round morphology, were present in low numbers within the scaffold. 
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Notably in this work, the recellularised rat and human scaffolds (SDS-treated 
pulp tissue) were able to support DPSCs viability and attachment following 
14 days culture in vitro.  This result is in agreement with several other studies 
demonstrating cell attachment and proliferation on SDS-treated decellularised 
scaffolds (Wilshaw et al., 2008; Song et al., 2017). 
Furthermore, H&E stained serial sections of the recellularised rat scaffolds 
revealed that DPSCs were attached to the outer surface and migrated within the 
scaffold.  As time elapsed, a decrease in the overall size of the seeded 
scaffolds was apparent, changing from original tubular shape observed at day 7 
to a circular shape at day 14.  Contraction of a pulp cell-seeded scaffold has 
been documented as early as mid-90s when Mooney et al. (1996) utilised 
cultured human fibroblast cells seeded on a synthetic polyglycolic acid matrix 
(Mooney et al., 1996).  A marked contraction of a collagen-glycosaminoglycan 
ECM seeded with DPSCs was also reported (Brock et al., 2002).  This matrix 
contraction was reported to be linked to the expression of α-SMA positive dental 
pulp cells and their ability to contract a collagen based matrix (Brock et al., 
2002), which was linked with myofibroblasts contractility activity (Yoshiba et al., 
2012).  In the light of the above reported studies, the expression of α-SMA by 
DPSCs cultured on rat decellularised dental pulp scaffolds demonstrated herein 
this work, more likely, contributed to the contraction of the scaffold.  Further 
work is needed to shed light on this observation and its long term effect on pulp 
tissue engineering. 
 173 
 
The differentiation of DPSCs was characterised based on the expression of 
odontoblastic markers, cytoskeleton proteins, and growth factors.  In this work, 
immunohistochemical labelling of recellularised rat scaffolds revealed high 
differentiation ability in standard culture media.  DPSCs seeded within the 
decellularised scaffolds expressed several putative markers of odontoblastic 
differentiation including DSPP, DMP-1, and ALP.  These markers, although 
non-specific, are commonly used by several researchers to identify cell 
differentiation towards odontoblastic lineage (Cordeiro et al., 2008; Prescott et 
al., 2008; Huang et al., 2010; Rosa et al., 2013).  The present study 
observations revealed ALP positive cells, weakly stained, by day 14 and a 
negative expression at day 7.  Negative ALP expression has been linked to the 
developmental stage of odontoblasts’ or to the ambiguous location of the 
enzyme (Yoshiki and Kurahashi, 1971). 
Furthermore, cytoskeleton proteins, vimentin and nestin positive cells were 
strongly expressed following recellularisation.  Although vimentin is not 
considered as a pulp tissue specific protein, it has been suggested as a dental 
pulp quality standard protein for characterisation of pulp regeneration 
(Murakami et al., 2012).  Vimentin is expressed by neuronal precursor cells and 
has been linked to neurogenesis (neuronal differentiation) (Yabe et al., 2003).  
In a study by Authur et al. (2008) DPSCs expressed nestin following incubation 
in specific neuronal inductive medium.  They further concluded, that exposure of 
DPSCs to the correct environment cues was crucial for their ultimate 
differentiation into active neurons (Arthur et al., 2008). 
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Growth factors are synthesised by cells and, when binding occurs to their 
specific receptors, consequently guide cell behaviour (Matsushita et al., 2000; 
Grando Mattuella et al., 2007).  Vascular endothelium growth factor and its 
receptor are known to be potent regulators of angiogenesis within the dental 
pulp tissue, which subsequently leads to sprouting of blood vessels (Ferrara, 
2004; Grando Mattuella et al., 2007; Saghiri et al., 2015).  Importantly, the 
development of a vascularised pulp construct is required for the maintenance of 
a vital engineered tissue (Cordeiro et al., 2008).  In this work, a positive cellular 
immunoreactivity to VEGF-A and VEGFR-2 antigens was evident following 
recellularisation. 
In summary, this chapter described the development of a non-cytotoxic scaffold 
that is able to support human DPSCs viability and attachment following in vitro 
culture.  Although the potential of the scaffold to support DPSCs growth and 
differentiation in this work is based on qualitative analysis, it was clearly evident 
that the seeded DPSCs co-expressed several genes following incubation in 
standard cell culture medium with no added specific inductive reagents. 
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  Chapter 6
General discussion, future work, and conclusions 
6.1 General discussion: 
The dental pulp is a specialised loose connective tissue surrounded by a hard 
dentine structure.  The function of a vital dental pulp contributes to tooth 
function, vitality, sensibility, and nutrition.  Dental pulp also offers protection with 
the ability to respond to injury through repair or regeneration (Yu and Abbott, 
2007; Pashley et al., 2008; Kumar, 2014).  Loss of vitality (necrosis) of the 
dental pulp halts normal tooth development in young patients with incomplete 
root formation (immature teeth).  Clinically these teeth suffer from a reduced 
crown to root ratio and thin dentinal walls, hence highly liable to fracture (Cvek, 
1992).  Despite improved clinical management of non-vital immature permanent 
teeth throughout the years, the long term prognosis remains compromised.  
Unfortunately, the gold standard MTA apical plug treatment does not contribute 
to any further root development nor does it restore the pulp tissue function 
(Torabinejad and Abu-Tahun, 2010; Diogenes et al., 2016). 
More recently, the use of regenerative endodontic procedures for the treatment 
of non-vital immature permanent teeth has increased.  The main fundamental 
step of these procedures is the cell influx within the canal following evoked 
periapical bleeding.  Indeed, the preapical area contains stem cells of a high 
regenerative ability (Sonoyama et al., 2006; Sonoyama et al., 2008; Lovelace et 
al., 2011).  Despite the available stem cells, regenerative endodontic 
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procedures in their current format have been associated with unpredictable 
results and non-specific tissue formation (Sloan and Smith, 2007; Wang et al., 
2010b; Shimizu et al., 2013; Nosrat et al., 2014; European Society of 
Endodontology, 2016).  The main reason, thought to be, behind the formation of 
bone- and cementum-like tissue is the non-specific surrounding environment 
caused by the formed blood clot acting as a temporary scaffold.  In line with the 
above, it is well known that cell growth and differentiation is strongly influenced 
by the surrounding microenvironment (Martinez et al., 2000; Nakashima et al., 
2013). 
Therefore, to address these limitations, researchers have focused on combining 
the principles of tissue engineering within the clinical practice of regenerative 
endodontics.  Of these principles, scaffold development is subject to intense 
research.  A recent systematic review highlighted a large heterogeneity of 
results on several tested dental scaffold materials (Conde et al., 2015; Tong et 
al., 2017), with the need to develop a new scaffold material with close 
resemblance to the natural pulp matrix (Dissanayaka et al., 2014; Conde et al., 
2015).  More recently, the use of biological scaffolds composed of an acellular 
ECM derived through tissue decellularisation is intensively researched in 
regenerative medicine (Gilbert et al., 2006; Crapo et al., 2011; Song and Ott, 
2011).  Ideally, the produced decellularised scaffold is composed of natural 
ECM components with preserved three-dimensional tissue architecture 
(Badylak et al., 2009; Wilshaw et al., 2012).  The ECM is regarded as a vital 
component of all tissues and, possibly, the ideal scaffold for tissue regeneration 
(Badylak, 2002; Badylak, 2007; Ma, 2008).  Therefore, the concept of a 
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decellularised pulp tissue scaffold, with preserved structural components, is an 
attractive alternative material that might enhance the clinical outcome (Nazzal 
and Duggal, 2017).  The overall aim of this research was to assess the 
feasibility of decellularising rat and human dental pulp tissues using a mild 
decellularisation method to produce a biocompatible acellular ECM scaffold 
which retains the structural and biochemical components of native dental pulp. 
In this work, decellularisation of rat and human pulp tissues for future scaffold 
development in regenerative endodontics was investigated.  Rat pulp tissues 
were used for proof of concept prior to the assessment of human pulp tissues 
due mainly to the limited availability of extracted sound human permanent teeth. 
The use of laboratory rats is inevitable part of biomedical research applications, 
with over 80 % of published studies performed on rodents (Sengupta, 2013). 
The laboratory rats are considered to be particularly useful in: cardiovascular 
research, experimental oncology, immunology, toxicology and dental research 
(Sengupta, 2013).  Indeed, multiple researchers studying the pulp tissue have 
been performed on rat incisors and molars.  These studies include, but not 
limited to, pulp tissue response following pulp capping  (Hu et al., 1998; 
Lovschall et al., 2001), bleaching application (Cintra et al., 2013), chronic 
exposure to sodium fluoride (Centeno et al., 2015) and to evaluate treatment 
options in necrotic immature teeth (Scarparo et al., 2011).  Rat pulp tissues 
share similar histological structures to human dental pulp tissue and its 
structural composition has been widely studied (Linde, 1973; Cournil et al., 
1979; van Amerongen et al., 1983).  The use of rat tissue also allows for future 
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ex vivo and in vivo animal transplantation work to be conducted on the same 
species, hence reducing variables and cross-species reactions. 
Decellularisation within the dental field has recently been attempted, with most 
studies published during the course of this work.  These studies included 
decellularisation of porcine tooth buds (Traphagen et al., 2012), miniature swine 
pulp tissues (Chen et al., 2015) and human tooth slices (Song et al., 2017) 
using various decellularisation protocols.  Although, in general terms, the above 
decellularisation protocols varied, the use of sodium dodecyl sulphate (SDS) 
and Triton X-100 as a detergent step was a common step in these protocols, 
however, with different concentrations, number of cycles, temperature, and 
duration of exposure. 
Chen et al. (2015) developed an acellular matrix with preservation of native pulp 
shape using 1 % (w/v) SDS and 1 % (w/v) Triton X-100.  In contrast, Song et al. 
(2017) reported incomplete decellularisation following one cycle of 1 % (w/v) 
SDS and one cycle of 1 % (w/v) Triton X-100.  These authors achieved 
complete decellularisation of the pulp tissue within tooth slices through 
increasing the number of SDS cycles to three cycles. 
Despite the above methods resulting in complete decellularisation of the dental 
tissues, harsh decellularisation protocols (mainly utilising chemicals of high 
concentration, multiple cycles, and long exposure duration) are more likely to 
alter the ECM.  Consequently, this may negatively affect the ECM properties, 
cellular activity and long term outcome.  SDS, an ionic detergent, at a 
concentration of 1 % (w/v), has been found to cause structural damage to 
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treated porcine valves (Bodnar et al., 1986).  Gratzer et al. (2006) also reported 
alteration to matrix structure and reduced GAGs content following use of 1 % 
SDS to decellularise bone–anterior cruciate ligament.  Furthermore, the use of 
Triton X-100, a non-ionic detergent, was linked to major loss of GAGs content in 
porcine aortic heart valves (Liao et al., 2008).  Therefore, a low concentration 
detergent based decellularisation protocol utilising multiple gentle steps is of 
clinical interest. 
The protocol used in this work was previously described by Wilshaw et al. 
(2006) and involved cell membrane lysis using hypotonic Tris buffer, 
solubilisation of cytoplasmic and nuclear components using a single detergent 
cycle of 0.03 % (w/v) SDS in a hypotonic buffer, followed by removal of cellular 
material using a nuclease treatment.  Protease inhibitors were added to various 
steps of the protocol, to assist matrix preservation.  Several washing steps with 
agitation were also performed to ensure sufficient removal of residual cellular 
material and reagents used. The choice of using this protocol was, therefore, 
based on the lower concentrations of SDS used with no incorporation of Triton 
X-100.  These authors were able to successfully decellularise human amniotic 
membrane (Wilshaw et al., 2006; Wilshaw et al., 2008).  Histologically the 
amniotic membrane consists of a single epithelial layer and a thick basement 
membrane.  In similarity with the pulp matrix, the ECM of the amniotic basement 
membrane is composed predominantly of collagen fibre bundles (types I and III) 
and non-collagen proteoglycans and glycoproteins, including fibronectin and 
laminin (Parry and Strauss, 1998; Niknejad et al., 2008).  The initial work of the 
present study in developing this protocol for use in decellularisation of human 
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dental pulp tissues showed incomplete decellularisation of the pulp tissue.  H&E 
staining revealed an acellular matrix, however, residual cellular materials were 
detected using more sensitive and specific staining methods, DAPI staining.  
Therefore to enhance tissue decellularisation without the addition of reagents or 
increasing exposure time/temperature (Burk et al., 2014; Fu et al., 2014; Keane 
et al., 2015), freeze-thaw cycles were incorporated at the start of treatment 
(experiment 2).  The temperature change, following freeze-thaw, leads to the 
formation of ice crystals opening up the structural matrix, consequently 
enhances tissue permeability and the diffusion of decellularisation solutions 
(Gilbert et al., 2006; Crapo et al., 2011; Wilshaw et al., 2012).  In line with the 
above, several decellularisation protocols that utilise freeze-thaw cycles and 
detergents have been successfully performed on various tissues including 
medial meniscus (Stapleton et al., 2008), femoral arteries (Wilshaw et al., 
2012), and pulmonary valves (Luo et al., 2014). 
Following the incorporation of freeze-thaw cycles into the Wilshaw protocol, 
results of experiment 2 showed complete decellularisation of both rat and 
human dental pulp tissues.  H&E staining revealed complete decellularisation 
with architectural preservation of the pulpal ECM zones, including 
sub-odontoblastic and pulp core zone with retained vascular channels.  
Furthermore, no nuclear material was visible following nuclear specific DAPI 
staining.  Additionally, further evaluation of the residual DNA content within the 
decellularised scaffold is of utmost importance and a commonly used 
assessment method by several researchers (Mirsadraee et al., 2006; Kheir et 
al., 2011; Traphagen et al., 2012; Wilshaw et al., 2012; Yoeruek et al., 2012; 
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Song et al., 2017).  Notably, residual DNA material within a decellularised 
matrix could consequently elicit a host inflammatory response and inhibit future 
tissue remodelling (Brown et al., 2009; Keane et al., 2015).  In this work, DNA 
quantification analysis confirmed the qualitative results and revealed significant 
reduction, greater than 98 %, in DNA content levels relative to the control 
tissues.  These results are in line with several previous studies which reported a 
reduction of greater than 96 % DNA content following tissue decellularisation 
(Wilshaw et al., 2012; Luo et al., 2014; Song et al., 2017). 
The residual DNA content was approximately 23.00 ± 1.430 ng.mg-1 in rat and 
19.56 ± 1.280 ng.mg-1 in human tissues.  These results are well below the 
benchmark criteria for the maximum amount (50 ng.mg-1) of DNA content in 
sufficiently decellularised tissues (Crapo et al., 2011; Kawecki et al., 2017), 
however, there was no given evidence behind the proposed criteria and the 
selected maximum threshold.  Furthermore, the United States Federal Drug 
Administration, to date, does not provide any regulatory limits to the amount of 
DNA material present in biological scaffolds (Gilbert et al., 2009).  To further 
understand the DNA content of biological scaffolds, Gilbert et al. (2009) 
analysed the DNA content of several commercially available biological scaffolds 
which were reported to be clinically successful. Interesting, their results 
indicated trace amounts of DNA material in most tested scaffolds.  However, 
they further explained that the presence of small amounts of residual DNA 
material was unlikely to cause any unwanted pro-inflammatory host response 
(Gilbert et al., 2009). 
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Major histocompatibility complex class II molecules evaluation of the 
decellularised scaffold was also considered necessary.  These molecules are 
expressed by immune cells (dendritic cells, monocytes and macrophages) that 
are commonly present throughout the pulp tissue (Jontell et al., 1987; Ohshima 
et al., 1999).  This group of cells serve as antigen-presenting cells and 
participate in initial tissue recognition response (Jontell et al., 1987; Ohshima et 
al., 1999).  In this work, immunohistochemical labelling against major 
histocompatibility complex class II molecules revealed negative expression 
following decellularisation. 
Preservation of the ECM structure and composition was essential in the 
development of the decellularised pulp tissue scaffold.  Histologically, the pulp 
matrix is composed of a complex mixture of collagen and non-collagenous 
proteins that contribute to several tissue functions.  Collagen fibres, the main 
structural component, contribute to the development and maintenance of the 
pulp matrix (Hillmann and Geurtsen, 1997).  GAG molecules provide crucial 
functions in regulating metabolism, water movement, and attachment sites for 
growth factors and cytokines (Linde, 1973; Badylak, 2002).  Fibronectin 
adhesive proteins are known to mediate several cellular and matrix interactions 
(Hynes, 1985), including the attachments of cellular and various extracellular 
components (Linde et al., 1982).  Laminin proteins are also implicated in tissue 
development and regeneration (Aumailley et al., 2005; Fried et al., 2005), 
odontoblast differentiation (Yuasa et al., 2004), and migration of dental pulp 
stem cells (Howard et al., 2010). 
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Preservation of the collagen structure was assessed qualitatively using 
Picrosirius red staining method, SEM imaging, and specific immunolabelling 
detection.  Picrosirius red staining viewed under the polarised microscope 
indicated collagen fibre preservation following decellularisation.  Collagen fibre 
structure, tissue porosity, and interfibrillar space preservation were also 
confirmed through the use of SEM imaging.  Specific antibody labelling against 
collagen type I and III fibres also revealed fibre preservation, albeit expressing a 
slightly weak stain in comparison to the native tissues.  In contrast, Chen et al. 
(2015) reported a significant decline in both collagen type I and III fibres 
following decellularisation of miniature swine dental pulps (Chen et al., 2015).  
The results of the above study could be a consequence of high SDS 
concentration used and/or the additional use of Triton X-100.  Indeed, structural 
disruption of the ECM has been reported following the use of Triton X-100 
(Gilbert et al., 2006; Crapo et al., 2011), and/or SDS concentrations of 1 % (w/v) 
SDS (Bodnar et al., 1986; Gratzer et al., 2006). 
Additional characterisation of the pulp tissue matrix composition (non-collagen 
proteins) was assessed qualitatively using specific histological staining methods 
and immunolabelling detection.  Alcian blue staining method is widely used as a 
specific stain to localise acidic polysaccharides present within the tissue matrix.  
Results of this work indicated preservation of GAG molecules following 
decellularisation with no visible difference in staining pattern, in comparison to 
the control tissues. 
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Antibody labelling against fibronectin and laminin adhesive proteins indicated 
preservation following decellularisation, albeit at a lower staining intensity.  
Preservation of fibronectin and laminin was also reported by Chen et al. (2015) 
and Traphagen et al. (2012) following decellularisation of miniature swine pulps 
and porcine tooth buds, respectively.  In contrast, reduced expression of 
fibronectin was reported following the use of three cycles of 1 % (w/v) SDS and 
1 % (w/v) Triton X-100 to decellularise tooth root slices (Song et al., 2017). 
Subsequently, following efficient decellularisation it was necessary to assess 
the scaffolds biocompatibility and ability to support cell growth and 
differentiation.  Scaffold disinfection or sterilisation is also essential prior to cell 
seeding.  Incubation in antibiotic (Chen et al., 2015) or peracetic acid (Hodde et 
al., 2007) solutions are reported as effective initial disinfection steps.  Tissue 
sterilisation through the use of antibiotic solutions had been reported as a 
successful sterilisation method by Chen et al. (2015) in the decellularisation of 
swine dental pulps using a combination of 100 U.mL-1 penicillin and 
100 mg.mL-1 streptomycin over 48 hours.  However, residues of antibiotics that 
remain in the decellularised scaffold present a potential regulatory hurdle for 
future clinical approval.  These produced scaffolds would be classified as a drug 
rather than a clinical biological scaffold (Gilbert et al., 2006; Crapo et al., 2011). 
Peracetic acid is known to rapidly penetrate microorganisms causing the 
release of oxygens and free radicals.  This oxidation process leads to the 
inactivation and destruction of a wide range microorganisms (Pruss et al., 
1999).  Furthermore, it is regarded as a successful disinfection agent for 
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collagen-based biological scaffolds (Hodde and Hiles, 2002; Hodde et al., 2007) 
and in line with several decellularisation protocols of various tissues (Wilshaw et 
al., 2006; Stapleton et al., 2008; Wilshaw et al., 2008; Kheir et al., 2011; Luo et 
al., 2014).  Therefore, in this work, peracetic acid was used in the final step of 
the decellularisation process. 
The biocompatibility of produced decellularised rat and human scaffolds were 
assessed using in vitro cytotoxicity assays.  Although, the appropriate cell type 
for in vitro cytotoxicity assays remains debatable (Murray et al., 2000; Saw et 
al., 2005), the use of established cell lines (L-929 murine fibroblasts) are 
commonly used in dental research due to their relatively standard growth, 
morphology characteristics, and high reproducibility (Hensten-Pettersen, 1988; 
Torabinejad et al., 1995b; Thonemann et al., 2002; Saw et al., 2005; Ozdemir et 
al., 2009).  Established cell lines are also recommended by the International 
Organisation for Standardisation and the British Standard Institute for 
cytotoxicity testing of medical devices (International Organisation for 
Standardisation, 2008; British Standard Institute, 2009).  Therefore, in this work, 
in vitro contact and extract cytotoxicity assessment of the produced scaffolds 
were assessed using L-929 cell lines.  Furthermore, to closely resemble the 
clinical environment, dental pulp stem cells (DPSCs) were chosen for cell 
viability assays and recellularisation of the decellularised scaffolds. 
Both contact and extract cytotoxicity assays using L-929 fibroblasts 
demonstrated a non-cytotoxic material with similar rates of cell growth and 
proliferation in comparison to the relevant controls.  Cell viability assay 
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(Live/Dead® staining) also indicated that both rat and human decellularised 
scaffolds supported DPSCs viability and attachment following 14 days culture.  
Furthermore, the ability of the produced scaffold to support cell differentiation 
was also determined.  Immunohistochemical labelling of recellularised rat 
scaffolds revealed high differentiation ability.  DPSCs survived and expressed 
cytoskeleton genes, growth factors, and markers of odontoblastic differentiation.  
In this work, the recellularised scaffolds expressed dentine sialophosphoprotein 
(DSPP), dentine matrix protein-1 (DMP-1), and alkaline phosphatase (ALP) 
antigens, markers of odontoblastic differentiation, as early as 7 and 14 days in 
standard culture media.  In vivo studies by Cavalcanti et al. (2013) and Rosa et 
al. (2013) assessed the odontoblastic differentiation of stem cells on different 
potential scaffolds.  Their results indicated a positive expression of DSPP and 
DMP-1 markers at 21 days culture following the use of PuramatrixTM seeded 
with DPSCs placed in tooth slice model (Cavalcanti et al., 2013) and 
PuramatrixTM seeded with SHED placed in full length root canals (Rosa et al., 
2013).  Furthermore, human recombinant collagen seeded with SHED and 
placed in full length root canals resulted in a positive expression for DSPP at 14 
days culture, while DMP-1 expression was only evident following 28 days 
culture (Rosa et al., 2013).   
Notably in both above studies, neither seeded scaffolds were able to induce 
odontoblastic differentiation of stem cells without the surrounding dentine 
structure.  Decellularised pulp tooth slice model performed by Song et al. (2017) 
also demonstrated the ability of SCAP to survive and express odontoblastic 
markers, ALP and dentine sialoprotein, following 14 days culture.  Indeed, it has 
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been shown that environmental cues generated by the tooth slice model have a 
direct impact on DPSCs and SHED differentiation into odontoblastic cell 
lineages (Cordeiro et al., 2008; Demarco et al., 2010; Sakai et al., 2010).  In 
comparison, this work demonstrated the ability of DPSCs to express markers of 
odontoblastic differentiation solely within the decellularised ECM.  Therefore, it 
could be hypothesised, that placement of the decellularised ECM in contact with 
the surrounding dentine structure results in enhanced stem cell differentiation, 
matrix deposition, and ultimately engineering a pulp-dentine complex with close 
resemblance to the native tissue. 
Immunolabelling of cellular cytoskeleton proteins and growth factors, expressed 
within the recellularised scaffolds, was also performed, due to their crucial roles 
in future tissue regeneration.  Vimentin, a major intermediate filament protein, 
regulates several functions including cell signalling, adhesion, and migration 
(Ivaska et al., 2007).  Alpha-smooth muscle actin (α-SMA), a cytoskeletal 
protein, is positively expressed in various tissues during repair and regeneration 
(van Beurden et al., 2005), including the dental pulp tissue (Shi and Gronthos, 
2003; Yoshiba et al., 2012).  Alpha-SMA also regulates various cell-cell 
interactions, including cell proliferation and differentiation (Saunders and 
D’Amore, 1992).  In this work, immunohistochemical analysis revealed a 
positive cellular expression against vimentin and α-SMA within the recellularised 
rat scaffolds. 
Furthermore, successful pulp-dentine complex regeneration also depends on 
neurogenesis and angiogenesis.  Nestin, a neural progenitor marker, has been 
identified in DPSCs (Arthur et al., 2008).  Positive nestin expression in newly 
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differentiated and functioning odontoblast cells has been reported in several 
studies utilising both rodent and human teeth (Terling et al., 1995; Kuratate et 
al., 2008; Lee et al., 2012).  The formation of blood vessels aids transport of 
oxygen and nutrient and attracts prevascular stem cells to the regenerated site, 
thereby preventing tissue necrosis (Nakashima et al., 2009; Bronckaers et al., 
2013; Saghiri et al., 2015). 
Notably, several studies have highlighted the ability of DPSCs to induce 
angiogenesis and express proangiogenic factors including vascular endothelial 
growth factor (VEGF) (Matsushita et al., 2000; Nakashima et al., 2009; 
Bronckaers et al., 2013).  VEGF-A and vascular kinase-insert domain 
containing receptor (VEGFR-2) are potent regulators of angiogenesis within the 
dental pulp tissue (Ferrara, 2004; Grando Mattuella et al., 2007; Janebodin et 
al., 2013).  They aid the differentiation of DPSCs into endothelial-like cells, 
subsequently leading to sprouting of blood vessels (Grando Mattuella et al., 
2007; Saghiri et al., 2015).  Immunolabelling results of this work also revealed a 
positive cellular expression against nestin, VEGF-A, and VEGFR-2 antigens in 
standard culture media.  
Although results of the regenerative potential of the recellularised scaffolds are 
derived from qualitative analysis, immunohistochemical labelling, the absence 
of quantitative data is a limitation in the interpretation of results.  The need for 
quantitative techniques such as Enzyme-linked Immunosorbent Assay (ELISA), 
western blotting, and reverse-transcription/polymerase-chain-reaction (RT-PCR) 
are required for further validation of results. Scaffold implantation in 
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well-established ex vivo and in vivo clinical models are also necessary to further 
evaluate and understand the scaffold recellularisation and tissue regeneration 
ability within environments closely resembling the human body. 
 
6.2 Conclusions: 
The data presented in this thesis reports the results of a novel approach in 
decellularising rat and human dental pulp tissues using a mild single detergent 
based decellularisation protocol.  This data confirmed the feasibility of 
decellularising both rat and human pulp tissues while preserving dental pulp 
structural components and adhesive proteins.  Using this protocol, the 
decellularised scaffolds elicited no apparent cytotoxicity to cell growth and 
proliferation.  The recellularised scaffolds also demonstrated the ability to 
support dental pulp stem cells viability and differentiation, with a positive cellular 
expression against odontoblastic markers, cytoskeleton proteins, and growth 
factors.  Overall, the results of the work presented in this thesis lay the 
foundation for developing decellularised dental pulp tissue scaffold for use in 
regenerative endodontics. 
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6.3 Recommendations for future work and clinical translation:  
For future use of decellularised scaffolds in regenerative endodontics, the 
following aspects should be addressed in developing this scaffold further:  
i.  Scaffold structure: The work presented in this thesis involved qualitative 
assessment of the scaffolds ECM using histological and 
immunohistochemical methods.  Additional quantification assessment of 
the presented ECM using a range of commercially available biochemical 
assays including: hydroxyproline, denatured collagen, and 
glycosaminoglycans assays are required.  Further structural assessment 
including pore size measurements and the investigation of the rheology 
(viscosity) properties can provide important information.  According to 
Rosa et al. (2013) scaffold viscosity properties may directly impact cell 
migration and the diffusion of signalling molecules, consequently 
affecting tissue regeneration. 
 
ii.  Stem cell source: The production of a laboratory made cell seeded 
scaffold is clinically attractive (cell transplantation approach) (Galler, 
2016).  Therefore the choice of stem cells is crucial if in vitro cell seeding 
is to be used.  Autologous stem cells are immunocompatible and the 
preferred choice for tissue engineering.  However, variability in the 
isolated cell properties exist which ultimately could affect a reproducible 
standardised clinical product (Sensebé et al., 2010; Wall et al., 2017). 
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Allogenic stem cells, on the other hand, are utilised with caution as they 
carry a risk of immunorejection (Wall et al., 2017).  Unfortunately, this 
approach is afflicted with excessive cost and regulatory hurdles that may 
hinder future clinical approval (Yuan et al., 2011; Galler et al., 2014; 
Galler, 2016). 
An alternative approach is cell homing, a cell-free approach (Hou et al., 
2004; Yuan et al., 2011; Galler et al., 2014; Galler, 2016).  Clinically, this 
involves placement of a cell free scaffold which relies on subsequent 
endogenous cells repopulating the scaffolds (Hou et al., 2004; Galler, 
2016).  Cellular migration within the canal space is trigged by inducing 
apical bleeding, as currently practiced during regenerative endodontic 
procedures. The biological acellular scaffold, in such a technique, is 
inserted into the root canal to provide a more controlled environment for 
cellular activity.  This approach has the advantage of reducing cost, as it 
eliminates laboratory handling of stem cells and therefore provides a less 
complicated pathway for regulatory approval and clinical translation 
(Yuan et al., 2011). 
 
iii. Optimal tissue source: Although a successful decellularised matrix was 
developed form the dental pulp tissues retrieved from human permanent 
teeth and rat incisors, limited availability of human permanent tissues 
and difficult retrieval of rat tissues require addressing in any future work. 
The use of pulp tissues obtained from exfoliated primary teeth is a 
possible approach, as these teeth naturally exfoliate.  An alternative 
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direction could involve the use of a larger animal source such as bovine 
or porcine dental pulp tissues.  The main advantages of such sources 
include better availability, simpler tissue retrieval techniques, larger 
tissues, and less ethical consideration as such animals are usually 
sacrificed for dietary requirements. The development of bovine, porcine, 
and human primary tooth scaffolds are currently being investigated by 
the Leeds research group. 
 
iv. Delivery methods: An intact porous scaffold or an injectable hydrogel are 
the main delivery methods and require further development.  The use of 
an intact porous scaffold that can be directly inserted into the root canal, 
replicating endodontic treatment with gutta-percha cones or MTA 
placement is a possible direction.  This method, if successful, offers a 
simple clinical pathway.  A second method of delivery, involves 
transforming the acellular scaffold into an injectable hydrogel.  The ability 
of the injectable material, in its initial liquid state, to closely adapt to the 
variable root canal shapes is an attractive property (Cavalcanti et al., 
2013).  It also offers clinicians an easy scaffold delivery method, 
especially in narrow and curved root canals (Demarco et al., 2011; Rosa 
et al., 2013). 
 
v. Scaffold sterilisation: The selection of the appropriate method to sterilise 
the final decellularised scaffolds without affecting its structural, 
mechanical and biological properties requires testing (Sun and Leung, 
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2008).  Aseptic production of a human acellular ECM may be acceptable 
for clinical use, in conjunction with routine medical history and serological 
screening.  The national screening criteria for donor suitability against 
Human Immunodeficiency Virus types 1 and 2, Hepatitis B, Hepatitis C, 
Syphilis and Human T-cell Lymphotropic Virus must be assessed.  In 
contrast, scaffolds derived from animal tissues must be sterilised.  
Terminal sterilisation methods include electron beam irradiation, ethylene 
oxide gas and gamma E-beam irradiation.  Incubation in acids has also 
been reported.  These methods have been tested individually or through 
a combined approach (hybrid) on several tissues/organs.  Changes in 
the mechanical properties of porcine urinary bladder were reported 
following use of either ethylene oxide, gamma irradiation or electron 
beam irradiation (Freytes et al., 2008).  The use of peracetic acid within 
an ethanol solution resulted in a non-cross linked viral free porcine small 
intestine scaffold (Hodde and Hiles, 2002).  Hybrid sterilisation methods 
using ethylene oxide gas combined with either peracetic acid or gamma 
irradiation resulted in efficient sterilisation of human-sized liver tissue 
(Kajbafzadeh et al., 2012).  The combined use of peracetic acid with 
ethylene oxide gas on porcine small intestine submucosa retained a 
bioactive scaffold that was able to support cellular activity (Hodde et al., 
2007).  
 
vi. Host immune response: The produced final product must undergo 
thorough immunological evaluation in vitro.  A major hurdle for tissue 
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transplantation of allogenic or xenogenic source is immune rejection 
(Galili, 2001; Wong and Griffiths, 2014).  This immune response of the 
transplanted tissues, if present, plays a pivotal role in the upcoming 
regeneration process (Daly et al., 2009; Wong and Griffiths, 2014).  
Previous attempts to overcome tissue antigenicity involved chemical 
fixation, mainly utilising cross-linking process, by masking the implanted 
tissue antigens (Okamura et al., 1980).  Unfortunately, chemical cross 
linking might negatively affect tissue function and biocompatibility (Manji 
et al., 2006; Williams, 2008).  More recently, tissue decellularisation has 
been advocated to eliminate the immune rejection, based on efficient 
removal of cellular material.  Indeed, scaffold acellularity has been 
regarded as an immunological measurement outcome and efficient 
assessment of the scaffold cellularity must be undertaken (Wong and 
Griffiths, 2014).  Furthermore, xenogenic hyperacute rejection is reported 
to be mediated by complement activation of antibodies against Alpha-1,3 
Galactose (α-gal) epitope (Galili, 2001; Daly et al., 2009).  The α-gal 
epitope has been found to be expressed in non-primate mammals and 
New World monkeys.  Exceptions include apes, humans and Old World 
monkeys which lack the presence of α-gal epitope and produce anti-Gal 
antibodies.  Upon exposure, the circulating anti-Gal antibodies in humans 
bind to α-gal epitope leading to a hyperacute rejection (Galili, 2001; Daly 
et al., 2009).  Therefore, assessing the complete removal of α-gal 
epitope from the xenogenic tissue is essential and can be assessed 
qualitatively through immunohistochemical labelling methods or 
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quantitatively using ELISA assay.  Indeed, the efficient removal of α-gal 
has been reported in several studies utilising animal tissues.  These 
results indicated no evidence of α-gal expression following 
decellularisation of porcine medial meniscus (Stapleton et al., 2008), 
porcine bone cartilage (Kheir et al., 2011) and porcine pulmonary valve 
(Luo et al., 2014).  
 
vii. Scaffold environment: To test the efficacy of the produced scaffold to 
regenerate and interact with the surrounding environment, ex vivo culture 
models have been introduced within this field (Sloan et al., 1998).  These 
ex vivo models aim to provide clinical relevant models that can be 
performed in a controlled laboratory setting.  These models take into 
account similar in vivo spatial organisation, thereby providing cells with a 
three-dimensional environment (Sloan et al., 2017).  The use of a tooth 
slice ex vivo culture model involves placement of a scaffold within 
prepared dentine disks of 1 – 2 mm thickness.  These dentine disks can 
be obtained from human or rodent teeth (Sloan et al., 2017).  The 
utilisation of ectopic root transplantation models has also been reported 
(Gotlieb et al., 2008; Huang et al., 2010).  This involves scaffold 
placement within empty full length root canal spaces.  The use of ectopic 
root transplantation models closely replicates the clinical environment 
and provides pivotal information regarding the shape and quality of the 
engineered pulp tissue (Gotlieb et al., 2008; Huang et al., 2010).  The 
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mandible slice ex vivo culture model could also be used for pulp tissue 
regeneration (Sloan et al., 2017).   
Following laboratory testing, the designed scaffolds should be tested 
using the gold standard in vivo studies using functional animal models 
and large animal studies.  If successful results are obtained from the 
above studies, the final step of this work would ultimately involve well 
controlled human clinical trials.  The scalability of a new treatment 
strategy from the laboratory bench to the chair side ideally should require 
early manufacturing considerations.  Protocol standardisation, reduced 
contamination risk, and in-process control are the minimal manufacturing 
demands that should be carefully addressed before using such scaffolds 
in human pulp regeneration (Wall et al., 2017). 
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Appendices 
Appendix (A): Tissue bank approval form for teeth collection 
and the use of dental pulp stem cells. 
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Appendix (B): Percentage of pulp tissue water content 
 
Pulp tissue wet 
weight 
Pulp tissue dry 
weight 
Percentage of water 
content 
13.15 mg 4.2 mg 68.06 % 
14.81 mg 4.05 mg 72.65 % 
12.85 mg 3.22 mg 74.94 % 
13.82 mg 4.9 mg 64.54 % 
11.82 mg 3.92 mg 66.83 % 
10.65 mg 3.15 mg 70.42 % 
10.50 mg 3.15 mg 69.01 % 
11.55 mg 3.66 mg 68.31 % 
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Appendix (C): National and international poster/oral 
presentations and awards achieved. 
Poster awards: 
Image A1: Matoug-Elwerfelli, Monty Duggal, El-Mostafa Raif, Stacey-Paul 
Wilshaw, Hani Nazzal (2017). A biocompatible acellular extracellular matrix 
scaffold for regenerative endodontics. Arabian Academy of Paediatric 
Dentistry (ArAcPD) Cairo congress. Prof Monty Duggal Trauma Award-first 
prize. 
Image A2: Manal Matoug-Elwerfelli, Hani Nazzal, Monty Duggal, Filomena 
Esteves, El-Mostafa Raif (2016). Decellularised dental pulp as a suitable 
scaffold for regenerative endodontic techniques. School Of Dentistry 
Research day, University of Leeds, UK. Awarded-first prize. 
Image A3: Manal Matoug-Elwerfelli, Hani Nazzal, Monty Duggal, Jennifer 
Graham, El-Mostafa Raif (2015). Decellularisation of dental pulp for use as a 
scaffold in regenerative endodontics. International Association of Paediatric 
Dentistry (IAPD), Glasgow congress. NuSmile Restorative Dentistry 
Research Award-first prize, combined oral and poster presentation. 
Presentation awards: 
Oral presentation: Manal Matoug-Elwerfelli, Hani Nazzal, Monty Duggal, 
Filomena Esteves, Mostafa El-Raif (2016). Decellularised dental pulp as a 
suitable scaffold for regenerative endodontic techniques. European 
Academy of Paediatric Dentistry (EAPD), Belgrade congress. Young 
Researcher of the Year Award-first prize  
Other presentations/posters:  
Oral presentation: Manal Matoug-Elwerfelli, El-Mostafa Raif, Hani Nazzal, 
Filomena Esteves, Monty Duggal (2015). Decellularisation of dental pulp for 
use as a scaffold in regenerative endodontics. School Of Dentistry Research 
day, University of Leeds, UK.  
Image A4: Manal Matoug-Elwerfelli, Hani Nazzal, Monty Duggal, Jennifer 
Graham, El-Mostafa Raif (2015). Developing an acellular dental pulp 
scaffold. LIMMs Symposium, University of Leeds, UK. 
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